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Resumen 
Mycobacterium tuberculosis es el agente causal de la tuberculosis (TB). Esta 
enfermedad ha acompañado a la raza humana a lo largo de su historia y hoy en día 
sigue siendo una de las enfermedades infecciosas que causa mayor número de 
muertes en el mundo. Aunque se han realizado grandes avances en la lucha contra 
esta enfermedad, sigue siendo un problema de salud mundial. 
En la actualidad, una de las familias de M. tuberculosis que más atención atrae en 
todo el mundo es la familia Beijing, debido a que muestran importantes características 
patogénicas. Diferentes estudios han indicado que un tercio de los casos de 
tuberculosis a nivel mundial son causados por cepas de M. tuberculosis pertenecientes 
a la familia Beijing, siendo ésta una de las familias de M. tuberculosis con mayores 
tasas de morbilidad y mortalidad. Su capacidad de infección, así como su capacidad 
para propagarse rápidamente, probablemente se deban a ventajas genéticas y a 
mecanismos de virulencia aún no identificados. Entre los mecanismos propuestos 
causantes de las diferencias de virulencia entre los fenotipos de las cepas de M. 
tuberculosis se encuentran inserciones de la secuencia IS6110, deleciones 
duplicaciones y reorganizaciones genéticas. Se ha demostrado que esta secuencia 
puede aumentar la expresión de genes adyacentes actuando como un promotor móvil 
localizado en su extremo 3’. El hecho de que las cepas de la familia Beijing tengan un 
mayor número de copias de IS6110 que otras familias, podría estar relacionado con 
las características especiales de virulencia y de transmisión de esta familia. La cepa 
de M. tuberculosis GC1237, perteneciente a la familia Beijing, ha demostrado una 
elevada capacidad de diseminación y transmisión dentro de una comunidad. 
Con el fin de comprender mejor algunos de los mecanismos de virulencia de las cepas 
Beijing y relacionarlos con la secuencia de inserción IS6110, se caracterizó el aislado 
clínico de M. tuberculosis GC1237. Se localizaron todas las copias de este elemento 
en el genoma de la cepa GC1237 y se realizó un análisis más detallado de una copia 
de IS6110 localizada a 31 nucleótidos del inicio del gen esencial Rv2179c y próxima al 
gen esencial aroG. Mediante el uso de varias técnicas se confirmó que esta copia de 
IS6110 está actuando como un promotor móvil de Rv2179c, tanto en cultivo líquido 
como en el interior del macrófago. A partir de estos resultados podemos sugerir que la 
sobre-expresión de este gen podría ser ventajosa para la cepa Beijing GC1237, al 
menos en ciertos entornos, como en el interior de las células infectadas. Además, esta 
localización resultó ser única de esta cepa lo que permitió el diseño de un test rápido 
para su detección. 
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Por otro lado, en anteriores investigaciones se estudió la actividad promotora de 
IS6110 en la copia de IS6110 localizada en la región promotora del gen phoP en M. 
bovis MBZ. Debido a la condición MDR esta cepa, este estudio se llevó a cabo 
mediante el uso de dos plásmidos recombinantes en el interior M. smegmatis mc2155, 
en cual se observó un incremento en la transcripción del gen phoP en la construcción 
que contenía la IS6110. Con el objetivo de profundizar en el estudio del efecto de esta 
copia de IS6110 sobre el gen phoP, se realizaron nuevas construcciones de plásmidos 
que contenían esta región y se introdujeron en M. tuberculosis. A continuación, se 
analizó la actividad promotora de IS6110 por varios métodos y en condiciones 
diferentes, tanto en cultivo líquido como en el interior de macrófagos. Los resultados 
obtenidos confirmaron que esta copia de IS6110 está actuando como secuencia 
promotora del gen phoP. Este hecho cobra gran importancia ya que el gen phoP 
codifica para un factor de transcripción que regula ~2% del genoma de M. tuberculosis 
y está implicado en virulencia.  
Por último, dado que las cepas de M. tuberculosis Beijing contienen un mayor número 
de copias de IS6110 lo que podría aportar alguna ventaja a este genotipo, se realizó 
una búsqueda de puntos de inserción de IS6110 en 61 aislados clínicos, entre ellos 17 
cepas Beijing y 44 cepas no-Beijing, los cuales presentaban un alto número de copias 
de este elemento. La ubicación de las copias de esta secuencia permitió la detección 
de los puntos de mayor frecuencia de inserción de IS6110, o “hot-spots”, en las cepas 
Beijing. Estas localizaciones podrían ser la clave de algunas ventajas del genotipo 
Beijing y su estudio debe de ser tenido en cuenta en una futura investigación. 
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Summary 
Mycobacterium tuberculosis is the aetiological agent of tuberculosis (TB). This disease 
has walked together with human beings along our history, and nowadays is still one of 
the infectious diseases that causes more deaths in the world. Although in the last 
century great advances have been done in our fight against TB, this disease is still a 
worldwide health problem. 
One of the families of M. tuberculosis currently attracting considerable worldwide 
attention is the Beijing family as they display important pathogenic features. Different 
studies have indicated that one-third of global TB cases are caused by this family 
assigning this lineage to one of the most successful mycobacterial families in terms of 
morbidity and mortality. The capacity of infection and the ability of M. tuberculosis 
Beijing strains to spread rapidly probably result from genetic advantages and 
unidentified mechanisms of virulence not yet thoroughly investigated. Among the 
mechanisms proposed to be responsible for differences in the virulence phenotypes of 
M. tuberculosis strains we find IS6110 insertions, genetic reorganizations, genetic 
duplications and deletions, which have strong influence on fitness. It has been 
demonstrated that IS6110 may increase the expression of neighboring genes through 
an outward-directed promoter in its 3’ end. The fact that the Beijing lineage contains a 
larger number of IS6110 copies than other lineages could be related with the special 
characteristics of this family in terms of virulence and capacity for rapid dissemination. 
The M. tuberculosis GC1237 strain, which belongs to Beijing family, has demonstrated 
an enhanced capacity to spread and transmit within a community.  
In order to better understand some mechanisms of virulence of Beijing strains and 
related them with the insertion sequence IS6110, we have characterized the clinical 
isolate M. tuberculosis GC1237 strain locating all the copies of this element. We 
focused in the characterization of one copy located 31 bp upstream of the essential 
gene Rv2179c and close to the essential gene aroG and, by several methods, we 
confirmed that this copy of IS6110 is acting as a mobile promoter both in broth and 
inside macrophages. From our results we can hypothesize that the over-expression of 
this gene could be advantageous for GC1237 at least in certain environments such as 
infecting macrophages. In addition, this location was unique of this strain allowing us 
the design of a rapid test for its detection. 
On the other hand, in previous investigations, the promoter activity of IS6110 was 
studied in the copy of IS6110 located in the promoter region of phoP gene of M. bovis 
MBZ. Due to the MDR condition of this strain, this study was carried out by using two 
recombinant plasmids inside M. smegmatis mc2155 obtaining an increment in the 
Mª Henar Alonso Ezcurra 
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transcription of phoP gene in the construction containing IS6110. To depth in the study 
of the promoter activity of this IS6110 in phoP gene, new plasmid constructions 
containing this region were made and introduced in M. tuberculosis. After that, the 
promoter activity was analyzed by several methods and in different conditions both in 
broth and inside macrophages. Our results confirmed that this copy of IS6110 is acting 
as a promoter of phoP gene. This fact could be important as this gene codifies for a 
transcription factor that regulates ~2% of M. tuberculosis genome and is involved in 
virulence.  
Finally, as M. tuberculosis Beijing contain a larger number of IS6110 copies and these 
could provide some advantages to this genotype, a scrutiny of points of insertion of 
IS6110 was carried out in 61 clinical isolates with high number of copies of this 
element, 17 Beijing and 44 non-Beijing strains. The location of the copies of this 
sequence allowed us to detect new hot-spots for the insertion of IS6110 specific of 
Beijing strains. These locations could be the key of some advantages of the Beijing 
genotype and its study should be taken into account in further research. 
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I.Tuberculosis, an old disease 
Tuberculosis (TB) is a common and often deadly infectious disease caused by 
Mycobacterium tuberculosis. Tuberculosis usually attacks the lungs (as pulmonary TB) 
but can also affect almost any organ system (extrapulmonary TB). M. tuberculosis is an 
evolutionary recent pathogen which is extremely well adapted to the human host and 
its success could be due to its ability to persist for years. Currently, one third of the 
world’s population is infected with M. tuberculosis, and new infections occur at a rate of 
one per second (134). However, most of these cases will not develop the full-blown 
disease; asymptomatic, latent infection is most common. About one in ten of these 
latent infections will eventually progress to active disease, which, if untreated, kills 
more than half of its victims. 
The History of tuberculosis: from prehistory to nowadays 
Tuberculosis is the greatest man killer in history; taking only the past two centuries into 
account, TB was responsible for the deaths of approximately one billion human beings 
(104). The first evidence was found in a cemetery near Heidelberg, in the Neolithic 
bone remains that show evidence of the type of angulation often seen with spinal 
tuberculosis. Some authors call TB the first disease known to mankind. Signs of the 
disease have also been found in Egyptian mummies dated between 3000 and 2400 
Before Christ (BC) (32, 91, 106). The most convincing case was found in the mummy 
of priest Nesperehen, discovered by Grebart in 1881, which featured evidence of spinal 
tuberculosis with the characteristic psoas abscesses. Similar features were discovered 
on other mummies like that of the priest Philoc and throughout the cemeteries of 
Thebes. It appears that Akhenaten and his wife Nefertiti both died from tuberculosis, 
and evidence indicates that TB hospitals existed in Egypt as early as 1500 BC. The 
Ebers papyrus, an important Egyptian medical treatise from around 1550 BC, 
describes a pulmonary consumption associated with the cervical lymph nodes. It 
recommended that it has to be treated with the surgical lancing of the cyst and the 
application of a ground mixture of acacia seyal, peas, fruits, animal blood, insect blood, 
honey and salt.  
Tuberculosis has also been called consumption, because it seemed to consume 
people from within, with a bloody cough, fever, pallor, and long relentless wasting. 
Another name was phthisis first appeared in Greek literature around 460 BC. 
Hippocrates identified phthisis as the most widespread disease of the times. It most 
commonly occurred between 18 and 35 years of age, and was almost always fatal. He 
wrote of patients with consumption, wasting away associated with chest pain and 
coughing, frequently with blood in the sputum (113). Although Aristotle believed that 
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the disease might be contagious, many of his contemporaries believed it to be 
hereditary. Galen, the most eminent Greek physician after Hippocrates, defined 
phthisis as the "ulceration of the lungs, thorax or throat, accompanied by a cough, 
fever, and consumption of the body by pus” (59). 
It is believed that Europe became the epicenter of many TB epidemics from the 16th 
and 17th century due to the growing population, the industrialization and the 
development of large urban settings. Tuberculosis was supposed to be an incurable 
disease and it was called “The Great White Plague” or the “White death” because 
sufferers appear markedly pale. Death by tuberculosis was considered inevitable, 
being the principal cause of death in 1650. The high population density as well as the 
poor sanitary conditions that characterized most European and North American cities 
created a perfect environment for the propagation of the disease. The epidemic 
reached its peak in Europe in the first half of the 19th century, and it is estimated that 
as many as one quarter of Europeans died of TB at this time (113).  
The hope: curable disease? 
In 1854, Hermann Brehmer proposed the idea that “tuberculosis was indeed a curable 
disease”. The introduction of the “sanatorium” cure provided the first big step toward 
treatment for tuberculosis (27, 59). Brehmer himself was a TB patient. His doctor 
advised him to move to a healthier climate, so he spent some time in the Himalayas 
and came home cured. This experience moved him to build the first sanatorium, a 
place where patients could get plenty of fresh air, exposure to sunlight and good 
nutrition. This setup became the blueprint for the subsequent development of 
sanatoriums. The measures available to doctors at the time were still modest. 
Improving social and sanitary conditions and ensuring adequate nutrition were all that 
could be done to strengthen the body's defenses against TB bacteria. Sanatoriums, 
founded throughout Europe and the United States, provided a dual function: to isolate 
the sick people from the general population, and to force the patients to rest, thus 
assisting the healing process. 
In 1865, Jean Antoine Villemin demonstrated that consumption could be transmitted 
from humans or cattle to rabbits. In the light of this revolutionary evidence, he 
postulated that a specific microorganism caused the disease (59). 
On March 24th 1882, Robert Koch presented his lecture “The etiology of tuberculosis”. 
The experiments he described in the lecture defined tuberculosis as an infectious 
disease in accordance with his postulates (Figure 1). Once M. tuberculosis had been 
identified, the next step of Koch was to find a cure for the disease. Eight years later 
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Koch announced the discovery of a vaccine against tuberculosis consisting of glycerol 
extracts of pure cultures of tubercle bacilli. The vaccine candidate was assayed in a 
clinical trial with disastrous results but in 1908, Charles Mantoux found that it was an 
effective intradermic test for diagnosing tuberculosis. Regardless of this failure, Koch’s 
observations settled the basis for microbiology known as the Koch’s postulates. These 
comprise identification of the pathogen in affected tissue, growth of single clones of the 
pathogen in vitro, and establishment of a similar disease in the experimental animals 
by means of the pure culture (64).  
With Edward Jenner’s successful invention, showing that infection with cowpox would 
give immunity against smallpox in humans, many doctors placed their hopes on the 
use of Mycobacterium bovis (the agent that causes bovine TB) for the development of 
a vaccine against human TB. In 1908 Albert Calmette and Camille Guérin started the 
development of a vaccine against tuberculosis. They isolated from a dead cow M. bovis 
and for the next 13 years, these scientists grew every fortnight a new batch of bacteria 
in a solution of beef bile and potato. Eventually, the bacteria lost their ability to cause 
disease, but were still capable of stimulating the immune system to protect mice, pigs, 
guinea pigs and monkeys from tuberculosis. The vaccine was called “Bacille de 
Calmette et Guérin” or “BCG” and it was first administered to an infant in 1921 (Figure 
1). A total of 8 million babies and nearly 14 million people were given the BCG vaccine 
in the International Tuberculosis Campaign, which ran through 1951. The project 
initially began in Europe in the aftermath of World War II. However, the program 
extended beyond Europe when UNICEF contributed two million dollars to expand the 
program to other continents. Since then more than a billion people have been 
vaccinated with BCG (9). 
In 1943, Selman A. Waksman, who had been working for decades to find an effective 
antibiotic against Mycobacterium tuberculosis, was finally successful (Figure 1). 
Streptomycin purified from Streptomyces griseus was first administered to a human on 
November 20th, 1944. The results were extremely impressive. The disease 
immediately stopped its progression, the bacteria disappeared from the patient's 
sputum, and he recovered fully. A rapid succession of anti-TB drugs appeared in the 
following years: para-aminosalicylic acid (PAS, 1949), isoniazid (INH, 1952), 
pyrazinamide (PAZ, 1954), ethambutol (EMB, 1962) and rifampicin (RIF, 1963).  This 
advance was very important because with the streptomycin (SM) treatment, resistant 
mutants appeared within a few months, endangering the success of antibiotic therapy. 
However, it was soon proven that using a combination of drugs would solve this 
problem (59). 
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II.The disease: Pathogenesis and intracellular lifestyle of M. tuberculosis
Pathogenesis of M. tuberculosis 
Tuberculosis is a contagious disease (113). Infection with M. tuberculosis occurs 
through inhalation of aerosols containing the bacteria which are spread by persons with 
active pulmonary TB. After inhalation, bacteria are settled in the alveoli and 
disseminated by the lymphatic circulation. Further dissemination to other parts of the 
lung and occasionally to other organs is achieved by haematogenous circulation. The 
most common form of the disease is pulmonary tuberculosis, although TB-meningitis, 
miliary (disseminated) tuberculosis, lymphadenitis, osteomyelitis and Pott’s disease 
(affected bones) also occur (113). Primary infection leads to active disease in about 
10% of infected individuals, in 80% of the cases in the period of two years (125). In the 
remaining 90%, the immune system controls the infection, and the individual is non-
infectious and asymptomatic. In this clinical state the TB bacilli can lie dormant for 
years (latent TB) (102). However, when the immune system is weakened, the latent 
infection can reactivate (113, 125). In an HIV-infected person the risk of reactivation of 
latent TB is higher than 10% per year, compared to a lifetime risk of 10-20% for HIV-
negative individuals (23, 111, 125).  
Life inside the macrophages 
Once the bacteria are phagocytosed by alveolar macrophages, mediated by specific 
macrophage receptors (36, 38, 62, 110), a localized proinflammatory response that 
leads to recruitment of mononuclear cells from neighboring blood vessels is induced. 
These cells will build the granuloma (necessary to contain infection) which consists of a 
group of infected macrophages, surrounded by foamy giant cells (multinuclear 
macrophages loaded with lipids) and macrophages with a layer of lymphocytes 
delineating its periphery (101-103) (Figure 2). 
Activated macrophages promote phagosomal maturation by a process that finally 
involves fusion with lysosomes and formation of the phagolysosome. These vesicles 
provide a hostile environment for the bacilli including acid pH, reactive oxygen 
intermediates (ROI), lysosomal enzymes and toxic peptides. M. tuberculosis has 
evolved to survive within macrophages by arresting the normal phagosomal maturation 
at an early stage, thereby restricting its acidification and limiting fusion with lysosomes 
(90, 98). Modulation of phagosome maturation seems to be mainly mediated by both 
mycobacterial cell-wall lipids and other bacterial effectors (e.g., SapM or PknG) (46, 
132, 133). Additionally, the screening of shotgun libraries has enabled the isolation of 
several M. tuberculosis mutants unable to induce phagosomal arrest (96, 118). Apart 
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from surviving within the macrophage, pathogenic mycobacteria have also been 
suggested to escape into the cytosol in an ESX-1-dependent manner (128). In addition, 
M. tuberculosis reduces phagosome acidification by the exclusion of the proton-
ATPase (119) and decreases ROI and nitric oxide (NO) synthesis and cytokine 
production by modulating Ca2+ fluxes in infected macrophages (76). Moreover, M. 
tuberculosis has evolved multiple strategies to detoxify ROI and RNI (37). Recently, 
authophagy (29, 57) and apoptosis (68) have been postulated as effective 
antimycobacterial mechanisms. 
 
 
Figure 2:  Progression of TB granuloma. In the early stage, the granuloma has a core of 
infected macrophages enclosed by foamy macrophages and other mononuclear phagocytes, 
surrounded by lymphocytes. As the granuloma matures, it develops a fibrous capsule that 
encases the macrophage core and excludes the majority of lymphocytes from the center of the 
structure. Adapted from (102). 
 
 
Measures against tuberculosis:  
? Antibiotic therapy 
Tuberculosis treatment is difficult and requires long courses (around 6 to 12 months) of 
multiple antibiotics. It consist of an initial intensive phase of treatment (2 months) with 
RIF, INH, PAZ and either EMB or SM designed to kill actively growing and semi-
dormant bacilli, followed by a continuation phase (4 months) with RIF and INH to 
eliminate residual bacilli and reduce the number of relapses. To complete the treatment 
it is critical to reduce the development of acquired drug resistance and therefore trained 
individual personnel supervises that the patient takes each dose of medication. This 
strategy is known as directly observed treatment short-course (DOTS) and was 
promoted as the official policy of the WHO in 1991 (136). 
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Isoniazid Preventive Treatment (IPT) for six months is recommended for high risk 
individuals, like HIV infected individuals, or children who are in close contact with an 
infectious person with the aim of decreasing the risk of primary infection with M. 
tuberculosis (63). 
Another major challenge is the ever-increasing resistance to anti-TB drugs. Multidrug-
resistant TB refers to TB caused by M. tuberculosis isolates that are resistant to the 
most effective drugs, INH and RIF. MDR strains take longer to treat (up to two years) 
with second-line drugs, which are more than 100 times more expensive, less effective 
and also much more toxic to the patients (49). The virtually untreatable extensively 
drug-resistant TB (XDR-TB) is defined as MDR-TB which is also resistant any of the 
fluoroquinolones and second-line anti-TB injectable drugs (Amikacin, Kanamycin (Km) 
or Capreomycin). 
? Vaccination 
BCG is one of the most widely used vaccine today (> 80 % of neonates and infants in 
some countries). Although it does not prevent primary infection or reactivation of latent 
pulmonary TB, the principal source of bacillary spread in the community, BCG protects 
against disseminated forms of TB, especially against meningitis in children. For that 
reason, BCG vaccination is still recommended by the WHO and applied widely (115, 
123). 
After its first use in humans in 1921, propagation of BCG in non-standardized 
conditions in different laboratories all around the world gave rise to different variant 
strains that differ in genotype and phenotypic characteristics (9). Strain differences 
could be one cause of the variable protective efficacy afforded by BCG (44), but other 
factors such as population genetics or exposure to environmental mycobacteria could 
be implicated (28). 
Due to this inconsistency in protective efficacy, and to the inability of BCG to prevent 
pulmonary forms of tuberculosis and consequently, to prevent transmission of the 
disease, great efforts are being made by governments, research institutions and private 
foundations for constructing and testing new promising vaccine candidates. 
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III.Biology of the bacillus and mycobacterial genetics 
General characteristics of mycobacteria 
Mycobacterium genus comprises a number of Gram-positive, acid-fast, rod-shaped 
aerobic bacteria and it is the only member of the family Mycobacteriaceae within the 
order Actinomycetales (117). Like other closely related Actinomycetales, such as 
Nocardia and Corynebacterium, mycobacteria have unusually high genomic DNA GC 
content and are capable of producing mycolic acids (m) as major components of their 
cell wall. Phenotypically M. tuberculosis is catalase and nitrate reductase positive, non-
motile and non-sporulating of 2-5μm in length and 0.2-0.5μm in width. 
To date, more than 100 species of mycobacteria have been described (122). Most of 
these species are environmental saprophytes. Phylogenetic analyses and phenotypic 
characteristics, such as growth rate and pigmentation, can be used to classify these 
species. The classical distinction between rapid and slow growth is based on the ability 
of strains to develop clearly visible colonies in less or more than 7 days, respectively. 
Rapid growers (< 7 days) are free, environmental, saprophytic species. Interestingly, 
the slow growing mycobacteria comprise most of the pathogenic species, including M. 
tuberculosis which has a generation time of ~24 hours. This contributes to the chronic 
nature of the infection, requires long-term treatment to fully eradicate the pathogen and 
imposes a barrier for microbiologists since it takes up to four weeks for a single M. 
tuberculosis cell to become a colony on solid media.  
The various etiologic agents of TB are clustered in the M. tuberculosis complex 
(MTBC), which currently includes eight species: The human-adapted strains M. 
tuberculosis, M. africanum and M. canettii (being M. canettii the most divergent within 
the MTBC) and MTBC also includes the animal-adapted strains M. bovis (primarily a 
pathogen of cattle), M. caprae (a pathogen of goats), M. microti (a pathogen of rodents) 
and M. pinnipedii (a pathogen of seals and sea lions) and, recently M. mungi was 
isolated from mongoose (2, 89). Mycobacteria grouped in MTBC are characterized by 
99.9% similarity at the nucleotide level and identical 16S rRNA but that differ in terms 
of phenotypes and host preference (13). 
The envelope of mycobacteria  
The unique cell wall of M. tuberculosis forms a waxy envelope and has been 
established as an important factor leading to bacterial virulence and survival. This 
envelope differs considerably from cell wall of both Gram-positive and Gram-negative 
bacteria. Even though they are structurally more closely related to Gram-positive 
bacteria, mycobacteria do not fit into the Gram-positive category as the molecules 
General Introduction 
29 
attached to the cell wall are distinctively lipids rather than proteins or polysaccharides. 
Frequently, they do not retain the crystal violet and appear as “ghosts” after Gram 
staining (7). Therefore, acid-fast stains, such as the Ziehl-Neelsen stain or the 
fluorescent auramine-rhodamine stain are recommended for the detection of 
mycobacteria. 
A characteristic feature of their cell envelope is the high proportion of lipid-rich 
molecules. Schematically, the cell envelope from the inside to the outside, comprises a 
typical bacterial plasma membrane, a cell wall and an external capsule, which contains 
proteins, polysaccharides and lipids (Figure 3) (26). The outer layer presents various 
non-covalently attached lipids and glycolipids esterified with multimethyl-branched 
long-chain fatty acids (61, 86). These complex lipids are restricted, with few exceptions, 
to pathogenic mycobacteria and are suggested to play important roles in pathogenicity. 
In M. tuberculosis, these lipids include the phthiocerol dimycocerosates (PDIM) (5, 18, 
24, 92, 100) and the closely related phenolic glycolipids (PGL) (93, 97, 112), the 
trehalose ester families that include sulfolipids (SL) (22, 31, 54), diacyltrehaloses (DAT) 
and polyacyltrehaloses (PAT) (69, 99), and the family of mannosyl-β-1-
phosphomycoketides (80). This highly hydrophobic envelope decreases the 
permeability and susceptibility to degradation and makes the bacterium naturally 
resistant to most of the antibiotics and chemical agents and confers unique staining 
properties. 
 
  
Figure 3: Arrangement of structural components in the cell envelope structure of 
M.tuberculosis. The cell wall consists of a peptidoglycan (PG) covalently attached to the 
mycolyl arabinogalactan (mAG), which is in turn esterified by mycolic acids (m). The 
lipopolysacharides lipomannan (LM) and lipoarabinomannan (LAM) are anchored to the 
plasmatic membrane through phosphatidylinositol mannosides (PIM) and they extend towards 
the exterior of the cell wall (86). 
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found in the two conserved N-terminal regions in each of these protein families that are 
approximately 110 and 180 amino acids long, respectively. Although the function of the 
members of the PE and PPE protein families has not been established, they are 
suggested to be involved in antigenic variation and disease pathogenesis (29). 
Tubercle bacilli also contain complex regulatory machinery comprising 11 two 
component systems, 11 serine/threonine protein kinases, 13 σ factors, and over 100 
repressors and activators, suggesting a tight regulation of transcription in response to 
different stimuli. Interestingly, the analysis of the DNA metabolic system of M. 
tuberculosis indicates a very efficient DNA repair system, in other words, replication 
machinery of exceptionally high fidelity. The genome of M. tuberculosis lacks the MutS-
based mismatch repair system. However, this absence is overcome by the presence of 
nearly 45 genes related to DNA repair mechanisms (87), including three copies of the 
mutT gene. This gene encodes the enzyme in charge of removing oxidized guanines 
whose incorporation during replication causes base-pair mismatching (20, 87). 
Repetitive DNA is very important in mycobacterial genomes. Elements like Tandem 
Repeats, Interspersed Repeats, and mobile genetic elements are common. In H37Rv, 
56 loci with similarity to IS elements have been found that can be classified into major 
IS families (IS3, IS5, IS605 or IS21). Mobile genetic elements will be widely analyzed in 
the following section as they could have an important role in genome plasticity and the 
virulence of the bacilli. 
Mobile genetic elements in mycobacteria 
Insertion sequence (IS) is a short DNA mobile genetic element coding for proteins 
involved in the transposition activity, which allows it to spread within the genome. ISs 
are widely distributed in prokaryotes and can be grouped into different families based 
on structure characteristics and transposase similarities (75). More than 46 ISs from 
different species have been located and identified in Mycobacterium, mostly on the 
basis of sequence similarities (15). 
In the genome of the members of MTBC it has been possible to find dispersed IS 
elements that could be included in several of the following families attending to their 
characteristics: IS3, IS5, IS21, IS30, IS110, IS256; IS1535, ISL3 and other IS-like 
elements (53).  
The IS3 family consist of an extensive set of insertion elements in bacteria. The 
features that characterize this family are their length, between 1200 and 1600 bp, and 
their inverted repeats (IRs), between 20 and 40 bp long, as well as the presence of two 
overlapping open reading frames (ORFs: orfA and orfB) (75, 81). After the insertion, a 
duplication of 3 or 4 bp occurs at the insertion point (85). Recombination is also 
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another mechanism participating in the changes of the location of ISs along the 
genomes. All those mechanisms lead to IS-mediated gene rearrangements, inversions, 
deletions and duplications in the bacterial genomes. Examples of sequences of this 
family in MTBC are IS1540, IS1604, IS1556/990 and IS6110. The IS1540, IS1604 and 
IS1556/990, have missed the IRs or contain mutations in orfB making them supposedly 
inactive and non-functional (34, 82). However, the most representative member of this 
family, IS6110, has the two overlapping ORFs intact and a functional transposase.  
The insertion sequence IS6110 
IS6110 was initially named IS986. Subsequently, a related element from M. bovis BCG 
was sequenced by Hermans et al. (58) and is referred to as IS987. The three 
sequences IS6110, IS986 and IS987 were practically identical and to avoid confusion, 
it was decided to use the same name IS6110 (81, 120). IS6110 is a genomic insertion 
element 1361 bp long, it shows 28 bp imperfect IRs, and due to the mechanism of 
transposition it generates duplications of 3 or 4 bp (known as Direct Repeat, DR) next 
to the insertion site (Figure 5). It may be present up to 25 copies per genome in M. 
tuberculosis (15) and only a few number of strains have no copies of this element (73). 
Recently, it has been suggested variations into the sequence of IS6110 copies from 
different strains of M. tuberculosis, which could have implications in its usefulness as 
target of PCR detection (109). 
 
 
Figure 5: Complete sequence of IS6110. The direct repeats (DR) (red) and the invert repeats 
(IR) (green) flanking the transposase gene are underlined. 
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? Its success as a diagnostic and epidemiological tool 
Soon after the discovery of IS6110 as a specific element in MTBC, its usefulness as 
diagnostic tool was explored (121). Subsequently, at the beginning of the nineties it 
was demonstrated that two strains isolated from different episodes of a patient had the 
same IS6110-RFLP in turn, a high degree of polymorphism was observed between 
strains isolated from different patients (95). The fact that IS6110 varies in copy number 
and it is randomly distributed throughout the genome, along with its stability over time 
showed usefulness in genotyping of the MTBC. DNA fingerprinting of M. tuberculosis, 
standardised in 1993 (129), has shown to be of great value in comparison of the results 
obtained by different laboratories, distinguishing between recent transmission and 
reactivation, reinfection, mixed infections, studies of outbreaks, and confirmation or 
ruling out laboratory errors. It has also been useful to identify some strains that may 
differ in transmission, suggesting that more virulent strains could show different 
pathogenesis and epidemiologic characteristics. Additionally, in some cases, the 
location of one copy of IS6110 specific to one strain can be used as a useful tool in its 
rapid diagnosis allowing the identification and differentiation of this particular strain 
(85). 
? Where is IS6110 inserted? 
IS6110 does not have a known target or consensus sequence, it has been found within 
ORFs and intergenic regions (39). The interruption of coding regions can be seen as a 
sort of natural knock-out mutation of the target gene. The IS6110 was found to be 
inserted more often in some genome regions (hot-spots). The first identified hot-spot 
was the Direct Repeat region (the DR region) (58) and with minor exceptions, all 
members of the MTBC carry a copy of the IS6110 integrated in that locus. Another 
study shows the possible conserved sites of insertion in strains of M. tuberculosis with 
less than seven copies (45); other hot-spots have also been shown such as the IS1547 
(iplA and iplB loci) (40, 41), the phospholipase C regions (locus plcABC and plcD gene) 
(60, 131), members of the PPE gene family (84) and the origin of replication (oriC) (67, 
126). 
The locations of the IS6110 along the genome are not equally distributed. This 
sequence was found to be inserted more often in some genome regions, whereas 
others lacked it (21). Nearly up to the first 800 nucleotides from the oriC fail in carrying 
copies of IS6110 in the strain H37Rv. Besides, IS6110 was otherwise located more or 
less randomly along the rest of the genome (Figure 6). The conclusion was that this 
part of the genome could be more abundant in essential genes. This result also was 
seen when studies of other strains were accomplished (3, 8, 108). 
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Figure 6: Example of locations of IS6110 relative to ORFs of the M. tuberculosis H37Rv. 
The ORF numbers of the disrupted genes are indicated in bold, while the intergenic insertions 
are represented by two ORF numbers separated by a colon. The M. tuberculosis H37Rv 
insertion sites are underlined. Adapted from (107). 
 
? IS6110 mediates genome plasticity of members of the MTBC  
In general, many mechanisms can be related to changes in the bacterial genomes, 
being those mediated by ISs one of the most relevant and better studied. It was 
considered that among 5 to 15% of spontaneous mutations in the bacterial genomes 
were due to changes in the IS locations. The more common mechanism used by an 
insertion sequence to move along genome is transposition. Another observed 
mechanism is recombination between two elements (83). For example, the deletion of 
the region RvD2 from M. tuberculosis H37Rv genome relative to M. bovis is due to the 
homologous recombination between two closed copies of IS6110 (14, 39, 52). All those 
changes could be a risk to the bacteria’s genomes integrity, being the carriage of 
mobile IS either a potential enemy with deadly influence on the bacterial fitness or a 
helpful ally contributing to the improvement of that fitness. 
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In summary, many events have been associated with IS6110, such as participation in 
adaptation to a particular host (94), activation of genes during infection (105), 
participation in the evolution as an epidemiological marker as we mention above (129) 
and activation of downstream genes with an activity promoter orientation-dependent (3, 
105, 114). 
The promoter activity of IS6110 will be widely studied in chapter 2. 
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IV.The phylogeny and spoligotype of M. tuberculosis  
 
TB researchers are relying on genomics and DNA sequence-based approaches to 
study the evolution and population genetics of M. tuberculosis. The analysis of 
synonymous single-nucleotide polymorphisms (SNPs) and the study of genomic 
deletions have led to the development of a phylogenetic structure that allows 
understanding the relationship and evolution of members of the MTBC. 
The Phylogeny of M. tuberculosis 
Silent mutations in housekeeping genes were the first candidates to be selected as 
evolutionary markers. Based on the combination of two polymorphisms that occur at 
high frequency in the genes encoding catalase-peroxidase (katG) and subunit A of 
gyrase (gyrA), Sreevatsan et al. proposed the first classification of M. tuberculosis in 
1997. Three Principal Genetic Groups (PGG 1-3) were identified (Figure 7). Group 1 or 
PGG1 is allied with M. bovis, M. microtti and M. africanum which is evolutionary closer 
to the common ancestor (116).  
 
 
Figure 7: Broad evolutionary scenario for M. tuberculosis complex. Adapted from (116) 
 
To group M. tuberculosis, Baker et al. divided M. tuberculosis into four main lineages 
(numbered I to IV) with the analysis of silent nucleotide sequence (sSNP) variation for 
seven genes associated with antimicrobial drug resistance. The M. bovis isolates 
formed an additional lineage (6) (Figure 8A). This phylogenetic structure is in 
concordance with PGG 1-3 of Sreevatsan et al. (116). 
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Spoligotype of M. tuberculosis 
Based on the genotype technique spoligotyping, we can group the global and local 
geographical structures of MTBC populations in families (16). Generally, a strain family 
can be described as a group of isolates that share specific biomarkers or properties 
indicative of a recent ancestor. MTBC strains contain a distinct chromosomal region 
consisting of multiple 36-bp direct repeats (DRs) interspersed by unique spacer DNA 
sequences (35 to 41 bp). Spoligotyping is based in the detection of 43 interspersed 
spacer sequences. Membranes spoted with 43 synthetic oligonucleotides are 
hybridized with labeled PCR-amplified DR region resulting in a pattern that can be 
detected by chemiluminiscence. The results are highly reproducible, and the binary 
(present/absent) data generated can be easily interpreted and computcrized and are 
amenable to intralaboratory comparisons (79). SpolDB4, the international spoligotyping 
database, contains 1939 different spoligotypes (ST), representing a total of 39,295 M. 
tuberculosis strains from 122 countries, and these are organized into 22 lineages/sub-
lineages (16). Among these families we can enhance the Beijing family, the Central-
Asian (CAS) family with two principal sublineages (CAS1 and CAS2), Zero, whose 
name comes from the absence of IS6110 insertion element (“Zero copy”), MANU (sub-
divided into MANU1 to MANU3), East-African-Indian (EAI) family, Haarlem family (H) 
with 4 sub lineages (H1-H4), Latin-American-Mediterranean (LAM), T family (modern 
TB strains) which is stratified into 5 sub-clades (T1-T5) and X (X1-X3 sub-lineages) 
which is well characterized as IS6110 low-banding family.  
? Variation in spoligotype among the IX genetic cluster groups and the 
SCGs. 
Analysis of the relationship between the SNP-based phylogenetic trees (17, 55, 79) 
showed that some spoligotype clades were phylogenetically accurate with the SNP-
derived phylogenetic framework trees while others were less so. For example, the 
spoligotype-defined Beijing clade was exclusively present in SCG-2 and exclusive to 
cluster II of the IX cluster groups described by Gutaker (Figure 10). 
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The M. tuberculosis Beijing family 
The M. tuberculosis Beijing genotype family, also named East Asian Lineage (47), 
constitutes a homogeneous group of strains sharing a closely related IS6110 RFLP 
patterns containing a high number of bands, identical spoligotyiping (deletion of 
spacers 1 to 34 in the Direct Repeat region) (130), an insertion of IS6110 between 
dnaA-dnaN genes (called insertion A1) (67) and one or two IS6110 copies in a DNA 
region called NTF locus (66, 67). The insertion of IS6110 in these regions subdivide 
Beijing genotype in ancestral or atypical and modern or typical being the modern 
sublineage which contains at least one copy of IS6110 upstream of the NTF region 
(88).   
Moreover, the deletion of the regions of difference (RD) 105 and RD207, which are 
LSP markers, are present in all Beijing strains (124) (detailed in chapter 1). A few 
outliers that do not meet all of the above-suggested criteria for identification have also 
been described, as strains with “Beijing-like” spoligo patterns (25) (lacking one or more 
of the last nine spacers) and strains that harbor the Beijing genotype and the A1 
insertion but which differ significantly in their IS6110 banding patterns from the regular 
Beijing strains (67). 
Strains of Beijing genotype were first described in China and neighbouring countries in 
1995. The name comes from the finding that more than 80% of strains from the Beijing 
area were of this type (130). However, currently they are widespread in many regions 
of the world and frequently cause epidemic outbreaks (10, 19, 42, 50). Different studies 
have indicated that one-third of global TB cases is caused by Beijing family strains 
assigning this lineage to one of the most successful mycobacterial families in terms of 
morbidity and mortality (10). In some areas, such as Vietnam, Cuba, and Estonia, 
Beijing strains were found to be strongly associated with drug resistance (4, 12, 30, 
65). This is consistent with the prolific spread of the (multidrug)-resistant strain W and 
its variants in the 1990s in Northern America (11). This strain and its variants exhibit 
highly similar IS6110 RFLP patterns and an identical spoligo pattern. It is now known 
that the W family and the Beijing family represent the same genotype which was 
concurrently identified in North America (12) and Asia (130). Both groups of strains are 
referred as Beijing family (Beijing/W or W-Beijing). A second group of strains with 
distantly related IS6110 RFLP profiles have been determined to belong to the Beijing 
lineage by other molecular techniques and are referred to as ancestral strains (88). 
They share a common predecessor with Beijing family strains, as illustrated by the 
extensive shared molecular characteristics, including chromosomal insertions and 
deletions, and single nucleotide polymorphisms (35). 
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The widely distributed association of drug resistance and the Beijing genotype suggest 
that these strains may have a particular propensity for acquiring drug resistance (51). It 
was reported that Beijing strains carry mutations in putative mutators genes, and this 
may explain a higher adaptability of these bacteria to stress conditions such as 
exposure to antituberculosis drugs and the hostile intracellular environment (35). 
A number of selective advantages have been associated with its success including a 
lower efficacy of BCG for Beijing strains (74, 130), higher virulence (74, 78), ability to 
induce a differential immune response (33, 77), higher transmissibility (10) and 
enhanced capacity to grow in human macrophages and monocytes (71, 137) and an 
enhanced capacity to acquire drug resistance (1, 11, 12). However, unidentified 
virulence factors and the modulation of specific host responses are not yet thoroughly 
investigated.  
General Introduction 
43 
References 
 
1. Agerton, T. B., S. E. Valway, R. J. Blinkhorn, K. L. Shilkret, R. Reves, W. W. 
Schluter, B. Gore, C. J. Pozsik, B. B. Plikaytis, C. Woodley, and I. M. Onorato. 
1999. Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, 
across the United States. Clin Infect Dis 29:85-92; discussion 93-5. 
2. Alexander, K. A., P. N. Laver, A. L. Michel, M. Williams, P. D. van Helden, R. M. 
Warren, and N. C. Gey van Pittius. Novel Mycobacterium tuberculosis complex 
pathogen, M. mungi. Emerg Infect Dis 16:1296-9. 
3. Alonso, H., J. I. Aguilo, S. Samper, J. A. Caminero, M. I. Campos-Herrero, B. 
Gicquel, R. Brosch, C. Martin, and I. Otal. Deciphering the role of IS6110 in a highly 
transmissible Mycobacterium tuberculosis Beijing strain, GC1237. Tuberculosis (Edinb). 
4. Anh, D. D., M. W. Borgdorff, L. N. Van, N. T. Lan, T. van Gorkom, K. Kremer, and 
D. van Soolingen. 2000. Mycobacterium tuberculosis Beijing genotype emerging in 
Vietnam. Emerg Infect Dis 6:302-5. 
5. Astarie-Dequeker, C., L. Le Guyader, W. Malaga, F. K. Seaphanh, C. Chalut, A. 
Lopez, and C. Guilhot. 2009. Phthiocerol dimycocerosates of M. tuberculosis 
participate in macrophage invasion by inducing changes in the organization of plasma 
membrane lipids. PLoS Pathog 5:e1000289. 
6. Baker, L., T. Brown, M. C. Maiden, and F. Drobniewski. 2004. Silent nucleotide 
polymorphisms and a phylogeny for Mycobacterium tuberculosis. Emerg Infect Dis 
10:1568-77. 
7. Barrera, L. 2007. The basics of clinical bacteriology. In J. C. Palomino, S. Cardoso-
Leao, and V. Ritacco (ed.), Tuberculosis. From basic science to patient care. 
8. Beggs, M. L., K. D. Eisenach, and M. D. Cave. 2000. Mapping of IS6110 insertion 
sites in two epidemic strains of Mycobacterium tuberculosis. J Clin Microbiol 38:2923-8. 
9. Behr, M. A. 2002. BCG--different strains, different vaccines? Lancet Infect Dis 2:86-92. 
10. Bifani, P. J., B. Mathema, N. E. Kurepina, and B. N. Kreiswirth. 2002. Global 
dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends 
Microbiol 10:45-52. 
11. Bifani, P. J., B. Mathema, Z. Liu, S. L. Moghazeh, B. Shopsin, B. Tempalski, J. 
Driscol, R. Frothingham, J. M. Musser, P. Alcabes, and B. N. Kreiswirth. 1999. 
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-
based molecular epidemiology. JAMA 282:2321-7. 
12. Bifani, P. J., B. B. Plikaytis, V. Kapur, K. Stockbauer, X. Pan, M. L. Lutfey, S. L. 
Moghazeh, W. Eisner, T. M. Daniel, M. H. Kaplan, J. T. Crawford, J. M. Musser, and 
B. N. Kreiswirth. 1996. Origin and interstate spread of a New York City multidrug-
resistant Mycobacterium tuberculosis clone family. Jama 275:452-7. 
13. Brosch, R., S. V. Gordon, M. Marmiesse, P. Brodin, C. Buchrieser, K. Eiglmeier, T. 
Garnier, C. Gutierrez, G. Hewinson, K. Kremer, L. M. Parsons, A. S. Pym, S. 
Samper, D. van Soolingen, and S. T. Cole. 2002. A new evolutionary scenario for the 
Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A 99:3684-9. 
14. Brosch, R., W. J. Philipp, E. Stavropoulos, M. J. Colston, S. T. Cole, and S. V. 
Gordon. 1999. Genomic analysis reveals variation between Mycobacterium 
tuberculosis H37Rv and the attenuated M. tuberculosis H37Ra strain. Infect Immun 
67:5768-74. 
15. Brosch, R. G., S.V.; Eiglmeier, K.; Garnier, T.; Tekaia, F.; Yeramian, E. & Cole, S.T. 
. 2000. Genomics, biology, and evolution of the Mycobacterium tuberculosis complex. 
Molecular Genetics of Mycobacteria, ISBN 1-55581-191-4:19-36. 
16. Brudey, K., J. R. Driscoll, L. Rigouts, W. M. Prodinger, A. Gori, S. A. Al-Hajoj, C. 
Allix, L. Aristimuno, J. Arora, V. Baumanis, L. Binder, P. Cafrune, A. Cataldi, S. 
Cheong, R. Diel, C. Ellermeier, J. T. Evans, M. Fauville-Dufaux, S. Ferdinand, D. 
Garcia de Viedma, C. Garzelli, L. Gazzola, H. M. Gomes, M. C. Guttierez, P. M. 
Hawkey, P. D. van Helden, G. V. Kadival, B. N. Kreiswirth, K. Kremer, M. Kubin, S. 
Mª Henar Alonso Ezcurra 
44 
P. Kulkarni, B. Liens, T. Lillebaek, M. L. Ho, C. Martin, I. Mokrousov, O. Narvskaia, 
Y. F. Ngeow, L. Naumann, S. Niemann, I. Parwati, Z. Rahim, V. Rasolofo-
Razanamparany, T. Rasolonavalona, M. L. Rossetti, S. Rusch-Gerdes, A. Sajduda, 
S. Samper, I. G. Shemyakin, U. B. Singh, A. Somoskovi, R. A. Skuce, D. van 
Soolingen, E. M. Streicher, P. N. Suffys, E. Tortoli, T. Tracevska, V. Vincent, T. C. 
Victor, R. M. Warren, S. F. Yap, K. Zaman, F. Portaels, N. Rastogi, and C. Sola. 
2006. Mycobacterium tuberculosis complex genetic diversity: mining the fourth 
international spoligotyping database (SpolDB4) for classification, population genetics 
and epidemiology. BMC Microbiol 6:23. 
17. Brudey, K., I. Filliol, S. Ferdinand, V. Guernier, P. Duval, B. Maubert, C. Sola, and 
N. Rastogi. 2006. Long-term population-based genotyping study of Mycobacterium 
tuberculosis complex isolates in the French departments of the Americas. J Clin 
Microbiol 44:183-91. 
18. Camacho, L. R., D. Ensergueix, E. Perez, B. Gicquel, and C. Guilhot. 1999. 
Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-
tagged transposon mutagenesis. Mol Microbiol 34:257-67. 
19. Caminero, J. A., M. J. Pena, M. I. Campos-Herrero, J. C. Rodriguez, I. Garcia, P. 
Cabrera, C. Lafoz, S. Samper, H. Takiff, O. Afonso, J. M. Pavon, M. J. Torres, D. 
van Soolingen, D. A. Enarson, and C. Martin. 2001. Epidemiological evidence of the 
spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria 
Island. Am J Respir Crit Care Med 164:1165-70. 
20. Cole, S. T. 1999. Learning from the genome sequence of Mycobacterium tuberculosis 
H37Rv. FEBS Lett 452:7-10. 
21. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, 
K. Eiglmeier, S. Gas, C. E. Barry, 3rd, F. Tekaia, K. Badcock, D. Basham, D. 
Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. 
Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. 
Murphy, K. Oliver, J. Osborne, M. A. Quail, M. A. Rajandream, J. Rogers, S. Rutter, 
K. Seeger, J. Skelton, R. Squares, S. Squares, J. E. Sulston, K. Taylor, S. 
Whitehead, and B. G. Barrell. 1998. Deciphering the biology of Mycobacterium 
tuberculosis from the complete genome sequence. Nature 393:537-44. 
22. Converse, S. E., J. D. Mougous, M. D. Leavell, J. A. Leary, C. R. Bertozzi, and J. S. 
Cox. 2003. MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium 
tuberculosis virulence. Proc Natl Acad Sci U S A 100:6121-6. 
23. Corbett, E. L., C. J. Watt, N. Walker, D. Maher, B. G. Williams, M. C. Raviglione, 
and C. Dye. 2003. The growing burden of tuberculosis: global trends and interactions 
with the HIV epidemic. Arch Intern Med 163:1009-21. 
24. Cox, J. S., B. Chen, M. McNeil, and W. R. Jacobs, Jr. 1999. Complex lipid determines 
tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402:79-83. 
25. Chan, M. Y., M. Borgdorff, C. W. Yip, P. E. de Haas, W. S. Wong, K. M. Kam, and D. 
Van Soolingen. 2001. Seventy percent of the Mycobacterium tuberculosis isolates in 
Hong Kong represent the Beijing genotype. Epidemiol Infect 127:169-71. 
26. Daffe, M., and P. Draper. 1998. The envelope layers of mycobacteria with reference to 
their pathogenicity. Adv Microb Physiol 39:131-203. 
27. Daniel, T. M. 2006. The history of tuberculosis. Respir Med 100:1862-70. 
28. Demangel, C., T. Garnier, I. Rosenkrands, and S. T. Cole. 2005. Differential effects 
of prior exposure to environmental mycobacteria on vaccination with Mycobacterium 
bovis BCG or a recombinant BCG strain expressing RD1 antigens. Infect Immun 
73:2190-6. 
29. Deretic, V., S. Singh, S. Master, J. Harris, E. Roberts, G. Kyei, A. Davis, S. de Haro, 
J. Naylor, H. H. Lee, and I. Vergne. 2006. Mycobacterium tuberculosis inhibition of 
phagolysosome biogenesis and autophagy as a host defence mechanism. Cell 
Microbiol 8:719-27. 
30. Diaz, R., K. Kremer, P. E. de Haas, R. I. Gomez, A. Marrero, J. A. Valdivia, J. D. van 
Embden, and D. van Soolingen. 1998. Molecular epidemiology of tuberculosis in 
General Introduction 
45 
Cuba outside of Havana, July 1994-June 1995: utility of spoligotyping versus IS6110 
restriction fragment length polymorphism. Int J Tuberc Lung Dis 2:743-50. 
31. Domenech, P., M. B. Reed, C. S. Dowd, C. Manca, G. Kaplan, and C. E. Barry, 3rd. 
2004. The role of MmpL8 in sulfatide biogenesis and virulence of Mycobacterium 
tuberculosis. J Biol Chem 279:21257-65. 
32. Donoghue, H. D., M. Spigelman, C. L. Greenblatt, G. Lev-Maor, G. K. Bar-Gal, C. 
Matheson, K. Vernon, A. G. Nerlich, and A. R. Zink. 2004. Tuberculosis: from 
prehistory to Robert Koch, as revealed by ancient DNA. Lancet Infect Dis 4:584-92. 
33. Dormans, J., M. Burger, D. Aguilar, R. Hernandez-Pando, K. Kremer, P. Roholl, S. 
M. Arend, and D. van Soolingen. 2004. Correlation of virulence, lung pathology, 
bacterial load and delayed type hypersensitivity responses after infection with different 
Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clin Exp Immunol 
137:460-8. 
34. Dziadek, J., A. Sajduda, J. W. Dale, and J. J. McFadden. 1998. IS990, a new 
species-specific insertion-sequence-related element of the Mycobacterium tuberculosis 
complex. Microbiology 144 ( Pt 12):3407-12. 
35. Ebrahimi-Rad, M., P. Bifani, C. Martin, K. Kremer, S. Samper, J. Rauzier, B. 
Kreiswirth, J. Blazquez, M. Jouan, D. van Soolingen, and B. Gicquel. 2003. 
Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-
Beijing family. Emerg Infect Dis 9:838-45. 
36. Ehlers, M. R., and M. Daffe. 1998. Interactions between Mycobacterium tuberculosis 
and host cells: are mycobacterial sugars the key? Trends Microbiol 6:328-35. 
37. Ehrt, S., and D. Schnappinger. 2009. Mycobacterial survival strategies in the 
phagosome: defence against host stresses. Cell Microbiol 11:1170-8. 
38. Ernst, J. D. 1998. Macrophage receptors for Mycobacterium tuberculosis. Infect Immun 
66:1277-81. 
39. Fang, Z., C. Doig, D. T. Kenna, N. Smittipat, P. Palittapongarnpim, B. Watt, and K. 
J. Forbes. 1999. IS6110-mediated deletions of wild-type chromosomes of 
Mycobacterium tuberculosis. J Bacteriol 181:1014-20. 
40. Fang, Z., and K. J. Forbes. 1997. A Mycobacterium tuberculosis IS6110 preferential 
locus (ipl) for insertion into the genome. J Clin Microbiol 35:479-81. 
41. Fang, Z., D. T. Kenna, C. Doig, D. N. Smittipat, P. Palittapongarnpim, B. Watt, and 
K. J. Forbes. 2001. Molecular evidence for independent occurrence of IS6110 
insertions at the same sites of the genome of Mycobacterium tuberculosis in different 
clinical isolates. J Bacteriol 183:5279-84. 
42. Filliol, I., J. R. Driscoll, D. van Soolingen, B. N. Kreiswirth, K. Kremer, G. 
Valetudie, D. A. Dang, R. Barlow, D. Banerjee, P. J. Bifani, K. Brudey, A. Cataldi, 
R. C. Cooksey, D. V. Cousins, J. W. Dale, O. A. Dellagostin, F. Drobniewski, G. 
Engelmann, S. Ferdinand, D. Gascoyne-Binzi, M. Gordon, M. C. Gutierrez, W. H. 
Haas, H. Heersma, E. Kassa-Kelembho, M. L. Ho, A. Makristathis, C. Mammina, G. 
Martin, P. Mostrom, I. Mokrousov, V. Narbonne, O. Narvskaya, A. Nastasi, S. N. 
Niobe-Eyangoh, J. W. Pape, V. Rasolofo-Razanamparany, M. Ridell, M. L. 
Rossetti, F. Stauffer, P. N. Suffys, H. Takiff, J. Texier-Maugein, V. Vincent, J. H. de 
Waard, C. Sola, and N. Rastogi. 2003. Snapshot of moving and expanding clones of 
Mycobacterium tuberculosis and their global distribution assessed by spoligotyping in 
an international study. J Clin Microbiol 41:1963-70. 
43. Filliol, I., A. S. Motiwala, M. Cavatore, W. Qi, M. H. Hazbon, M. Bobadilla del Valle, 
J. Fyfe, L. Garcia-Garcia, N. Rastogi, C. Sola, T. Zozio, M. I. Guerrero, C. I. Leon, J. 
Crabtree, S. Angiuoli, K. D. Eisenach, R. Durmaz, M. L. Joloba, A. Rendon, J. 
Sifuentes-Osornio, A. Ponce de Leon, M. D. Cave, R. Fleischmann, T. S. Whittam, 
and D. Alland. 2006. Global phylogeny of Mycobacterium tuberculosis based on single 
nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, 
phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a 
minimal standard SNP set. J Bacteriol 188:759-72. 
Mª Henar Alonso Ezcurra 
46 
44. Fine, P. E. 1995. Variation in protection by BCG: implications of and for heterologous 
immunity. Lancet 346:1339-45. 
45. Fomukong, N., M. Beggs, H. el Hajj, G. Templeton, K. Eisenach, and M. D. Cave. 
1997. Differences in the prevalence of IS6110 insertion sites in Mycobacterium 
tuberculosis strains: low and high copy number of IS6110. Tuber Lung Dis 78:109-16. 
46. Fratti, R. A., J. Chua, I. Vergne, and V. Deretic. 2003. Mycobacterium tuberculosis 
glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc Natl Acad 
Sci U S A 100:5437-42. 
47. Gagneux, S., K. DeRiemer, T. Van, M. Kato-Maeda, B. C. de Jong, S. Narayanan, 
M. Nicol, S. Niemann, K. Kremer, M. C. Gutierrez, M. Hilty, P. C. Hopewell, and P. 
M. Small. 2006. Variable host-pathogen compatibility in Mycobacterium tuberculosis. 
Proc Natl Acad Sci U S A 103:2869-73. 
48. Gandhi, N. R., A. Moll, A. W. Sturm, R. Pawinski, T. Govender, U. Lalloo, K. Zeller, 
J. Andrews, and G. Friedland. 2006. Extensively drug-resistant tuberculosis as a 
cause of death in patients co-infected with tuberculosis and HIV in a rural area of South 
Africa. Lancet 368:1575-80. 
49. Geerligs, W. A., R. Van Altena, W. C. M. De Lange, D. Van Soolingen, and T. S. Van 
Der Werf. 2000. Multidrug-resistant tuberculosis: long-term treatment outcome in the 
Netherlands. Int J Tuberc Lung Dis 4:758-64. 
50. Glynn, J. R., A. C. Crampin, H. Traore, M. D. Yates, F. D. Mwaungulu, B. M. Ngwira, 
S. D. Chaguluka, D. T. Mwafulirwa, S. Floyd, C. Murphy, F. A. Drobniewski, and P. 
E. Fine. 2005. Mycobacterium tuberculosis Beijing genotype, northern Malawi. Emerg 
Infect Dis 11:150-3. 
51. Glynn, J. R., J. Whiteley, P. J. Bifani, K. Kremer, and D. van Soolingen. 2002. 
Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic 
review. Emerg Infect Dis 8:843-9. 
52. Gordon, S. V., R. Brosch, A. Billault, T. Garnier, K. Eiglmeier, and S. T. Cole. 1999. 
Identification of variable regions in the genomes of tubercle bacilli using bacterial 
artificial chromosome arrays. Mol Microbiol 32:643-55. 
53. Gordon, S. V., B. Heym, J. Parkhill, B. Barrell, and S. T. Cole. 1999. New insertion 
sequences and a novel repeated sequence in the genome of Mycobacterium 
tuberculosis H37Rv. Microbiology 145 ( Pt 4):881-92. 
54. Guiard, J., A. Collmann, L. F. Garcia-Alles, L. Mourey, T. Brando, L. Mori, M. 
Gilleron, J. Prandi, G. De Libero, and G. Puzo. 2009. Fatty acyl structures of 
mycobacterium tuberculosis sulfoglycolipid govern T cell response. J Immunol 
182:7030-7. 
55. Gutacker, M. M., B. Mathema, H. Soini, E. Shashkina, B. N. Kreiswirth, E. A. 
Graviss, and J. M. Musser. 2006. Single-nucleotide polymorphism-based population 
genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites. J Infect 
Dis 193:121-8. 
56. Gutacker, M. M., J. C. Smoot, C. A. Migliaccio, S. M. Ricklefs, S. Hua, D. V. 
Cousins, E. A. Graviss, E. Shashkina, B. N. Kreiswirth, and J. M. Musser. 2002. 
Genome-wide analysis of synonymous single nucleotide polymorphisms in 
Mycobacterium tuberculosis complex organisms: resolution of genetic relationships 
among closely related microbial strains. Genetics 162:1533-43. 
57. Gutierrez, M. G., S. S. Master, S. B. Singh, G. A. Taylor, M. I. Colombo, and V. 
Deretic. 2004. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium 
tuberculosis survival in infected macrophages. Cell 119:753-66. 
58. Hermans, P. W., D. van Soolingen, E. M. Bik, P. E. de Haas, J. W. Dale, and J. D. 
van Embden. 1991. Insertion element IS987 from Mycobacterium bovis BCG is located 
in a hot-spot integration region for insertion elements in Mycobacterium tuberculosis 
complex strains. Infect Immun 59:2695-705. 
59. Herzog, H. 1998. History of tuberculosis. Respiration 65:5-15. 
60. Ioerger, T. R., Y. Feng, K. Ganesula, X. Chen, K. M. Dobos, S. Fortune, W. R. 
Jacobs, Jr., V. Mizrahi, T. Parish, E. Rubin, C. Sassetti, and J. C. Sacchettini. 
General Introduction 
47 
Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis 
from multiple laboratories. J Bacteriol 192:3645-53. 
61. Jackson, M., G. Stadthagen, and B. Gicquel. 2007. Long-chain multiple methyl-
branched fatty acid-containing lipids of Mycobacterium tuberculosis: biosynthesis, 
transport, regulation and biological activities. Tuberculosis (Edinb) 87:78-86. 
62. Kang, B. K., and L. S. Schlesinger. 1998. Characterization of mannose receptor-
dependent phagocytosis mediated by Mycobacterium tuberculosis lipoarabinomannan. 
Infect Immun 66:2769-77. 
63. Kaufmann, S., and P. v. Helden (ed.). 2008. Handbook of Tuberculosis. 
64. Kaufmann, S. H. 2005. Robert Koch, the Nobel Prize, and the ongoing threat of 
tuberculosis. N Engl J Med 353:2423-6. 
65. Kruuner, A., S. E. Hoffner, H. Sillastu, M. Danilovits, K. Levina, S. B. Svenson, S. 
Ghebremichael, T. Koivula, and G. Kallenius. 2001. Spread of drug-resistant 
pulmonary tuberculosis in Estonia. J Clin Microbiol 39:3339-45. 
66. Kurepina, N., E. Likhoshvay, E. Shashkina, B. Mathema, K. Kremer, D. van 
Soolingen, P. Bifani, and B. N. Kreiswirth. 2005. Targeted hybridization of IS6110 
fingerprints identifies the W-Beijing Mycobacterium tuberculosis strains among clinical 
isolates. J Clin Microbiol 43:2148-54. 
67. Kurepina, N. E., S. Sreevatsan, B. B. Plikaytis, P. J. Bifani, N. D. Connell, R. J. 
Donnelly, D. van Sooligen, J. M. Musser, and B. N. Kreiswirth. 1998. 
Characterization of the phylogenetic distribution and chromosomal insertion sites of five 
IS6110 elements in Mycobacterium tuberculosis: non-random integration in the dnaA-
dnaN region. Tuber Lung Dis 79:31-42. 
68. Lee, J., M. Hartman, and H. Kornfeld. 2009. Macrophage apoptosis in tuberculosis. 
Yonsei Med J 50:1-11. 
69. Lee, K. S., V. S. Dubey, P. E. Kolattukudy, C. H. Song, A. R. Shin, S. B. Jung, C. S. 
Yang, S. Y. Kim, E. K. Jo, J. K. Park, and H. J. Kim. 2007. Diacyltrehalose of 
Mycobacterium tuberculosis inhibits lipopolysaccharide- and mycobacteria-induced 
proinflammatory cytokine production in human monocytic cells. FEMS Microbiol Lett 
267:121-8. 
70. Lew, J. M., A. Kapopoulou, L. M. Jones, and S. T. Cole. TubercuList--10 years after. 
Tuberculosis (Edinb) 91:1-7. 
71. Li, Q., C. C. Whalen, J. M. Albert, R. Larkin, L. Zukowski, M. D. Cave, and R. F. 
Silver. 2002. Differences in rate and variability of intracellular growth of a panel of 
Mycobacterium tuberculosis clinical isolates within a human monocyte model. Infect 
Immun 70:6489-93. 
72. Loewenberg, S. India reports cases of totally drug-resistant tuberculosis. Lancet 
379:205. 
73. Lok, K. H., W. H. Benjamin, Jr., M. E. Kimerling, V. Pruitt, M. Lathan, J. Razeq, N. 
Hooper, W. Cronin, and N. E. Dunlap. 2002. Molecular differentiation of 
Mycobacterium tuberculosis strains without IS6110 insertions. Emerg Infect Dis 8:1310-
3. 
74. Lopez, B., D. Aguilar, H. Orozco, M. Burger, C. Espitia, V. Ritacco, L. Barrera, K. 
Kremer, R. Hernandez-Pando, K. Huygen, and D. van Soolingen. 2003. A marked 
difference in pathogenesis and immune response induced by different Mycobacterium 
tuberculosis genotypes. Clin Exp Immunol 133:30-7. 
75. Mahillon, J., and M. Chandler. 1998. Insertion sequences. Microbiol Mol Biol Rev 
62:725-74. 
76. Malik, Z. A., C. R. Thompson, S. Hashimi, B. Porter, S. S. Iyer, and D. J. Kusner. 
2003. Cutting edge: Mycobacterium tuberculosis blocks Ca2+ signaling and phagosome 
maturation in human macrophages via specific inhibition of sphingosine kinase. J 
Immunol 170:2811-5. 
77. Manca, C., M. B. Reed, S. Freeman, B. Mathema, B. Kreiswirth, C. E. Barry, 3rd, 
and G. Kaplan. 2004. Differential monocyte activation underlies strain-specific 
Mycobacterium tuberculosis pathogenesis. Infect Immun 72:5511-4. 
Mª Henar Alonso Ezcurra 
48 
78. Manca, C., L. Tsenova, A. Bergtold, S. Freeman, M. Tovey, J. M. Musser, C. E. 
Barry, 3rd, V. H. Freedman, and G. Kaplan. 2001. Virulence of a Mycobacterium 
tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity 
and is associated with induction of IFN-alpha /beta. Proc Natl Acad Sci U S A 98:5752-
7. 
79. Mathema, B., N. E. Kurepina, P. J. Bifani, and B. N. Kreiswirth. 2006. Molecular 
epidemiology of tuberculosis: current insights. Clin Microbiol Rev 19:658-85. 
80. Matsunaga, I., A. Bhatt, D. C. Young, T. Y. Cheng, S. J. Eyles, G. S. Besra, V. 
Briken, S. A. Porcelli, C. E. Costello, W. R. Jacobs, Jr., and D. B. Moody. 2004. 
Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T 
cells. J Exp Med 200:1559-69. 
81. McAdam, R. A., P. W. Hermans, D. van Soolingen, Z. F. Zainuddin, D. Catty, J. D. 
van Embden, and J. W. Dale. 1990. Characterization of a Mycobacterium tuberculosis 
insertion sequence belonging to the IS3 family. Mol Microbiol 4:1607-13. 
82. McAdam, R. A. Q., S. & Guilhot, C. 2000. Mycobacterial Tansposons and their 
applications. Molecular Genetics of Mycobacteria American Society for Microbiology 
Press, ISBN 1-55581-191-4, Washington DC, USA.:69−84. 
83. McEvoy, C. R., A. A. Falmer, N. C. Gey van Pittius, T. C. Victor, P. D. van Helden, 
and R. M. Warren. 2007. The role of IS6110 in the evolution of Mycobacterium 
tuberculosis. Tuberculosis (Edinb) 87:393-404. 
84. McEvoy, C. R., R. M. Warren, P. D. van Helden, and N. C. Gey van Pittius. 2009. 
Multiple, independent, identical IS6110 insertions in Mycobacterium tuberculosis PPE 
genes. Tuberculosis (Edinb) 89:439-42. 
85. Mendiola, M. V., C. Martin, I. Otal, and B. Gicquel. 1992. Analysis of the regions 
responsible for IS6110 RFLP in a single Mycobacterium tuberculosis strain. Res 
Microbiol 143:767-72. 
86. Minnikin, D. E., L. Kremer, L. G. Dover, and G. S. Besra. 2002. The methyl-branched 
fortifications of Mycobacterium tuberculosis. Chem Biol 9:545-53. 
87. Mizrahi, V., and S. J. Andersen. 1998. DNA repair in Mycobacterium tuberculosis. 
What have we learnt from the genome sequence? Mol Microbiol 29:1331-9. 
88. Mokrousov, I., O. Narvskaya, T. Otten, A. Vyazovaya, E. Limeschenko, L. Steklova, 
and B. Vyshnevskyi. 2002. Phylogenetic reconstruction within Mycobacterium 
tuberculosis Beijing genotype in northwestern Russia. Res Microbiol 153:629-37. 
89. Mostowy, S., J. Inwald, S. Gordon, C. Martin, R. Warren, K. Kremer, D. Cousins, 
and M. A. Behr. 2005. Revisiting the evolution of Mycobacterium bovis. J Bacteriol 
187:6386-95. 
90. Mueller, P., and J. Pieters. 2006. Modulation of macrophage antimicrobial 
mechanisms by pathogenic mycobacteria. Immunobiology 211:549-56. 
91. Nerlich, A. G., C. J. Haas, A. Zink, U. Szeimies, and H. G. Hagedorn. 1997. 
Molecular evidence for tuberculosis in an ancient Egyptian mummy. Lancet 350:1404. 
92. Onwueme, K. C., C. J. Vos, J. Zurita, J. A. Ferreras, and L. E. Quadri. 2005. The 
dimycocerosate ester polyketide virulence factors of mycobacteria. Prog Lipid Res 
44:259-302. 
93. Ordway, D., M. Henao-Tamayo, M. Harton, G. Palanisamy, J. Troudt, C. Shanley, 
R. J. Basaraba, and I. M. Orme. 2007. The hypervirulent Mycobacterium tuberculosis 
strain HN878 induces a potent TH1 response followed by rapid down-regulation. J 
Immunol 179:522-31. 
94. Otal, I., A. B. Gomez, K. Kremer, P. de Haas, M. J. Garcia, C. Martin, and D. van 
Soolingen. 2008. Mapping of IS6110 insertion sites in Mycobacterium bovis isolates in 
relation to adaptation from the animal to human host. Vet Microbiol 129:333-41. 
95. Otal, I., C. Martin, V. Vincent-Levy-Frebault, D. Thierry, and B. Gicquel. 1991. 
Restriction fragment length polymorphism analysis using IS6110 as an epidemiological 
marker in tuberculosis. J Clin Microbiol 29:1252-4. 
General Introduction 
49 
96. Pethe, K., D. L. Swenson, S. Alonso, J. Anderson, C. Wang, and D. G. Russell. 
2004. Isolation of Mycobacterium tuberculosis mutants defective in the arrest of 
phagosome maturation. Proc Natl Acad Sci U S A 101:13642-7. 
97. Reed, M. B., P. Domenech, C. Manca, H. Su, A. K. Barczak, B. N. Kreiswirth, G. 
Kaplan, and C. E. Barry, 3rd. 2004. A glycolipid of hypervirulent tuberculosis strains 
that inhibits the innate immune response. Nature 431:84-7. 
98. Rohde, K., R. M. Yates, G. E. Purdy, and D. G. Russell. 2007. Mycobacterium 
tuberculosis and the environment within the phagosome. Immunol Rev 219:37-54. 
99. Rousseau, C., O. Neyrolles, Y. Bordat, S. Giroux, T. D. Sirakova, M. C. Prevost, P. 
E. Kolattukudy, B. Gicquel, and M. Jackson. 2003. Deficiency in mycolipenate- and 
mycosanoate-derived acyltrehaloses enhances early interactions of Mycobacterium 
tuberculosis with host cells. Cell Microbiol 5:405-15. 
100. Rousseau, C., N. Winter, E. Pivert, Y. Bordat, O. Neyrolles, P. Ave, M. Huerre, B. 
Gicquel, and M. Jackson. 2004. Production of phthiocerol dimycocerosates protects 
Mycobacterium tuberculosis from the cidal activity of reactive nitrogen intermediates 
produced by macrophages and modulates the early immune response to infection. Cell 
Microbiol 6:277-87. 
101. Russell, D. G. 2001. Mycobacterium tuberculosis: here today, and here tomorrow. Nat 
Rev Mol Cell Biol 2:569-77. 
102. Russell, D. G. 2007. Who puts the tubercle in tuberculosis? Nat Rev Microbiol 5:39-47. 
103. Russell, D. G., P. J. Cardona, M. J. Kim, S. Allain, and F. Altare. 2009. Foamy 
macrophages and the progression of the human tuberculosis granuloma. Nat Immunol 
10:943-8. 
104. Ryan, F. 1992. Tuberculosis: The greatest story never told. Swift Publishers, 
Worcestershire, Great Britain. 
105. Safi, H., P. F. Barnes, D. L. Lakey, H. Shams, B. Samten, R. Vankayalapati, and S. 
T. Howard. 2004. IS6110 functions as a mobile, monocyte-activated promoter in 
Mycobacterium tuberculosis. Mol Microbiol 52:999-1012. 
106. Salo, W. L., A. C. Aufderheide, J. Buikstra, and T. A. Holcomb. 1994. Identification 
of Mycobacterium tuberculosis DNA in a pre-Columbian Peruvian mummy. Proc Natl 
Acad Sci U S A 91:2091-4. 
107. Sampson, S., R. Warren, M. Richardson, G. van der Spuy, and P. van Helden. 
2001. IS6110 insertions in Mycobacterium tuberculosis: predominantly into coding 
regions. J Clin Microbiol 39:3423-4. 
108. Sampson, S. L., R. M. Warren, M. Richardson, G. D. van der Spuy, and P. D. van 
Helden. 1999. Disruption of coding regions by IS6110 insertion in Mycobacterium 
tuberculosis. Tuber Lung Dis 79:349-59. 
109. Sankar, S., S. Kuppanan, B. Balakrishnan, and B. Nandagopal. Analysis of 
sequence diversity among IS6110 sequence of Mycobacterium tuberculosis: possible 
implications for PCR based detection. Bioinformation 6:283-5. 
110. Schlesinger, L. S. 1993. Macrophage phagocytosis of virulent but not attenuated 
strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to 
complement receptors. J Immunol 150:2920-30. 
111. Selwyn, P. A., D. Hartel, V. A. Lewis, E. E. Schoenbaum, S. H. Vermund, R. S. 
Klein, A. T. Walker, and G. H. Friedland. 1989. A prospective study of the risk of 
tuberculosis among intravenous drug users with human immunodeficiency virus 
infection. N Engl J Med 320:545-50. 
112. Sinsimer, D., G. Huet, C. Manca, L. Tsenova, M. S. Koo, N. Kurepina, B. Kana, B. 
Mathema, S. A. Marras, B. N. Kreiswirth, C. Guilhot, and G. Kaplan. 2008. The 
phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host 
cytokine response but does not in itself confer hypervirulence. Infect Immun 76:3027-
36. 
113. Smith, I. 2003. Mycobacterium tuberculosis pathogenesis and molecular determinants 
of virulence. Clin Microbiol Rev 16:463-96. 
Mª Henar Alonso Ezcurra 
50 
114. Soto, C. Y., M. C. Menendez, E. Perez, S. Samper, A. B. Gomez, M. J. Garcia, and 
C. Martin. 2004. IS6110 mediates increased transcription of the phoP virulence gene in 
a multidrug-resistant clinical isolate responsible for tuberculosis outbreaks. J Clin 
Microbiol 42:212-9. 
115. Soysal, A., K. A. Millington, M. Bakir, D. Dosanjh, Y. Aslan, J. J. Deeks, S. Efe, I. 
Staveley, K. Ewer, and A. Lalvani. 2005. Effect of BCG vaccination on risk of 
Mycobacterium tuberculosis infection in children with household tuberculosis contact: a 
prospective community-based study. Lancet 366:1443-51. 
116. Sreevatsan, S., X. Pan, K. E. Stockbauer, N. D. Connell, B. N. Kreiswirth, T. S. 
Whittam, and J. M. Musser. 1997. Restricted structural gene polymorphism in the 
Mycobacterium tuberculosis complex indicates evolutionarily recent global 
dissemination. Proc Natl Acad Sci U S A 94:9869-74. 
117. Stackebrandt, E., F. A. Rainey, and N. L. Ward-Rainey. 1997. Proposal for a new 
hierarchic classification system Actinobacteria classis nov Int J Syst Evol Microbiol 
47:479-91  
118. Stewart, G. R., J. Patel, B. D. Robertson, A. Rae, and D. B. Young. 2005. 
Mycobacterial mutants with defective control of phagosomal acidification. PLoS Pathog 
1:269-78. 
119. Sturgill-Koszycki, S., P. H. Schlesinger, P. Chakraborty, P. L. Haddix, H. L. Collins, 
A. K. Fok, R. D. Allen, S. L. Gluck, J. Heuser, and D. G. Russell. 1994. Lack of 
acidification in Mycobacterium phagosomes produced by exclusion of the vesicular 
proton-ATPase. Science 263:678-81. 
120. Thierry, D., A. Brisson-Noel, V. Vincent-Levy-Frebault, S. Nguyen, J. L. Guesdon, 
and B. Gicquel. 1990. Characterization of a Mycobacterium tuberculosis insertion 
sequence, IS6110, and its application in diagnosis. J Clin Microbiol 28:2668-73. 
121. Thierry, D., M. D. Cave, K. D. Eisenach, J. T. Crawford, J. H. Bates, B. Gicquel, and 
J. L. Guesdon. 1990. IS6110, an IS-like element of Mycobacterium tuberculosis 
complex. Nucleic Acids Res 18:188. 
122. Tortoli, E. 2006. The new mycobacteria: an update. FEMS Immunol Med Microbiol 
48:159-78. 
123. Trunz, B. B., P. Fine, and C. Dye. 2006. Effect of BCG vaccination on childhood 
tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and 
assessment of cost-effectiveness. Lancet 367:1173-80. 
124. Tsolaki, A. G., S. Gagneux, A. S. Pym, Y. O. Goguet de la Salmoniere, B. N. 
Kreiswirth, D. Van Soolingen, and P. M. Small. 2005. Genomic deletions classify the 
Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J Clin 
Microbiol 43:3185-91. 
125. Tufariello, J. M., J. Chan, and J. L. Flynn. 2003. Latent tuberculosis: mechanisms of 
host and bacillus that contribute to persistent infection. Lancet Infect Dis 3:578-90. 
126. Turcios, L., Y. Casart, I. Florez, J. de Waard, and L. Salazar. 2009. Characterization 
of IS6110 insertions in the dnaA-dnaN intergenic region of Mycobacterium tuberculosis 
clinical isolates. Clin Microbiol Infect 15:200-3. 
127. Udwadia, Z. F., R. A. Amale, K. K. Ajbani, and C. Rodrigues. Totally drug-resistant 
tuberculosis in India. Clin Infect Dis 54:579-81. 
128. van der Wel, N., D. Hava, D. Houben, D. Fluitsma, M. van Zon, J. Pierson, M. 
Brenner, and P. J. Peters. 2007. M. tuberculosis and M. leprae translocate from the 
phagolysosome to the cytosol in myeloid cells. Cell 129:1287-98. 
129. van Embden, J. D., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. 
Gicquel, P. Hermans, C. Martin, R. McAdam, T. M. Shinnick, and et al. 1993. Strain 
identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations 
for a standardized methodology. J Clin Microbiol 31:406-9. 
130. van Soolingen, D., L. Qian, P. E. de Haas, J. T. Douglas, H. Traore, F. Portaels, H. 
Z. Qing, D. Enkhsaikan, P. Nymadawa, and J. D. van Embden. 1995. Predominance 
of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin 
Microbiol 33:3234-8. 
General Introduction 
51 
131. Vera-Cabrera, L., M. A. Hernandez-Vera, O. Welsh, W. M. Johnson, and J. Castro-
Garza. 2001. Phospholipase region of Mycobacterium tuberculosis is a preferential 
locus for IS6110 transposition. J Clin Microbiol 39:3499-504. 
132. Vergne, I., R. A. Fratti, P. J. Hill, J. Chua, J. Belisle, and V. Deretic. 2004. 
Mycobacterium tuberculosis phagosome maturation arrest: mycobacterial 
phosphatidylinositol analog phosphatidylinositol mannoside stimulates early endosomal 
fusion. Mol Biol Cell 15:751-60. 
133. Walburger, A., A. Koul, G. Ferrari, L. Nguyen, C. Prescianotto-Baschong, K. 
Huygen, B. Klebl, C. Thompson, G. Bacher, and J. Pieters. 2004. Protein kinase G 
from pathogenic mycobacteria promotes survival within macrophages. Science 
304:1800-4. 
134. WHO. 2011. Global tuberculosis control 2011. World Health 
Organization/HTM/TB/2011.16 
 
135. WHO. 1994. TB: a global emergency. World Health Organization. . 
136. WHO. 1999. What is DOTS? A guide to understanding the WHO-recommended TB 
control strategy known as DOTS. World Health Organization. . 
137. Zhang, M., J. Gong, Z. Yang, B. Samten, M. D. Cave, and P. F. Barnes. 1999. 
Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in 
human macrophages. J Infect Dis 179:1213-7. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter I: Characterization of M. tuberculosis Beijing strain GC1237 
55 
Introduction 
Since the first description in 1995, M. tuberculosis Beijing strains became a main health 
problem worldwide. Strains of this genotype are widespread in many regions of the 
world and frequently cause epidemic outbreaks (5, 10, 20). The distribution of Beijing 
strains differs, being low in Western Europe, although a slight increase in the number 
of Beijing strains has been detected over time (5). Recent studies have illustrated the 
high frequency of this genotype in different regions of China being around 80%. 
Moreover, according to spoligotyping database (SpolDB4), strains from this genotype 
were found to be present in the largest number of countries globally (13% of global 
isolates) (22). This family is generally considered to be associated with drug-resistance 
(2, 6, 7), although this association has not been found in all geographic settings (1, 20).  
The predominance of this lineage probably results from genetic advantages, including 
unidentified virulence factors and the modulation of specific host responses not yet 
thoroughly investigated. For example, a study using human macrophages found that 
Beijing strains grew significantly faster than non-Beijing strains (49). However, when it 
was analyzed whether this characteristic was common to Beijing strains, it was found 
that not all Beijing strains grew rapidly (46). In addition to this, there are some studies 
that relate hypervirulence of Beijing strains with production of PGL (12, 39), which is a 
putative virulence factor that attenuates the host’s innate immune response and ability 
to control infection (39). The pks15/1 locus, described to be polymorphic among 
members of the MTBC (14), is involved in the biosynthesis of the PGL and it is 
characteristic of Beijing strains to have an intact pks15/1 region for which they could 
produce a functional Pks15/1 synthase (14, 43, 45). However, when monocytes were 
infected with a non-Beijing strain transformed with the functional pks15/1 gene, growth 
was similar to the wild-type non-Beijing strain, suggesting that PGL did not influence 
growth of M. tuberculosis (22). Another example of virulence factor could be that 
Beijing strains have a basal level of transcription for the dormancy regulon genes 
(dosR, Rv3130c, hspX, fdxA and narX) that is up to 50-fold higher than that of non-
Beijing genotype strains (40). More recently, it was found that Beijing strains possess 
two copies of dosR which was suggested to be partly responsible for the constitutive 
dosR over-expression phenotype (15). 
Beijing strains are currently attracting considerable worldwide attention because they 
display important pathogenic features (30, 49). 
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Subfamilies Beijing 
Members of this family were subdivided into modern/typical and ancient/atypical 
sublineages based on the analysis of the NTF locus (34). In addition to the 
characteristic deletion of the DR locus, Tsolaki et al. described LSPs (RD105, RD142, 
RD150, and RD181) which further divided this family into four monophyletic subgroups 
(47). They sought LSPs that were unique-event polymorphism (UEPs) within Beijing 
genotype. A total of 21 distinct LSPs were identified that were present in H37Rv but 
absent from the Beijing strains. Based on the frequency of these 21 LSPs, three 
classes were identified: four common LSPs (RD105, RD149, RD152 and RD207) were 
found deleted in all Beijing strains. RD207 (also detected by spoligotyping), RD149 and 
RD152 are associated with mobile genetic elements and may not be UEPs. Three 
LSPs (RD181, RD142 and RD150) were found variably deleted and these are not 
associated with either repetitive DNA or mobile genetic elements therefore likely to 
represent UEPs and the remaining 14 LSPs were unique to a single strain. Based on 
this, Beijing lineage is principally defined by deletion RD105, which is a useful marker 
for the identification of this family. RD181, RD142 and RD150 further divided this family 
into four monophyletic subgroups. RD142 and RD150 are only observed in strains with 
RD181 being this the more ancestral event (47). After that, the RD207 was included 
within the monophyletic subgroups of the East-Asian lineage (19) (Figure 11). 
 
 
Figure 11: Subfamilies Beijing. (A) Schematic phylogenetic tree of the M. tuberculosis Beijing 
family. The name of the LSPs or regions of difference are shown in rectangles. The evolutionary 
process of the lineage (ancient to modern) is also indicated. (B) Genes affected for the deletion 
of the RD. The genes affected for the deletion of RD149 and RD152 (common in all Beijing 
strains) are included (*). Adapted from (19, 31, 47). 
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Some authors have proposed an evolutionary pathway of Beijing lineage based on RD 
deletions and on the IS6110 insertions in the NTF region indicating that ancient strains 
have neither deletion RD181 nor insertion of IS in NTF region (16). However, recent 
studies have shown that not all ancient/atypical strains are RD181 intact which 
indicates that the RD181 deletion occurred before the insertion of an IS element in the 
NTF locus (24, 31) (Figure 11). Moreover, it has been demonstrated that the 3’ 
common truncation in the gene Rv2820c (RD207, figure 11B) of Beijing strains could 
enhance mycobacterial virulence ex vivo and in vivo. This enhancement was not 
observed in non-Beijing strains with intact gene (29).  
IS6110 in Beijing family 
Three features which characterize this family are related to IS6110 insertion sequence: 
The presence of one copy of this element in the oriC region, the deletion of the right-
site DR spacers (the so-called deletion RD207) and similar RFLP multiband pattern 
profile (22). Members of this genotype usually are high copy number of IS6110 
(between 15-25 copies per genome) suggesting the relevance of this element in the 
variability of their genomes. IS6110 insertions, genetic reorganizations and deletions 
(gene deletion can occur by homologous recombination between 2 flanking copies of 
IS6110) are some of the mechanisms proposed to be responsible for differences in the 
virulence phenotypes of M. tuberculosis. Supporting this possibility, sublineages of this 
family were identified to carry an important genome duplication that involves up to 8% 
of the genome (corresponding to more than 300 genes). Copies of IS6110 were 
identified flanking that duplication, thus suggesting the occurrence of homologous 
recombination event mediated by this IS (15). It has been demonstrated that IS6110 
can upregulate downstream genes through an outward-directed promoter in its 3’ end 
(41, 44). The fact that the Beijing lineage contains a larger number of IS6110 copies 
than other lineages (21) could be related to the special characteristics of this family in 
terms of virulence and capacity for rapid dissemination. 
The clinical isolate M. tuberculosis GC1237 
M. tuberculosis GC1237, which belongs to the Beijing family, has been responsible for 
different epidemic outbreaks in the Gran Canary Island. The first case recognized on 
the island with this strain was a refugee from Liberia (Africa) diagnosed with smear-
positive pulmonary tuberculosis in 1993. Its explosive spread in this community over 
the next few years was reported in 2001 (11). Nowadays, this strain continues being 
predominant in the area due to its rapid and successful dissemination within the 
community (Table 1). 
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Table 1. Percentage of Beijing isolates in Canary Island from 1991 to 2008. Adapted 
from (11, 33). 
Period Method Total isolates Beijing percent (%) 
1991-1992 RFLP 85 0 
1993 RFLP, spoligotyping 179 5.5 
1994 RFLP, spoligotyping 148 8.1 
1995 RFLP, spoligotyping 110 16.4 
1996 RFLP, spoligotyping 129 27.1 
1999 Spoligotyping 40 22.5 
2002 Spoligotyping 154 28.57 
2003 Spoligotyping 49 28.57 
2004 Spoligotyping 120 29.16 
2007-2008 Spoligotyping 214 25.23 
 
 
It was reported that one isolate with the same RFLP was detected in Madrid. Although 
in that study the strain did not show increased intracellular replication (THP1-cells) and 
it was not distinguishable from other isolates (3), the increased capacity of infection 
and the high success rate of this strain to spread rapidly could be a consequence of 
genetic advantages and unidentified mechanisms of virulence not yet thoroughly 
investigated. 
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Objectives 
• To classify the clinical isolate M. tuberculosis GC1237 within the Beijing family with 
the analysis of several Region of Differences (RD). 
• To localize all the copies of IS6110 insertion sequence in the genome of M. 
tuberculosis GC1237. 
• To study the direct repeats flanking each copy of IS6110 of GC1237. 
• To analyze the orientation and distance to neighbouring genes of each copy of 
IS6110 present in M. tuberculosis GC1237. 
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Material and Methods 
Bacterial strains, culture media, and growth conditions 
BACs library of M. tuberculosis GC1237 (Figure 14A) was used in this study. This 
library, which represents around 75% of the chromosome of GC1237, was constructed 
in a previous work using pBeloBAC11 plasmid. 
E. coli DH10B cultures were used in order to isolate the BACs. Strains were grown at 
37ºC in Lurina-Bertani (LB) broth supplemented with chloramphenicol (CM) 
(12.5μg/ml). 
The clinical isolate M. tuberculosis GC1237, M. bovis BCG and the reference M. 
tuberculosis H37Rv strains were used in this work. Mycobacterial strains were grown at 
37ºC in Middlebrook 7H9 broth supplemented with albumin-dextrose-catalase (ADC) 
and 0.05% Tween 80 or in Middlebrook 7H10 medium Bacto agar supplemented with 
oleic acid-albumin-dextrose-catalase (OADC) (Difco Laboratories, Detroit, Mich.) and 
0.05% Tween 80 (23). Liquid cultures were grown to logarithmic phase for 
mycobacterial DNA extraction.  
M. tuberculosis manipulation was carried out in a biosafety level 3 (BSL3) laboratory 
(facilities notification A/ES/04/I-05; activity A/ES/06/03). 
Mycobacterial DNA extraction 
Genomic DNA of mycobacterial strains was isolated using the CTAB method (48). 
Briefly, mycobacteria were resuspended in 400μl TE (100mM Tris/HCl, 10mM EDTA, 
pH 8.0) and heated for 20min at 80ºC. Samples were slightly cooled at room 
temperature before adding 0.5mg lysozyme and were then incubated for at least 1h at 
37ºC. Subsequently, 0.05mg proteinase K dissolved in 75μl 10% SDS were added and 
the suspension warmed for 10min at 65ºC. Hereafter, 100μl 5M NaCl and 100μl 
CTAB/NaCl (10% CTAB in 0.7M NaCl) pre-warmed at 65ºC were added and samples 
incubated for further 10min at 65ºC. Genomic DNA was extracted by adding 750μl of 
chloroform:isoamylalcohol 24:1 (v/v). Samples were mixed by vortexing for 10s before 
centrifugation (13,000rpm for 5min). The upper (aqueous) phase was transferred to a 
fresh tube containing 450μl isopropanol and samples incubated overnight at -20ºC. 
Precipitated nucleic acids were collected by centrifugation (13,000rpm for 10min at 
4ºC). The pellets were dissolved in 50μl double-distilled water and extracted DNA was 
quantified by Abs260 readings using a ND-1000 spectrophotometer (NanoDrop 
Technologies). 
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BAC DNA extraction 
BAC DNA extraction was done as previously described by Birnboim et al. (8) with 
minor modifications. Briefly, 100ml of BAC-transformed E. coli was prepared in LB 
medium containing 12.5μg/ml CM, and the cultures were grown overnight at 37ºC with 
vigorous and continuous agitation. Then, the bacterial cells were collected by 
centrifugation. The bacterial pellet was softly resuspended in a solution of 5ml of 50mM 
glucose 10mM EDTA, 25mM Tris pH 8, 200mg lysozime was added to the tube and a 
solution of 4ml of ice-cold NaAc pH 4.8 was added to the mixture. The tube was placed 
on ice and the precipitated debris was removed by centrifugation. Then, 14ml of 
chloroform/isoamilic alcohol (24/1) were added to the supernatant and after 
centrifugation the aqueous phase was transferred to a new microfuge tube. DNA of the 
BACs was precipitated adding isopropanol and finally obtained by centrifugation. 
Identification of genomic deletions and analysis of pks15/1 region in M. 
tuberculosis GC1237 strain 
The study of the genomic deletions of the regions of difference 105, RD142, RD150, 
RD181 and RD207 in M. tuberculosis GC1237 strain, which identify and 
phylogenetically sub-classify the Beijing lineage, was performed by PCR. Other regions 
of difference (RD108, RD110a, RD127, RD129, RD139BW, RD149, RD152, RD165, 
RD166 and RD182a) were also analysed. The primers used in these amplifications 
were as described elsewhere (47) and are included in Table 1 of Annex I. The PCR 
was carried out in a total volume of 50μl, containing 0.5μg of DNA, 5μl of 10x PCR 
buffer, 200μM dNTPs, 12.5pmol of each primer and 1U of Taq Gold polymerase 
(Roche). Before the amplification, the template was initially denatured by incubation at 
94ºC for 9min then the amplification was performed in 35 cycles of 94ºC for 30s, 
corresponding annealing temperature for 30s, and 72ºC for 2 to 3min depending on the 
amplified product. After the last cycle, the samples were incubated at 72ºC for 10min. 
The RD deletions were confirmed by DNA sequencing using H37Rv as reference 
genome. 
The pks15/1 polymorphism in this clinical isolate was determined by PCR, as above 
described, with the primers pks1I and pks1J (Table 2 of Annex I) and sequencing and 
analyzed as previously described (14). 
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Location of the copies of IS6110 insertion sequence in M. tuberculosis GC1237 
• BACs with IS6110 
The study of the presence of IS6110 insertion sequence in GC1237 BACs library was 
carried out by PCR with the specific primers of this sequence, Gab 1 and Gab 2 (42) 
(Table 5 of Annex I) and was performed as explained before in this chapter changing 
the final volume to 25μl. After that, PCR products were analyzed by 0.8% agarose gel 
electrophoresis and visualized by ethidium bromide staining. 
• Ligation mediated PCR (LMPCR) 
LMPCR was used to locate the copies of IS6110 as previously described by Prod’hom 
et al. (38). This technique amplifies both ends of each copy of IS6110. Briefly, BACs 
containing IS6110 and genomic DNA of M. tuberculosis GC1237 were digested with 
SalI or with SmaI and ligated to a linker containing a SalI restriction site or a SmaI 
restriction site, respectively. The resulting template was then digested by SalI or with 
SmaI. PCR was performed using ISA1 and ISA3 (Table 2 Annex I), specific primers for 
IS6110 directed outwards (32) and the common linker primer Salgd (38) (Table 2 
Annex I) (Figure 12). PCR products were purified using GFX PCR DNA gel band 
purification kit (Amersham Pharmacia Biotech) and the restriction enzyme ExoSAP-IT® 
(Affymetrix).  
 
Figure 12: Ligation Mediated PCR (LMPCR). (1) Total DNA or BACs containing IS6110 are 
restriction digested, (2) linkers are ligated, (3) unspecified ligations are removed and (4) 
transposon junctions are PCR amplified. 
 
The amplified products were sequenced using CNIO service with the corresponding 
oligonucleotides and when a match was found for a flanking region in the databases, 
additional primers were designed to verify the point of insertion. PCR amplification was 
carried out as previously described in this chapter with genomic DNA of GC1237. PCR 
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products included the complete sequence of IS6110 and approximately 100-200 bp of 
both flanking sequences.  
Each amplified PCR product was sequenced and analysed for homology with 
Tuberculist (http://genolist.pasteur.fr/TubercuList), Bovilist 
(http://genolist.pasteur.fr/BoviList) and NCBI (http://www.ncbi.nlm.nih.gov/) database 
Blast analysis. 
• PCR with specific primers 
In addition, we designed primers to amplify the different regions that might include 
IS6110 based in the published genome locations of IS6110 in 210 and W Beijing 
strains (4). As controls H37Rv and BCG genomes were used. 
The primers used to localize IS6110 are collected in Table 5 of Annex I. 
Determination of Direct Repeats (DR) of each copy of IS6110 in GC1237 genome 
The DR generated by the mechanism of the transposition of IS6110 was determined 
with the sequence analysis of the flanking regions of each copy of IS6110 in GC1237 
genome. 
Design of a multiplex PCR to detect the clinical isolate M. tuberculosis GC1237 
To detect the clinical isolate M. tuberculosis GC1237 faster than by RFLP and 
spolygotyping, a multiplex PCR based on the detection of two of its IS-locations was 
designed in this study. The first target (fragment of 550bp) is the IS6110 located 
between dnaA:dnaN genes which is common to all Beijing strains (26) and it is 
amplified with the primers dnaII and dnaAIII (Table 3 of Annex I). This last 
oligonucleotide is more specific to Beijing genotype as it anneals in the 3’ end of the 
IS6110 and the following nucleotides of that region. The second target, amplified with 
primers Rv2179cfw and Rv2179crv (Table 3 of Annex I), is specific of GC1237 (see 
results of this chapter). In this case, the GC1237-PCR product includes the entire 
sequence of IS6110 (1626 bp) and the PCR fragment of the rest of the strains 
correspond to 261 bp. 
The multiplex PCR was carried out as describe above with minor modifications. Briefly, 
PCR was performed in a final volume of 25μl, containing 200μM dNTPs, 50mM KCl, 
1.5mM MgCl2, 2.5U of puReTaq DNA polymerase (puReTaq Ready-to-go, GE 
Healthcare), reaction buffer, 25μM of each primer and 0.5μg of DNA. Temperature 
cycling conditions included 94°C for 10 min, followed by 35 cycles of 94°C for 30s, 
70°C for 30s, and 72°C for 1.5min, and 10min for a final extension at 72°C. PCR 
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products were analyzed by 1% agarose gel electrophoresis and visualized by ethidium 
bromide staining. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter I: Characterization of M. tuberculosis Beijing strain GC1237 
65 
Results and discussion 
Characterization of M. tuberculosis GC1237: study of Regions of difference (RD) 
and pks15/1 region 
Comparative whole-genome hybridization of Beijing strains showed LSPs also known 
as RDs, which subdivide the Beijing family into at least four phylogenetic subgroups 
(47), raising the possibility that there are phenotypic differences within the Beijing 
family. The subdivisions are made on the basis of RD105 and RD207, and the variable 
appearance of RD181, RD150 and RD142 deletions (47). With the aim to classify 
GC1237 strain within this genotype, these regions of difference were studied and the 
results indicated that GC1237 has deleted RD105 and RD207, as all Beijing strains, 
and RD181. This strain also has deleted RD149 and RD152 which is common to find in 
all Beijing strains (25). 
A copy of IS6110 without flanking DR was detected in RD152 and in RD207 confirming 
a recombination event of two previous copies of IS6110 resulting in the loss of these 
regions. This finding is in agreement with different studies indicating that strains with a 
high number of IS6110 copies (>14) have lost genomic regions more often than strains 
with only few copies (9), as in the case of GC1237. RD149 has also been associated 
with recombinations between mobile genetic elements (47) but IS6110 is not implicated 
in the deletion of this region as we show the absence of IS6110 in this region in 
GC1237 (Figure 14B-14C). 
The deletion of other RD observed in clinical strains belonging to Beijing family from 
East Asia clade was also studied (RD110a, RD127, RD129, RD139BW, RD165, 
RD166 and RD182a) (47); GC1237 has these RD intact. However, the possibility of the 
presence of specific deleted regions in GC1237 is not ruled out. The high number of 
different combinations of deleted RD that we can find in Beijing strains shows that 
although the Beijing genotype is considered as a homogenous group, genetic variability 
can be found these strains. 
The study of pks15/1 region revealed an intact gene in GC1237 indicating that this 
strain could retain the ability to produce functional glycolipid PGL in contrast to the 
reference strain H37Rv. 
Another feature of GC1237 is the presence of two extra regions, Mb2047c-Mb2048c 
and Mb3356-Mb3357, with respect to H37Rv. These regions, present in other 
sequenced strains of M. tuberculosis and M. bovis, do not correspond exactly to the 
described RvD1 and RvD5, respectively. The two IS6110 localized in these regions 
suggest possible implication in new genomic reorganizations with loss of these regions. 
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By studying the flanking regions of IS6110 compared with H37Rv, we have detected as 
many new regions as loss of other ones. These findings confirm the implication of 
IS6110 in genomic reorganizations and its capacity to generate genomic plasticity. 
Different strategies to localize all copies of IS6110 insertion sequence in M. 
tuberculosis GC1237 
In this study, nineteen different copies of IS6110 were localized in GC1237 applying 
two main strategies: LMPCR technique with BAC library and genomic DNA of the 
studied strain and PCR with designed primers based on the known points of the 
insertion sequence in the two reference Beijing strains 210 and W (4). The presence of 
IS6110 in the representative GC1237 BAC library (Figure 14A) was detected using 
PCR with specific primers of this element and 10 of total of 59 BACs were positive for 
IS6110 (Table 2). Using LMPCR the ten different copies were localized in GC1237. 
This technique was further utilized with genomic DNA (Figure 13A) to detect the rest of 
the copies present in GC1237 by amplifying one or both ends of each copy of IS6110 
and its flanquing sequences.  
As a second strategy, based on genome known locations of IS6110 in 210 and W 
strains (4), we designed primers to amplify the different regions that might include 
IS6110 in the studied strain (Figure 13B). This design was realized using M. 
tuberculosis H37Rv as genome reference.  
 
 
Figure 13: Example of PCR analysis. (A) LMPCR of GC1237 genome. The flanking regions of 
IS6110 were amplified with the oligonucleotides ISA1 or ISA3 and SalgD. (B) PCR analysis of 
different regions that might include IS6110 based in genome known locations of IS6110 in 210 
and W Beijing strains. Each set of four reactions consists of two positive controls PCR assay 
with genomic DNA of H37Rv and BCG (H+ and B+, respectively), PCR with genomic DNA of 
GC1237 and a negative control assay. 
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LMPCR technique was useful to determine the points of insertion of this sequence in 
M. bovis strains (35), which contain very minor number of IS6110 (1 to 5). However, 
strains of M. tuberculosis present a high level of copies of IS6110 and the probability to 
localize all the copies by LMPCR technique lowers significantly. In this regard, the use 
of BAC library of GC1237 strain has been a successful tool. 
By RFLP, GC1237 strain presents 15-16 copies of IS6110. However, using two 
different molecular strategies it was possible to determine the exact location of the 19 
copies of IS6110 in GC1237 genome (Table 2). Except for some sequenced strains, to 
our knowledge this was the first time to localize all IS6110 copies in a strain of M. 
tuberculosis containing a high number of this element. 
The three Beijing strains share a high number of locations of IS6110 
Comparing the three Beijing strains (210, W and GC1237) it was observed that they 
share nine IS6110 positions, these include the two insertions characteristic of the 
Beijing family, the insertion A1, and in the Direct Repeat Region (Figure 4C and Table 
2). GC1237 strain contains eight copies of IS6110 in intergenic regions and eleven in 
intragenic regions (Table 2). Of the eleven interrupted genes, pip, ctpD, idsB and 
Rv2180c are involved in bacterial metabolism and respiration, four correspond to 
genes with no predicted function and three are members of the PE and PPE family. 
The interruption of these ORFs by the IS6110 probably causes their no-transcription 
and consequently, these genes would be non-essential for M. tuberculosis. 
Interestingly, it was found that the two copies of IS6110 within the PPE34 were 
consecutive and in the same orientation but the second copy lacked 60 bp at the 5’ 
end. Moreover, the copy located between PPE39 and PPE40 genes, is also present in 
H37Rv but the region is longer in the studied strain. 
Numerous studies have indicated that IS6110 has some preferential points of insertion 
(hot-spots) in the genome. Both IS1547 (ipl loci) is an example of a site of intensive 
insertion of this element (17, 18). The studied strain corroborates this hot-spot with the 
insertion of a copy of IS6110 in each ipl region: one between Rv0794c and Rv0797, 
which is in the opposite orientation in H37Rv and other studied Beijing strains and the 
second one was located between Rv3324A:Rv3327 in the same orientation as H37Rv. 
With the exception of the copy of IS6110 located between dnaA:dnaN genes, we have 
not found any copy of IS6110 in the quarter of M. tuberculosis GC1237 circular 
genome surrounding these genes (Figure 14C). This fact was also observed in the two 
Beijing strains 210 and W. This result is in agreement with other authors when they 
have characterized IS6110 integration loci (43). This finding could indicate that in this 
part of the genome there are no specific sequences or regions recognised by the 
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sequence or that these genes have an important role in M. tuberculosis and the 
interruption or modulation of their expression could result in no benefit or even be a 
disadvantage for the bacteria. 
It is frequent to find at least a copy of IS6110 in the NTF region in strains belonging to 
Beijing family (37) and some members of this family may have a second insertion 
within this locus such as the MDR strain W and its progenies (5, 27). However, the 
absence of IS6110 in NTF locus is characteristic of ancestral sublineages within the 
Beijing genotype (26). Due to the course of evolution, some strains (“modern” 
sublineages) have acquired the insertion of IS6110 in this region (27). In addition to 
this, some authors have proposed an evolutionary pathway of the Beijing lineages 
based on the RD deletions and on the IS6110 insertions in the NTF region indicating 
that ancient strains could have the deletion of RD181 and modern strains have RD181 
and at least one insertion of IS6110 in NTF region indicating that the RD181 deletion 
occurred before the insertion of an IS6110 in the NTF locus (24, 31). Our results are in 
agreement with this classification because GC1237 presents a deletion in RD181 but 
lacks IS6110 in NTF locus. 
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Figure 14: Circular plots of GC1237 genome prepared with DNAplotter. (A) BACs regions 
of the representative library of M. tuberculosis GC1237. (B) Genomic regions absent in M. 
tuberculosis H37Rv (RvDs), lacking regions of difference (RD) and extra regions in GC1237 
strain. (C) Locations of IS6110 in the Beijing strains GC1237, 210 and W. The Direct Repeat 
region (or DR locus) and the dnaA:dnaN region are indicated. 
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Table 2: Insertion sites of IS6110 in M. tuberculosis GC1237, 210 and W. 
GENES a 
GC1237 
210 d W e 
GC1237 genome b BACsc
Rv0001 (dnaA):Rv0002 (dnaN) + - + + 
Rv0794c:Rv0797 (IS1547) + B4   
Rv0840c (pip) + -   
Rv1135c  B11 + + 
Rv1371 + C7 + + 
*Rv1469 (ctpD) + C10 + + 
Rv1754c  D4 + + 
Rv1754c-Rv1765c (RD152) + D4   
Rv1798:Rv1799 (lppT)  D6 +  
Rv1917c (PPE34)  D9 +  
Rv1917c (PPE34)  D9 + + 
Rv1917c (PPE34) ++ D9   
Rv2016 + D12 + + 
MT2080 (Mb2047c):MT2081 (Mb2048c) + D12   
Rv2077A:Rv2078 + E1   
Rv2104c:Rv2107 (PE22)  E1 +  
Rv2104c:Rv2107 (PE22)  E1  + 
Rv2107 (PE22):Rv2108 (PPE36)  E1 +  
*Rv2180c + -   
Rv2286c + E7   
Rv2352c (PPE38)  E8 + + 
Rv2353c (PPE39):Rv2356c (PPE40) + E8   
Rv2813-Rv2820c (RD207) + - + + 
*Rv3018A (PE27A):Rv3019c (esxR) + - + + 
Rv3019c (esxR):Rv3020c (esxS)  - + + 
Rv3128c  G1 + + 
Rv3128c:Rv3129  G1  + 
Rv3178:Rv3179  - +  
Rv3179:Rv3180c  - + + 
Rv3184:Rv3187  - + + 
Rv3324A:Rv3327 (IS1547) + - + + 
Rv3383c (idsB) + G7 + + 
*Rv3427c (IS1532):Rv3428c (IS1532) + G8 + + 
 
a Gene names come from the M. tuberculosis H37Rv genome map. One gene is listed when the location of insertion is 
in that gene and two genes are listed when the insertion of IS6110 is between both. 
b Sites are in order of appearance on the M. tuberculosis H37Rv genome map. 
c Name of BAC. 
d, e The plus sign indicates that the M. tuberculosis 210 and W contain a copy of IS6110 in those regions (4). 
* Candidate locations to act as a promoter. 
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The open reading frames represent 91% of M. tuberculosis genome (13) but in 
GC1237 the insertion of IS6110 into coding regions occurred in 42% of the cases then, 
apparently the transposition is relatively more frequent in intergenic regions. Our 
results agreed with other studies that found that 58% of discrete IS6110 insertion sites 
occurred within coding regions in M. tuberculosis (43) and in M. bovis strains (35). In 
this context, because of the insertion of IS6110 in possible promoter regions the 
probability of IS6110 influencing the expression of the neighbouring genes is 
increased. It is necessary to take into account that the locations of IS6110 observed in 
the different genomes are the result of the transposition and selection of viable 
infecting mycobacteria because when insertion occurs in a gene necessary for 
virulence, we cannot observe it.  
Analysis of Direct Repeats (DR) of each copy of IS6110 in GC1237 genome 
The flanking regions of each of the nineteen copies of IS6110 in GC1237 genome were 
analyzed and the presence of DR of 3-4 nucleotides at the extremities of sixteen 
IS6110 sequences were detected (Table 3). These DR indicate that the presence of 
IS6110 was due to transposition events. The other three copies analysed were not 
flanked by DRs. Genomic regions loss was observed in two of these locations which 
correspond to Rv1754c-Rv1765c (RD152) and RD207 respectively, and this is 
probably a consequence of recombination between two adjacent copies of IS6110 (47). 
The last of the three IS6110 elements without DR, which was localized between 
Rv0794c:Rv0797, was in the opposite orientation with respect to the IS6110 in the 
reference genome H37Rv. The IS6110 in H37Rv contains DR and the lack of DR in the 
studied IS6110 could be explained by reorganization of this region in GC1237 genome.  
The two copies localized in PPE34 are flanked by the direct repeat sequence TTA. 
These DRs were located in the 5’ end of the first IS6110 and the 3’ end of the second 
one, probably due to simultaneous transposition of the two copies. The DR sequences 
differ among each other indicating the lack of transposition specificity. 
There are very few studies where authors report DR flanking IS6110 (32, 35). In these 
studies the number of copies is low (<6) and all of them were flanked by DR, indicating 
that these IS6110 are consequence of transposition. In our study, because of the high 
number of copies of IS6110 we observed some copies flanked by DR and other copies 
without DR suggesting that the probability of rearrangement process between copies 
rises when the number of those increases producing more variability among strains. 
This finding is in agreement with different studies indicating that strains with a high 
number of IS6110 copies (>14) have lost genomic regions more often than strains with 
only few copies (9), as is in the case of GC1237. 
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Table 3. Direct repeats of IS6110 insertion sequence in M. tuberculosis GC1237. 
Genes of IS6110 in GC1237 genome DRsa 
Rv0001 (dnaA):Rv0002 (dnaN) ATT 
Rv0794c:Rv0797 - 
Rv0840c (pip) ACG 
Rv1371 GAGG
Rv1469 (ctpD) CGT 
Rv1754c-Rv1765c (RD152) - 
Rv1917c (PPE34) TTA 
Rv1917c (PPE34) TTA 
Rv2016 AGG 
MT2080 (Mb2047c):MT2081 (Mb2048c) GAA 
Rv2077A:Rv2078 AGG 
Rv2180c AGC 
Rv2286c ATC 
Rv2353 (PPE39):Rv2356c (PPE40) CCG 
Rv2813-Rv2820c (RD207) - 
Rv3018A (PE27A):Rv3019c (esxR) GCC 
Rv3324A:Rv3327 (IS1547) GGC 
Rv3383c (idsB) ATC 
Rv3427c (IS1532):Rv3428c (IS1532) CCCG 
               aThe absence of DR is indicated by minus. 
 
 
Study of the orientation and the distance of IS6110 to the neighbouring genes 
Different studies have indicated that IS6110 could up-regulate the expression of 
downstream genes. Previous studies have shown that when IS6110 is inserted in the 
same orientation as, and close enough to, a downstream gene, IS6110 could 
potentially function as a promoter (41). We analysed the orientation of each copy of the 
IS6110 in GC1237 strain and the distance to the close gene in order to test the 
promoter function of IS6110. We obtained 8 genes with an IS6110 inserted upstream in 
the right orientation but in 4 locations the distance is reasonable to act as a mobile 
promoter (Table 2). One of them is located 297 bp upstream of the Rv1468c gene, 
another 138 bp upstream of PE27A gene, the third one 41 bp upstream Rv3427c gene 
and the last one is located 31 bp upstream of the essential gene Rv2179c.  
The analysis of the natural insertion site of IS6110 upstream the gene ctpD in the M. 
tuberculosis Beijing strain 210 was carried out both in broth and in monocytes and 
compared with that in H37Rv (41). In broth, transcriptional levels of this gene were 
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similar in the two strains. However, the expression of ctpD was three to fivefold higher 
levels inside monocytes when IS was upstream (41). As GC1237 presents a copy of 
IS6110 in this same point and in the same orientation, the expression of ctpD in this 
strain was analysed (by qRT-PCR) and compared with its expression in H37Rv. Similar 
results to those reported were obtained both in broth and inside the cells corroborating 
the promoter activity of IS6110 in this location. 
The insertion of IS6110 in Rv2180c gene stands out as it is located 31 bp upstream of 
the essential gene Rv2179c and close to the essential gene AroG which is involved in 
the common aromatic amino acid biosynthesis in M. tuberculosis (36). This location 
was also investigated in other M. tuberculosis strains, including Beijing and non-Beijing 
strains, and surprisingly, this point of insertion is unique to GC1237 strain. For that, the 
promoter activity in this location will be studied widely in Chapter 2. 
Detection of the clinical isolate M. tuberculosis GC1237 by multiplex PCR 
With the aim of facilitating the detection of this isolate faster than with traditional 
techniques, a multiplex PCR based on the detection of two locations of IS6110 in 
GC1237 genome was developed in this study (Figure 15). The design of this assay 
was possible as we located all the copies of IS6110 in this strain.  
The first step of the design was to distinguish between Beijing and non-Beijing 
genotypes. For that, the IS6110 located between dnaA:dnaN (Target 1 in Figure 15A) 
and the genomic deletion of the region of difference RD105 were chosen. These two 
targets were selected for its specificity of Beijing genotype. Given that the presence of 
a copy of IS6110 between dnaA:dnaN is not exclusive of Beijing strains (28), one of the 
primers used for the amplification of this region was designed annealing in the 3’ end of 
the IS6110 and the following nucleotides (Target 1 of Figure 15A) becoming totally 
specific of Beijing genotype. The second step was to distinguish the GC1237 genotype 
among Beijing genotypes. To obtain this, screening of IS6110 locations in Beijing 
strains and non-Beijing strains was carried out as mentioned above and finally, the 
IS6110 located in Rv2180c was selected as specific of this strain (Target 2 of Figure 
15A). The multiplex PCR was performed with these three targets and it was possible to 
differentiate GC1237 genotype from the rest of the strains used as control strains. 
However, this PCR was performed with pure DNA and when it was performed with 
DNA obtained from boiled samples (it is important to remember that the main objective 
was to obtain a rapid test for the identification of GC1237 genotype), the PCR results 
failed with high frequency. After this data, the detection of RD105 region was removed 
from the multiplex PCR and on this occasion, as Figure 15B shows, it was a success. 
Although Figure 15 only shows the PCR results obtained with M. tuberculosis (Beijing 
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and non-Beijing), this multiplex was also tested with different mycobacteria genomes 
as M. vaccae, M. bovis and M. smegmatis obtaining in all cases the same profile as 
H37Rv strain. 
 
 
Figure 15: Detection of GC1237 genotype by multiplex PCR. (A) Schematic representation 
of the two targets selected for the multiplex PCR. Target 1 (primers dnaII and dnaIII) permits to 
differentiate between Beijing and non-Beijing genotypes. Target 2 (primers Rv2179c fw and 
Rv2179c rv) was selected to identify GC1237 genotype among Beijing strains. (B) PCR analysis 
of the multiplex PCR. Two fragments were obtained for isolates with GC1237 genotype (1626 
bp and 550 bp). Two amplicons of 550 bp and the 261 bp were obtained as expected for other 
Beijing isolates and only one fragment of 261 bp in H37Rv used as non-Beijing strain. 
 
Due to the high incidence of this strain in the Gran Canary Island, its rapid detection 
would be useful for better control of TB cases. Considering that the RFLP and 
spoligotyping methods are difficult to implement in the clinical setting, the described 
multiplex PCR could bring the possibility of in situ identification of GC1237 genotype. 
The incidence of this strain in this Island has been screened by spoligotyping until now. 
This technique is good distinguishing the Beijing lineage from the rest; however this 
method does not provided the information about clonality within this genotype. In 
addition, the better use of this method is for the study of 40 isolates at a time. The 
RFLP based on IS6110 give the clonality information, but this technique requires higher 
quantity of DNA of high quality. In contrast to spoligotyping and RFLP, this multiplex 
PCR can be used to identify one or more positive isolates. It is quick and inexpensive, 
it has a simple interpretation and it can be completed in one day. 
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Conclusions 
• Based on NTF classification, M. tuberculosis GC1237 is an ancestral strain. 
• The LSPs RD105, RD149, RD152, RD181 and RD207 are deleted in GC1237 
strain. 
• The representative BAC library of M. tuberculosis GC1237 was a useful tool for 
locating IS6110 in a high-copy strain. 
• M. tuberculosis GC1237 has 19 copies of the insertion sequence IS6110. 
• The complementation of different techniques guaranteed the success in the search 
of IS6110 in GC1237 genome. 
• Sixteen copies of IS6110 have DR indicating that its presence was due to a 
transposition event. In two of the other 3 copies recombination between two 
adjacent copies of IS6110 was observed and the presence of the last one is 
implicated in genomic reorganization.  
• According to the locations, four of the nineteen copies could act as a mobile 
promoter: one of them is located 297 bp upstream of the Rv1468c gene, another 
138 bp upstream of PE27A gene, the third one 41 bp upstream Rv3427c gene and 
the last one is located 31 bp upstream of the essential gene Rv2179c. 
• The copy of IS6110 locates 31 bp upstream of the essential gene Rv2179c and is 
specific of GC1237 strain. 
• The study of all the copies of IS6110 in M. tuberculosis GC1237 allowed us to 
design an assay based on its specific location of IS6110. 
• The multiplex PCR facilitates the identification of GC1237 quickly and easily.  
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Introduction  
Promoter activity of IS6110 insertion sequence 
In spite of studies that show that IS6110 transposes in microaerobic atmosphere (7), in 
patient to patient transmission (17) and in the adaptation to a particular host (13), the 
physiological role and impact of specific IS6110 insertions on the biology of bacilli are 
not well known. However, we can affirm that this sequence induces duplications, 
inversions, deletions, and rearrangements in the bacteria genome, all of them 
essentials changes for the genome plasticity of the members of MTBC (10).  
Moreover, this element has been related with a promoter activity inducing transcription 
of downstream genes, during infection (16) or not (2, 16, 18). IS6110 can upregulate 
downstream genes through an outward-directed promoter in its 3’end. The promoter 
region of IS6110, called OP6110, is localized within a 110 bp fragment adjacent to the 
right terminal IR (16). This promoter activity was demonstrated in several natural 
insertions of IS6110 such as the located upstream Rv2280 gene in H37Rv strain (16), 
the located upstream Rv1468c gene in 210 Beijing strain (16) and the copy located 75 
bp upstream phoP gene in the MDR M. bovis strain MBZ (18). These three locations of 
IS6110 are widely explained in next section.  
Studied locations of IS6110 where is acting as a mobile promoter 
The genomic data of the strains H37Rv and 210, which is member of Beijing family, 
were examined for locations where IS6110 was inserted in the same orientation as, 
and close enough to, a downstream gene potentially to function as a promoter (16). 
The 210 strain has a copy of IS6110 inserted 297 bp upstream the Rv1468c 
(PE_PGRS29) gene and in H37Rv a copy of IS6110 is located 191 bp of Rv2280 gene 
(Figure 16A). The effect of IS6110 (OP6110) in these two genes was studied both in 
broth and inside monocytes (16). The expression of the two genes was analyzed by 
qRT-PCR and compared between both strains. During exponential growth in broth, 
transcription levels of Rv1468c and Rv2280 were similar in both strains indicating that, 
in that condition, an upstream copy of IS6110 had minimal overall effects on gene 
expression. However, in monocytes, IS6110 was associated with three to fivefold 
higher levels of transcription of both downstream genes (Figure 16B). Moreover, the 
transcription between IS6110 and these downstream genes was demonstrated (16). 
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The selected copies of IS6110 to be studied: The copy upstream Rv2179c of 
GC1237 strain and the insertion A1 common of all Beijing strains 
Another of our major objective was to study the promoter activity of IS6110 in the 
clinical isolate M. tuberculosis GC1237. As it was explained in Chapter 1, four of the 19 
copies of IS6110 localized in GC1237 could act as a mobile promoter as the orientation 
is the same as and are close enough to the neighboring gene. We focused the study in 
the copy of IS6110 located 31 bp upstream of the essential gene Rv2179c and close to 
the essential gene aroG which is involved in the common aromatic amino acid 
biosynthesis in M. tuberculosis (14).  
In addition to this, we decided to analyze the copy of IS6110 located between 
dnaA:dnaN (insertion A1), inserted 460 bp upstream dnaN, as this copy could be 
relevant in the phenotype of Beijing strains as it is one of the common locations; for this 
reason, this copy was also study in detail. 
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Objectives 
• To evaluate the promoter activity of three natural insertions of IS6110 (before dnaN 
gene which is characteristic of all Beijing strains, before the gene Rv2179c in M. 
tuberculosis GC1237 Beijing strain and before phoP gene in M. bovis B strain) by 
using several GFP-constructions containing promoter regions.  
 
• To study the promoter activity inside three different mycobacteria, the reference 
strain H37Rv, the clinical isolate GC1237 and M. bovis BCG, to demonstrate that 
this activity does not depend on the genetic background in MTBC. 
 
• To verify the promoter activity of these three locations in the corresponding wild-type 
strain. 
 
• To analyze these promoter activity inside macrophages with the GFP-constructions 
and with the wild-type strains.  
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Material and methods 
Bacterial strains, culture media, and growth conditions 
The clinical isolate M. tuberculosis GC1237, the reference M. tuberculosis H37Rv, M. 
bovis BCG and the M. tuberculosis H37Rv ΔphoP strains were used. Mycobacterial 
strains were grown in Middlebrook 7H9 broth supplemented with ADC and 0.05% 
Tween 80 or in Middlebrook 7H10 mediumBacto agar supplemented with OADC (Difco 
Laboratories, Detroit, Mich.) and 0.05% Tween 80 (9). Liquid cultures were grown to 
logarithmic and stationary phases to be used for macrophage infection in vitro and for 
mycobacterial RNA extraction.  
E. coli XL1 was used for cloning experiments. Strains were grown in LB broth or LB 
agar plates. When necessary, media were supplemented with kanamycin (Km) 
(20μg/ml) or hygromicing (Hyg) (50μg/ml). The plasmid pFPV27-int (Figure 18A), 
derived from pFPV27 (1), was used for the construction of the strains expressing GFP. 
Electrotransformation of E. coli and of mycobacteria 
To prepare E. coli competent cells, bacteria were grown to an OD600nm of 0.4 to 0.6. 
Then the growth was stopped for 30min on ice, and bacteria were washed twice in 
chilled-cold water, and once in chilled-cold 10% glycerol. Aliquots of 50μl were 
directly used or frozen at -80ºC. Aliquots of 50μl were electroporated with plasmid 
DNA in 0.2cm gap cuvettes (Bio-Rad) with a single pulse (2.5kV, 25μF, 200Ω) in a 
GenePulser XcellTM (Bio-Rad). Cells were resuspended in LB to a final volume of 1ml 
and incubated for 1h at 37ºC if required before plating. 
M. tuberculosis competent cells were prepared as described by Wards et al. (20). 
Bacteria were grown until an OD600nm of 0.6 to 0.8. After two washes in 0.05% Tween-
80 and one wash in 10% glycerol-0.05% Tween-80, cells were resuspended in 2ml of 
10% glycerol-0.05% Tween-80. Aliquots of 400μl were electroporated with plasmid 
DNA in 0.2cm gap cuvettes (Bio-Rad) with a single pulse (2.5kV, 25μF, 1000Ω) in a 
GenePulser XcellTM (Bio-Rad). Cells were recovered with 1ml of 7H9-ADC-0.05% 
Tween-80 and incubated for 24h at 37ºC, to express the antibiotic resistance, before 
plating several dilutions on plates containing the relevant antibiotic. 
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Construction of GFP-strains 
• From the copy of IS6110 located upstream dnaN in GC1237 strain: 
To construct pFPVdnaN-int plasmid, primers dnaN-EcoRI and dnaN-kpnI (Table 6 
Annex I) were used to amplify a 913 bp fragment from H37Rv strain. To construct 
pFPVISdnaN-int plasmid, ISA4-Eco and dnaN-kpnI (Table 6 Annex I) were used to 
amplified 713 bp segment from GC1237 strain. The PCR products were inserted in 
pFPV27-int, which had been cut with EcoRI and KpnI enzymes (Figure 18B). The 
plasmids were sequenced and electroporated into H37Rv strain obtaining HFPVdnaN 
and HFPVISdnaN strains. 
• From the IS6110 located upstream phoP gene in MBZ strain: 
Plasmids pFPVSO5-int and pFPVSO7-int (Figure 18C) were constructed in a previous 
work (not published). Briefly, to construct pFPVSO5-int plasmid, primers BCG2B-Eco 
and PhoBO3.1-Kpn (Table 6 Annex I) were used to amplify a 351 bp fragment from 
H37Rv strain. To construct pFPVSO7-int plasmid, primers ISA4-Eco and PhoBO3.1-
Kpn (Table 6 Annex I) were used to amplify a 350 bp segment from MBZ strain. The 
PCR products were inserted in pFPV27-int that had been cut with EcoRI and KpnI 
enzymes. Both plasmids were sequenced to verify the constructions. 
In this work the plasmids were electroporated into H37Rv, GC1237 and BCG strains 
obtaining HFPVSO5, HFPVSO7, GFPVSO5, GFPVSO7, BFPVSO5 and BFPVSO7 
strains respectively. 
• From the IS6110 located upstream Rv2179c in GC1237 strain: 
To construct pFPV79c-int plasmid, primers Rv2179c-Eco and Rv2179c-Kpn (Table 6 
Annex I) were used to amplify a 670 bp fragment from H37Rv strain. To construct 
pFPVIS79c-int plasmid, primers ISA4-Eco and Rv2179c-Kpn (Table 6 Annex I) were 
used to amplify a 210 bp segment from GC1237 strain. The PCR products were 
inserted in pFPV27-int, which had been cut with EcoRI and KpnI enzymes (Figure 
18D). To verify the constructions, both plasmids were sequenced with the 
corresponding primers. After that, they were electroporated into H37Rv, GC1237 and 
BCG strains obtaining HFPV79c, HFPVIS79c, GFPV79c, GFPVIS79c BFPV79c and 
BFPVIS79c strains. 
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Raw 264.7 cells were grown in RPMI 1640 medium supplemented with 10% of FBS. 
Infections were performed during 2h at MOI 3. After incubating with bacteria, cells were 
washed three times with phosphate buffered saline (PBS), and cultured in complete 
medium during the time indicated for each experiment. 
• Experiments of replication: 
The studies of intracellular replication of M. tuberculosis were carried out in 24-well 
plate. Briefly, the infections were performed at a MOI of 1 bacterium per 20 cells and 2 
wells were used per strain and per day of processing. After 4h, infection was 
terminated by removing the overlaying medium and washing three times with PBS 
before adding 1ml of fresh complete culture medium per well. At 0 (4h post-infection), 4 
and 7 days, the number of intracellular bacteria was evaluated by plating appropriate 
dilutions of lysed macrophages (0.1% triton X-100) on 7H10-ADC solid medium. After 
2-4 weeks, CFUs were evaluated. 
• M. tuberculosis infection in vivo in mice: 
Intratracheal infection was performed with 100 CFU of bacteria in 50μl of PBS per 
mouse and 5 mice were used per strain. To deliver bacterial suspension, isoflurane 
anesthetized mice were orally intubated with a lachrymal olive luer-lock (UNIMED), 
30mm in length and 0.6mm in diameter. Four weeks post-infection, lungs from each 
animal were harvested and placed in PBS for bacterial burden evaluation. To analyze 
bacterial replication, lungs were homogenized using GentleMacs homogeneizer 
(Miltenyi Biotec) and CFU counted by plating serial dilutions on 7H11-ADC solid 
medium. 
The protocol for animal handling was previously approved by University of Zaragoza 
Animal Ethics Committee. 
Isolation of RNA from mycobacteria 
• Extracellular conditions: 
M. tuberculosis strains were grown at 37ºC until the desired OD600 under aerobic 
conditions. The RNA from bacterial pellet was stabilized using the RNAprotect Bacteria 
Reagent (QIAGEN) following manufacturer’s recommendations. Cells were 
resuspended in 1ml acid phenol:chloroform (5:1) and 0.4ml lysis buffer (0.5% SDS, 
20mM NaAc, 0.1mM EDTA) and transferred to 2ml Lysing Matrix B screw-cap tubes 
containing 0.1mm silica spheres (Q-BIOgene). Cells were disrupted by three 30s 
pulses in a FastPrep homogenizer (Q-BIOgene). After centrifugation, RNA from the 
supernatant was further extracted with 0.9ml chloroform:isoamyl alcohol (24:1). Total 
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RNA was precipitated with NaAc/isopropanol and washed with 70% ethanol. RNA 
pellet was treated with RNase-free DNase (Ambion), and the DNA free RNA was then 
further purified using and RNeasy kit (Qiagen). DNA contamination was ruled out by 
lack of amplification products after 35 cycles of PCR and the integrity of the RNA from 
the different strains were checked by gel electrophoresis on a 1% agarose gel. Purified 
RNA was kept at -80ºC until further use. 
• Intracellular conditions: 
Intracellular mycobacteria RNA extraction was performed with a modified protocol 
based on the one described by Fontan et al. (5). Briefly, 12.106 MH-S cells per flask 
were seeded in 150cm2 flasks. An appropriate volume of liquid mycobacteria culture 
was suspended in complete medium and added to each flask containing cells. After 
incubation, cells were washed with PBS to remove extracellular bacteria, and cultured 
in complete medium for 0 and 48h post-infection, when they were treated to extract 
intracellular mycobacteria. With this aim, cells were lysed and homogeneized during 
5min adding 10ml per flask of GTC buffer (25mM sodium citrate, 4M guanidine 
thiocyanate, 0.5% N-lauryl sarcosine, 0.125M 2-mercaptoethanol and 0.5% Tween 80, 
pH 7.0). Next, samples were collected in 15ml centrifuge tubes and centrifuged for one 
hour at 4000rpm. Bacterial pellets were washed with GTC buffer and centrifuged again 
for one hour at 4000rpm. After that, dry bacterial pellets were treated as described 
above to extract mycobacterial RNA. 
RT-PCR 
Reverse transcription-PCR (RT-PCR) was carried out in two steps. RT was carried out 
with Expand Reverse Transcriptase (Roche) using 1μg RNA as the template and the 
appropriate reverse primer. Reaction mixtures were incubated at 42ºC for 90min. RT 
products were the subjected to PCR amplification, using TaqGold polymerase (Roche) 
as we previously described with the appropriate primers. Samples were analyzed by 
electrophoresis on a 1% agarose gel. 
qRT-PCR 
cDNA libraries from mycobacteria were constructed as follows. One μm of RNA was 
mixed with 25pmol of random hexanucleotides primers (Sigma) and 50U of Expand 
Reverse Trancriptase (Roche) in a final volume of 20μl. Reaction mixtures were 
incubated at 65ºC for 10min and then at 42ºC for 90min. The gene expressions were 
measured and normalized with respect to the levels of rrnaP1 mRNA by quantitative 
real-time PCR (qRT-PCR). qRT-PCR was carried out in a StepOne Plus (Applied 
Biosystems) instrument, using the cDNA generated by RT from 25ng of RNA as a 
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template, 1X Power SYBER green PCR master mix (Applied Biosystems), and the 
appropriated primers, each at a concentration of 250nM. The PCR program involved an 
initial denaturation step for 10min at 95ºC, followed by 40cycles at 95ºC for 15s and 
60ºC for 1min. The specificity of the PCR products was confirmed by the loss of 
fluorescence at a single temperature, when the double-stranded DNA melted to single-
stranded DNA. 
Protein extraction from mycobacteria 
• Extraction of cellular proteins: 
Cell-free protein extracts of mycobacteria were prepared from early log-phase cultures 
grown in Middlebrook 7H9-ADC-0.05% Tween-80. Cells from 50ml of culture were 
pelleted by centrifugation (3500rpm for 15min at 4ºC). Mycobacterial cell pellets were 
washed twice with PBS and then resuspended in cold PBS. Mycobacterial suspensions 
were transferred to tubes containing glass beads (Qbiogene) and were disrupted by 
mechanical traction (Fast-prep instrument) in two cycles (15s at speed 6.5m/s and 15s 
at 4.0m/s, respectively) cooling the samples on ice 5min between the pulses. The 
proteins were centrifuged at 5000rpm for 15min at 16ºC and the supernatant containing 
whole-cell protein extracts was filtered through a 0.22μm-pore-size low protein binding 
filter (Pall).  
• Extraction of culture filtrate proteins: 
Mycobacterial strains were cultured in 7H9 Middlebrook medium supplemented with 
dextrose in the absence of Albumin. Cultures were grown 4 weeks and then 
centrifuged (3500rpm for 15min at 37ºC). The supernatant was filtered through 0.22μm 
filter Stericup systems (Millipore). The extracellular proteins were precipitated during 1h 
at 4ºC with the 10% v/v of Trichlore acetic acid. After that, pellets were collected by 
centrifugation (4000rpm 1h at 4ºC), washed twice with cold acetone and resuspended 
in 250μl of PBS 1x.  
In both cases, proteins were quantified using the RC DC protein assay (BioRad) and 
stored at -80ºC.  
Western blot analysis 
Western blot analysis was carried out using standard procedures. Equivalent quantities 
of protein extracts were boiled (for 5min) in presence of 5μl of 150mM Tris/HCl pH 7.4, 
3% SDS, 0.3mM sodium molybdate, 30mM sodium pyrophosphate, 30mM NaF, 30% 
glycerol, 30% mercaptoethanol and 0.06% bromophenol blue. Cellular proteins were 
separated by electrophoresis through a 15% polyacrylmide gel containing 0.1% SDS in 
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running buffer (25mM Tris, 192mM glycine, 3.4mM SDS) at constant amperage of 
20mA/gel. Proteins were transferred to PVDF membranes (pre-activated with 
methanol) in transfer buffer (48mM Tris/HCl pH 8.3, 39mM glycine, 0.037% SDS, 20% 
methanol) for 1h at 20V with a semi-dry electrophoretic transfer cell (BioRad).  
Blotted proteins were analyzed using specific antibodies: polyclonal antibodies against 
phoP protein (ZEU-immunotec) (12) and monoclonal antibody against ESAT-6 protein 
(Abcam). 
The membrane was blocked with 5% skim powdered milk in buffer B (0.12M NaCl, 
10mM Tris/HCl pH 8.0, 0.5% Tween-20 in PBS pH 7.4) for 30min at room temperature 
and mild shaking. Hereafter, the membrane was incubated with primary antibody anti-
PhoP (1:2000) or anti-ESAT-6 (1:5000) in buffer A (2.5% skim powdered milk in buffer 
B) over night. Three washes with buffer B were performed previous to the incubation 
with commercial anti-rabbit (in the case of PhoP) or anti-mouse (for ESAT-6) 
secondary antibodies (1:20,000 in buffer A) conjugated with horseradish peroxidase, 
for 1h at room temperature and mild shaking. Then, the membrane was washed three 
times with buffer B. Immunocomplex detection was performed by incubation (for 90s) 
with a chemiluminiscent AP substrate (ImmobilonTM western, Millipore) and 
subsequent exposure (for 2min) to a photographic film. Molecular weights of the 
detected proteins were estimated relative to the standard protein ladder. 
Analysis of GFP expression 
• Extracellular conditions: 
To study the expression of the GFP protein in GFP strains, the fluorescence was 
measured by fluorometric method (Synergy_HT, BioTek) during the bacterial growth 
and normalized with OD600nm. Briefly, 1ml of the mycobacterial broth cultures was 
collected and 200μl of the total volume were added to a 96-well plate and the GFP 
expression was measured at λ 485nm. After that, the OD600nm of the broth culture was 
measured using the rest of the volume (800μl). The obtained value of fluorescence was 
normalized with the OD of the culture. 
Fluorescence median intensity (FMI) of the different GFP strains was measured by 
Fluorescence activated cell sorting (FACS). Thus, 800μl of mycobacterial logarithmic 
cultures were centrifugated at 14000rpm 5min and the pellets were resuspended with 
1ml of paraformaldehide (PFA) 4% and incubate 30min. After this time, the mixtures 
were centrifugated and resuspended in PBS. The cytometer used in this work was a 
FACSaria (BDBiosciences) and the analysis was performed with the software Weasel. 
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• Intracellular conditions: 
The GFP expression under intracellular conditions was studied by two methods. The 
first one, MH-S cells were infected with different GFP strains and H37Rv or GC1237 
were used as reference. Infections were carried out in 24-well plates, where cells were 
seeded at 105 cells per well. Cells were collected at 0, 24, 48 and 72h post-infection 
and they were analyzed by FACS. Previously, cells were labeled with annexinV to 
discern between live and dead cells. Briefly, after washing collected cells once with 
AnnexinV binding buffer (ABB) (BD Biosciences), they were incubated for 15min at 
room temperature with annexinV APC-conjugated diluted in ABB, and then fixed with 
PFA 4% in calcium-containing buffer.  
The second one was carried out as previously describe by Brodin et al (3). Briefly, Raw 
cells were seeded at a density of 3x105 cells per well in 384-well plates in 50μl of 
medium. Adherent cells were then infected with bacterial suspensions at MOI of 3 and 
incubated for 2h. Cells were then washed three times with PBS and fixed with 1.5% 
formaldehyde for 10min, washed twice and stained with 5μg/ml DAPI dilactate (Sigma) 
in 0.1% triton X-100 (Sigma) in PBS. After that, confocal images were recorded on an 
automated fluorescent confocal microscope Opera (Evotec) using a 20X water 
immersion objective (NA 0.7). Subsequently, 405nm and 488nm lasers were used for 
excitation of DAPI and GFP, in two sequential exposures. Because the 20X 
magnification does not allow the acquisition of the entire 384-well plate, 6 fields within 
each well were recorded. For each field, two channels were recorded using two 
different cameras: the blue image for nuclei channel (Figure 20A) and the green image 
for GFP (Figure 20B). Each image was then processed using dedicated in-house 
image analysis software (IM 3.0). To determine the number of macrophages and 
delineate their outlines, cell centers were positioned using an algorithm that identifies 
the pixels with a maximum local intensity in the blue image. Cells that were too small 
based on cell radius area enclosed were discarded. The result of this step was the 
acquisition of the average cell surface that is the number of cells and their spatial 
localization (Figure 20D). To quantify the bacterial load, a similar procedure was 
carried out with green image (Figure 20B). In this case, the GFP-intensity of the 
different strains was one of the important parameters and for that, a threshold for GFP 
signal was determined with GFP-control strains. As DAPI stain did not allow us to 
define the contour of the cell, a macrophage was considered infected if labeled 
bacterium objects were distant of less than 5 pixels from the cell nucleus (Figure 20F). 
Proximity is a parameter manually set-up by the user given the fact that one cell has 
only one nucleus and a macrophage was labeled as infected if there were at least three 
contiguous green pixels overlapping the cell surface. Once images were processes 
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Results and Discussion 
The interest on the different functions of IS6110 in MTBC strains has been gaining 
force and importance. It has been related with genomic reorganizations, deletions and 
it is known that its insertion in an ORF causes loss of gene activity. This phenomenon 
can affect the regulation of the surrounding genes or can alter the regulation of the 
mycobacteria in general. There are several studies which defend that IS6110 is 
maintained within the genome because it may confer some selective advantage. It is 
considered that the influence of the promoter activity of IS6110 on the downstream 
genes is related to the distance among the gene and the 3’-end of this sequence. Thus, 
a promoter influence is possible within the range of 31 to 300 bp of distance among 
them.  
With the aim of analyzing in depth this activity, three insertions of IS6110 were 
selected. The first one is located 460 bp upstream dnaN gene. Although this distance is 
longer than the mentioned above, the study of this region was of interest as being 
common in Beijing genotype. The second insertion, located in Rv2180c was selected 
for being unique to M. tuberculosis GC1237 and for its proximity to the essential genes 
Rv2179c and aroG. The third one, before phoP gene in M. bovis B strain, was selected 
due to the possible relation of IS6110 with the virulence of this strain as it has been 
demonstrated that phoP is related with the virulence of the mycobacteria.  
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To check that the data obtained with mRNA could be related with the IS6110 located 
upstream dnaN gene, we constructed the integrative plasmids pFPVdnaN and 
pFPVISdnaN containing the promoterless gfp gene preceded by the region upstream 
dnaN gene in H37Rv strain (913 bp) or in GC1237 strain (713 bp), respectively. They 
were transformed into H37Rv obtaining HFPVdnaN and HFPVISdnaN strains. As 
control, we used H37Rv transformed with pFPV27-int which contains gfp gene without 
promoter (HFPV27 strain). 
The GFP expression of these strains was measured by fluorometry during the growth 
in broth and as Figure 22 shows, similar GFP levels were observed in the two strains 
(HFPVdnaN and HFPVISdnaN), indicating that, an upstream copy of IS6110 had 
minimal overall effects on this gene expression in broth. This result could be due to the 
IS6110 is not located close enough to dnaN gene to act as a promoter.  
 
 
Figure 22: GFP expression of HFPVdnaN and HFPVISdnaN strains. Time course the 
evolution of the GFP-fluorescence of HFPV27, HFPVdnaN and HFPVISdnaN strains during the 
bacterial growth normalized with OD600nm. 
 
dnaN gene expression of H37Rv and GC1237 strains was also similar in 
intracellular conditions 
To determine the effect of IS6110 on dnaN gene expression during infection, bacterial 
RNA was obtained both from intracellular and broth growth conditions. The results 
showed (Figure 23) that dnaN gene expression is greatly increased in both strains 
when they are inside macrophages. Moreover, as Figure 23 shows the expression of 
this gene rises with the time of infection. This result corroborates the data obtained with 
GFP-strains and it could be indicating that in these conditions, the copy of IS6110 
located upstream dnaN gene in GC1237 and consequently in Beijing strains, causes 
minimal effect in dnaN gene expression. 
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Transcripts from IS6110 to aroG and from Rv2180c to aroG were detected in 
GC1237 strain and in H37Rv strain, respectively 
To determine if a transcript extended from IS6110 or Rv2180c into downstream genes 
Rv2179c and aroG, RNA from broth cultures of GC1237 and H37Rv strains was 
extracted and RT-PCR was performed as previously described in this chapter. We 
obtained amplification products from Rv2180c to aroG in H37Rv strain (Figure 25A and 
C). These results indicate that the three genes are cotranscribed in an operon. In the 
case of GC1237 strain, amplification products were obtained from 3’ end of IS6110 to 
aroG suggesting that the 3’ end of IS6110, Rv2179c and aroG genes are cotranscribed 
(Figure 25B and D). All the RT-PCR products were sequenced and the blast results 
verified their specificity.  
 
 
Figure 25: RT-PCR analysis of Rv2179c region from M. tuberculosis H37Rv and GC1237 
strains. (A). Schematic diagram of Rv2179c region in H37Rv strain. (B) Schematic diagram of 
Rv2179c region in GC1237 strain. In both diagrams, the primers used for RT-PCR and the sizes 
of the fragments obtained with each pair of primers are indicated. The direction of transcription 
for Rv2179c is indicated by arrows. (C) RT-PCR analysis of this region in H37Rv. (D) RT-PCR 
analysis of this region in GC1237. In both RT-PCR the combination of primers is indicated 
above each set of reaction. Each set of three reaction consist of a positive control PCR assay 
with genomic DNA as the template (+), an RT-PCR (*), and a negative control assay without 
reverse transcriptase (-). 
 
The aroG gene is an essential gene involved in the biosynthesis of chorismate 
precursor of the three aromatic amino acids in M. tuberculosis (14). There are no 
available data about the function of the protein encoded by Rv2179c gene. In fact, 
according to Tuberculist database, the product of this gene is a conserved essential 
hypothetical protein and it is conserved in different mycobacterial strains (11). From our 
results we can hypothesize that the overexpression of this gene would be 
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A previous work showed a reinforcement of IS6110 promoter activity under intracellular 
conditions (16). However, in that work authors studied the expression of different genes 
and the presence or not of IS6110 upstream in two different strains. Nevertheless, 
authors did not discern the possibility of a regulation due to the different genetic 
background of the studied strains. Our results clearly show that the promoter activity of 
IS6110 on Rv2179c gene is only related to disposition of the sequence with respect to 
this gene. 
As part of the three genes forming an operon we analyzed the expression of aroG gene 
by qRT-PCR, but we could not observe significant increment of this gene in GC1237 
strain compared with H37Rv strain. This result does not exclude the possibility of 
another regulation of aroG gene. 
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3. The effect of IS6110 in phoP of the location of MBZ strain 
Soto et al. demonstrated that the presence of IS6110 insertion sequence 75 bp 
upstream the phoP gene in the MDR M. bovis B strain causes an increment in its 
transcription (18). This fact could have an important consequence due to this gene is 
an important transcriptional regulator. 
To depth in the study of the promoter activity of IS6110 in phoP of MBZ strain the 
plasmids pFPVSO5, pFPVSO7 containing the promoterless gfp gene preceded by the 
region upstream phoP in H37Rv strain or in MBZ strain, respectively were used. The 
plasmids were then transformed in H37Rv strain obtaining HFPVSO5 and HFPVSO7 
strains and the RNA at logarithmic and stationary phase were obtained. The GFP 
expression of HFPVSO7 strain was measured by qRT-PCR and compared with that in 
HFPVSO5 strain. Figure 30 shows that the GFP expression of the mutant which 
contains IS6110 is 3.5 (logarithmic phase) to 8 (stationary phase) times higher than 
that in HFPVSO5 strain. 
 
 
Figure 30: Relative quantification (RQ) of GFP in HFPVSO5 and HFPVSO7 strains. The 
GFP expression (normalized with rrnaP1 levels) of both strains was measured by qRT-PCR at 
logarithmic and stationary phases. In both cases the expression was referred to GFP levels of 
HFPV27 strain. The results are a mean of three independent experiments. 
 
Once the overexpression of gfp gene in HFPVSO7 strain was confirmed by qRT-PCR 
(Figure 30), this overexpression was analyzed in three different genetic backgrounds. 
For that issue, these two gfp-plasmids were transformed into two more strains: the 
clinical isolate GC1237 and M. bovis BCG and the GFP expression during the growth 
curve was studied in the three groups of strains both by fluorometry and flow 
cytometry. As controls, HFPV27, GFPV27 and BFPV27 strains were used. Similar high 
increment in the GFP expression was observed when IS6110 was located upstream of 
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This result indicates that, independently of the genetic background, IS6110 acts as a 
promoter in the studied region in different mycobacteria of M. tuberculosis complex 
causing a similar increment of expression of the upstream gene. Furthermore, this 
result corroborates the data obtained with the natural insertion of IS6110 upstream the 
Rv2179c gene indicating that the increment of the expression caused for IS6110 when 
it is acting as a promoter is regardless of the region. 
The next step was to analyze whether the behavior of the promoter activity of this 
sequence in this location was also independent of the strain or genetic background 
inside the cell so, two different macrophages cell lines, MHS and Raw, were infected 
with the GFP-expressing H37Rv and GC1237 strains, and the fluorescence was 
analyzed at different times with two methods, by cytometry and by confocal 
microscope. In this case we do not infect with BCG-GFP strains due to the lack of 
replication inside the host.  
MHS Infected cells FMI were measured by FACS. Thus, to exclude non-infected cells, 
we also infected with non-fluorescent H37Rv and GC1237, considering their FMI as 
negative fluorescence level. Data was referred to annexinV-negative cells, in order to 
analyze only live cells. Moreover, the FMI levels were normalized with respect to 
promoterless gfp strains. As it is observed in Figure 32A-B cells infected with 
HFPVSO7 and GFPVSO7 strains respectively, shows a clear increase of their FMI 
values regarding the control (HFPVSO5 and GFPVSO5 strains) at all times studied. 
These results are in agreement with the obtained data in extracellular conditions. The 
increment observed in HFPVSO7 strain was slightly higher than that in GFPVSO7 
strain but the tendency of both mutants is exactly the same. This result confirms the 
promoter activity of IS6110 in this location under intracellular conditions. 
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The high expression of phoP gene in H37Rv ΔphoP pSO5k strain could be due to 
pSO5k is a replicative plasmid and probably there is more than one copy of the plasmid 
inside H37Rv ΔphoP. The fact that no difference of transcriptional levels of phoP gen 
was observed between H37Rv ΔphoP pSO5k and H37Rv ΔphoP pSO7k strains could 
be due to the RNA generate from IS6110 to phoP (from tsp1*, figure 17) is less stable 
than that in wile-type phoP (from tsp1). 
Furthermore, it was studied the protein expression of phoP. Thus, western-blot analysis 
was carried out using H37Rv, H37Rv ΔphoP, H37Rv ΔphoP pSO5k and H37Rv ΔphoP 
pSO7k cell protein extracts and antibodies against PhoP and ESAT-6 proteins. The 
results clearly showed that PhoP is constitutively expressed in H37Rv strain while 
absent in H37Rv ΔphoP strain and the expression is recovered in the phoP-
complemented strain H37Rv ΔphoP pSO5k and slightly more intense in H37Rv ΔphoP 
pSO7k strain (Figure 36A). This result is in agreement with the result obtained with 
RNA. However, the expected overexpression of phoP was not observed.  
ESAT-6 is an immunodominant antigen whose gene (Rv3875) is absent in all M. bovis 
BCG strains, indicating a possible role in virulence. In previous studies, both PhoP and 
the ESAT-6 secretion system (ESX-1) have been identified independently as major 
virulence determinants of M. tuberculosis. The secretion of ESAT-6 was analyzed and 
it was observed that a strain with a no-functional PhoP did not secret ESAT-6 indicating 
that a direct link exists between the PhoP regulator and ESAT-6 secretion (6). 
 
With the aim of checking whether an over-secretion of ESAT-6 is observed in H37Rv 
ΔphoP pSO7k strain, an extraction of culture filtrate proteins was carried out with 
H37Rv, H37Rv ΔphoP, H37Rv ΔphoP pSO5k and H37Rv ΔphoP pSO7k strains and a 
western-blot analysis was made comparing ESAT-6 in cell protein extracts (obtained 
previously) and filtrate protein extracts. As it is reflected in the Figure 36A-B, H37Rv 
ΔphoP pSO7k strain presents the least amount of ESAT-6 inside the cells and the 
highest expression in filtrate extracts. Due to the lack of a fully functional PhoP in 
H37Rv ΔphoP, a lack of ESAT-6 secretion is observed (Figure 36B) remaining this 
protein inside the cell (Figure 36A). The secretion of this protein gets back with the 
complementation of H37Rv ΔphoP with pSO5k and when the IS6110 is acting as a 
promoter of phoP gene as in H37Rv ΔphoP pSO7k, an over-secretion of ESAT-6 is 
observed. 
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Figure 37: Replication of M. tuberculosis H37Rv, H37Rv ΔphoP, H37Rv ΔphoP pSO5k and 
H37Rv ΔphoP pSO7k strains in MHS-infected cells. Data are expressed as Log10 ± s.d. of 
CFU counts obtained and normalized with the CFUs values at 0h post-infection from two 
independent wells in one typical experiment. 
 
As it has been explained before in this chapter, it was suggested that the insertion of 
IS6110 at this particular locus could be responsible for the slowly grow of MBZ strain 
and for its peculiar colony morphology (smaller colonies than other M. bovis strains) 
(18). In order to check whether there were any differences in colony morphology of 
H37Rv ΔphoP pSO7k and H37Rv ΔphoP pSO5k, serial dilutions of both strains were 
plated in 7H10-ADC and incubate at 37ºC during 3 weeks. As figure 38 shows, H37Rv 
ΔphoP pSO7k has colony morphology smaller than H37Rv ΔphoP pSO5k; therefore, a 
similar behavior observed in MBZ strain is also observed in this strain. However, the 
bacterial growth in broth of H37Rv ΔphoP pSO7k was similar to that in H37Rv ΔphoP 
pSO5k. 
The slow but constant replication of H37Rv ΔphoP pSO7k inside the cells could be due 
to a slower adaptation of this strain inside the host or a possible tendency of this strain 
to dormancy. 
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Conclusions 
• The insertion sequence IS6110 located upstream dnaN gene in M. tuberculosis 
Beijing strain GC1237, has minimal effect on its gene expression both, in broth and 
in intracellular conditions. 
• The copy of IS6110 located upstream Rv2179c gene in M. tuberculosis GC1237 is 
acting as a mobile promoter both in broth and inside macrophages. Furthermore, 
this IS-promoter activity was checked in three different mycobacteria and the 
results indicated that this activity is independent of the genetic background. 
• Rv2180c, Rv2179c and aroG genes are cotranscribed in H37Rv strain and the 3’ 
end of IS6110 (OP6110), Rv2179c and aroG genes are cotranscribed in GC1237 
strain indicating the existence of an operon. 
• The overexpression of gfp gene in HFPVSO7, which contain the region upstream 
phoP gene of MBZ (including the OP6110), was confirmed by qRT-PCR and the 
high GFP expression of this strain was confirmed by cytometry and fluorometry in 
broth. These results demonstrated the promoter activity of IS6110 in this location. 
• A high expression of GFP in HFPVSO7 and with similar profile was observed 
inside two different cell lines and by two different methods as flow cytometry and 
confocal microscope indicating the robustness of these results. 
• H37Rv ΔphoP pSO5k and H37Rv ΔphoP pSO7k strains presented similar 
transcriptional levels of phoP gene and similar PhoP protein expression. 
Furthermore, both strains presented similar replication inside the cell. 
• The colony morphology of H37Rv ΔphoP pSO7k strain is smaller than that in 
H37Rv ΔphoP pSO5k strain however; the bacterial growth in broth of H37Rv 
ΔphoP pSO7k strain was similar to that in H37Rv ΔphoP pSO5k strain. 
• No difference on replication in mice was observed between H37Rv ΔphoP pSO5k 
and H37Rv ΔphoP pSO7k strain. 
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Introduction 
The insertion sequence IS6110 was isolated from a Mycobacterium tuberculosis (MTB) 
cosmid library as a repetitive sequence and was found to be specific to mycobacteria 
belonging to the MTBC (35). MTB strains typically contain multiple copies of this 
element (up to 25 copies per genome), although strains with only a single copy or no 
copies have been identified (14). In contrast, M. bovis usually have a low copy number 
such as M. bovis BCG which has either one or two copies (13). Although the genome 
of M. tuberculosis is highly homogeneous, strains are highly polymorphic with respect 
to copy number and location of IS6110. This sequence does not have a known target 
or consensus sequence; it has been found within ORFs and intergenic regions. 
However, M. tuberculosis and M. bovis strains with only one copy of this sequence 
show that it is inserted conservatively into one of array of 36-bp directly repeated 
sequences (16). Another study shows the possible conserved sites of insertion in 
strains of M. tuberculosis with less than seven copies (12) and also other hot-spots of 
IS6110 have been shown such as the ipl loci (11), the phospholipase C regions (17, 
39) and the oriC (20). 
M. tuberculosis low copy number strains (LCS) and high copy number strains 
(HCS) 
M. tuberculosis strains with less than six copies of IS6110 are usually referred as low 
copy number strains (LCS) in the literature. Several studies reported the presence of 
LCS from regions as India, Vietnam or Tanzania (3, 27, 31). Furthermore, the 66% of 
the M. tuberculosis strains isolated in Tiruvallur, South India presented a single IS6110 
(32). High copy number strains (HCS), with six or more copies of IS6110, were 
reported by a greater number of papers. One study from Brazil, reported that 93.6% of 
M. tuberculosis strains had at least six copies ranging from 1 to 18 (34). In San 
Francisco, of 1,326 isolates investigated, 90% had six o more copies and only two 
isolates had no copies of IS6110 (42). A majority (96.2%) of the 183 strains 
fingerprinted from Kampala were HCS, the number of IS6110 copies ranged from 1 to 
20 (2). Chauhan et al. analyzed 308 isolates of M. tuberculosis, from different parts of 
India and 56% of the isolates showed HCS of IS6110 (9). 
Both groups of strains, LCS and HCS, can originate outbreaks at similar proportion. 
The Beijing family is one of the lineages with the highest number of copies of IS6110. 
There are controversies among the factors that contribute to the success of this family. 
On the one hand, it is well known the wide distribution of Beijing strain 210 in the 
United States in 1995 (42) and its MDR clone, W, which caused disease in more than 
350 patients in New York City (5, 6) and as we mention previously (Chapter 1), the 
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clinical isolate GC1237 has been responsible of epidemic outbreaks since it appeared 
in 1993 (7). However, one study conducted in Cape Town (South Africa) found no 
significant association between the M. tuberculosis genotype and transmissibility within 
the household (21). Besides, there are outbreaks reported caused by LCS, as was the 
extensive transmission of M. tuberculosis in a rural population with minimal risk factors 
for TB. This strain was designated as CDC1551 and the fingerprint showed 4 copies of 
IS6110 (38). 
LCS versus HCS and IS6110 locations 
Several reports have strongly suggested that the severity and clinical manifestations of 
tuberculosis depend on the immunogenicity and pathogenicity of the infecting M. 
tuberculosis strain. In this regard the IS6110 sequence varies in number and position 
within the genome generating a high level of DNA polymorphism among strains. 
Interestingly, the location of IS6110 in M. bovis isolates from endogenous reactivation 
cases from elderly people were studied in comparison to the bovine M. bovis strains, 
concluding that the presence of more copies in human strains could be related to the 
adaptation from the animal to the human host (25). On the other hand, a highly 
preferred site of insertion of IS6110 was detected and designated as “DK1” (Rv0403c) 
in M. tuberculosis LCS but the prevalence of this site decreases sharply in HCS, 
suggesting a separate lineage for the HCS and the LCS (12). This contrasts with M 
bovis analysed without copy inserted at the same genomic position that M tuberculosis 
strains (25). This agreed with the idea that LCS of M. tuberculosis and M. bovis 
evolved separately after the progenitor acquired IS6110 at the DR region. IS6110 has 
been also checked as a tool to analyze the evolution of members of the MTBC. In such 
a case, transposition may have influence on the evolution of the strains, the parental 
strains should carry low copy number and the descendant, more evolved, would carry 
high copy number. One example that theoretically support that consideration are the 
Beijing lineage, members of this family are HCS of IS6110 (between 15-25 copies per 
genome) and have shown high prevalence and high transmissibility (22). These 
characteristics could be seen as selective advantages of bacteria to its main purpose: 
infect humans (15). 
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Objectives 
• To locate the common points of insertion of IS6110 in Beijing strains. 
• To carry out a scrutiny of points of insertion of IS6110 in available literature and in 
the DNA sequence databases. 
• To generate a representative primer collection of Beijing-IS6110 points of insertion.  
• To identify and analyze the common sites of IS6110 in non-Beijing strains with 
respect to Beijing strains, being both groups HCS. 
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Material and methods 
Bacterial selected strains, culture media, growth conditions and isolation of 
mycobacteria genomic DNA 
Sixty-one M. tuberculosis clinical isolates were used in this work. The 61 isolates 
comprised 17 Beijing and 44 non-Beijing strains. Among the 17 Beijing strains 8 
(NHN5, HM77, HM903, HM764, 990172, W4, N4 and CAM22) were previously 
selected as representative of this genotype using several typing methods from Europe. 
These 8 strains were selected as they share 80% or more of identity with Beijing 
strains from Shanghai area, China. The rest of the strains, each representing a 
different cluster, were selected for its high number copies of IS6110 and were collected 
from Hospital Universitario Miguel Servet (HMS), Hospital Clínico Universitario Lozano-
Blesa (HCU) from Zaragoza and Hospital General San Jorge from Huesca. Finally, M. 
tuberculosis H37Rv and M. tuberculosis GC1237 were used as control strains. An 
internal control, HMS 1301, was included in the study due to its RFLP is identical to 
GC1237 strain. Mycobacterial strains were grown at 37ºC in Middlebrook 7H9 broth 
supplemented with ADC and 0.05% Tween 80 and genomic DNA of all of them was 
isolated as it was described in Chapter 1. Table 4 summarizes the clinical isolates used 
in this work and figure 39 shows the RFLP, the spoligotyping and the family of all of 
them. 
Location of the copies of IS6110 insertion sequence in the eight Beijing strains 
selected as representative strains of this genotype 
The study of the localization of the copies of IS6110 in the eight representative Beijing 
strains (NHN5, HM77, HM903, HM764, 990172, W4, N4 and CAM22) was carried out 
by two methods, both based on PCR. A first research was conducted by LMPCR as 
previously described in Chapter 1. Briefly, LMPCR was performed with SalI enzyme 
and the digestions were then subjected to PCR with the primers SalgD and ISA1 or 
ISA3 (Table 2 of Annex I). The amplified products were treated and sequenced and 
when a match was found, additional primers were designed and used with the eight 
strains to verify the point of insertion. These primers amplify the completed sequence 
of IS6110 and approximately 300bp of both flanking sequences. Secondly, it was 
performed PCRs with specific primers, previously designed for amplifying the locations 
of IS6110 in 210, W and GC1237 strains (Chapter 1). H37Rv and GC1237 were used 
as control strains in both cases. All this primers are collected in Table 5 of Annex I. 
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Table 4: Strains used in this study 
Strain a Family b Year c  Strain a Family b Year c  Controls d 
HMS 1356 Beijing 2003  HMS 2584 Beijing-like 2011  H37Rv e 
HMS 1470 Beijing 2003  HCU 2398 Beijing 2002  GC1237 f 
HMS 1480 Beijing 2004  HCU 2613 LAM 9 2004  HMS 1301g 
HMS 1834 S 2005  HCU 2617 Beijing 2004   
HMS 2103  - 2007  HCU 2633 LAM 2 2004   
HMS 2193 LAM 9 2008  HCU 2647 LAM 5 2004   
HMS 2200 T1 2008  HCU 2654 LAM 3 2005   
HMS 2206 U 2008  HCU 2663 LAM 9 2005   
HMS 2208 LAM 3 2008  HCU 2671 T1 2005   
HMS 2224 H3 2008  HCU 2703 LAM12_MAD1  2005   
HMS 2227  - 2008  HCU 2706  - 2005   
HMS 2237 H3 2008  HCU 2728 T3 2005   
HMS 2241 LAM 10_CAM 2008  HCU 2777 T1 2006   
HMS 2258 T1 2008  HCU 2821 H3 2007   
HMS 2268 LAM 9 2008  HCU 2864 H1 2007   
HMS 2271 LAM 9-S 2008  HCU 2886 LAM 2 2007   
HMS 2280 LAM 9 2008  HCU 2875 T1 2007   
HMS 2281 LAM 9 2008  HCU 2942 S 2008   
HMS 2296 CAS 2008  HCU 3151 CAS 2010   
HMS 2310 T1 2008  HSJ 025 CAS 2008   
HMS 2355  - 2009  HSJ 029 U 2008   
HMS 2370 T1 2009  HSJ 067 Beijing 2010   
HMS 2391 U 2009  NHN5 Beijing -   
HMS 2394 T2-T3 2009  HM 77 Beijing -   
HMS 2400 Beijing 2009  HM 764 Beijing -   
HMS 2405 T1 2009  HM 903 Beijing -   
HMS 2414 H3 2009  N4 Beijing -   
HMS 2513 T4_CEU1  2010  W4 Beijing -   
HMS 2536 U 2010  990172 Beijing -   
HMS 2580 Beijing 2011  CAM 22 Beijing -   
 
a Names of the strains 
b Family which belongs to by spoligotyping 
c Year when they were isolated 
d Control strains used in this study: e and f External controls of the study and g Internal control of the study 
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Figure 39: IS6110-RFLP and spoligotyping of the 61 strains used in this work. The RFLP 
and the spoligotyping of M. tuberculosis GC1237 and H37Rv were included. 
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Sequence analysis of points of insertion of IS6110 in the DNA database and in 
the available literature 
The points of insertion of IS6110 of the reference sequenced strains: Beijing (210, 
02_1987, 94_M4241A, HN878, R1207, T85, X-122, W and W-148 ) and non-Beijing 
(98-R604 INH-RIF-EM, BTB05-552, BTB05-559, C, CDC1551, CDC1551A, CPHL_A, 
EAS054, F11, GM 1503, K85, KZN 605, KZN R506, KZN V2475, KZN 1435, KZN 
4207, NCGM 2209, str.Haarlem, S96-129, SUMu001, SUMu002, SUMu003, 
SUMu004, SUMu005, SUMu006, SUMu007, SUMu008, SUMu009, SUMu010, 
SUMu011, SUMu012, T17, T46 and T92), were obtained comparing the flanking 
regions of each IS6110 in the genome sequences with the reference strain H37Rv 
using NCBI genetic sequence database (GeneBank) 
(http://www.ncbi.nlm.nih.gov/genome/166). 
Moreover, available literature was analyzed to identify any further point of insertion of 
this sequence not described in DNA database (1, 4, 10-12, 18, 20, 23-25, 28-30, 33, 
39-41).  
After this sequence analysis, when a point of insertion of a Beijing strain (of GeneBank 
or available literature) was found outside of the amplified regions of our primer 
collection, additional primers were designed and included in the collection (Table 5 
Annex I). In addition, flanking primers of DK regions (12) were designed to detect 
whether these frequent locations of IS6110 in LCS were also present in the HCS 
selected in this study. Moreover, the primers BCG2A and BCG2B which amplify the 
promoter region of phoP (33) were included in the primer list to check whether another 
strain presented an IS6110 in this region and finally, the primers designed for the study 
of locations of IS6110 in clinical isolates of M. bovis with human host (25) were also 
included to study whether preferred locations of IS6110 in these M. bovis strains were 
also present in the selected M. tuberculosis strains. 
Location and analysis of copies of IS6110 insertion sequence in the sixty-one 
selected clinical isolates 
The localization of copies of IS6110 in the 61 clinical isolates was carried out by PCR 
with all the pairs of oligonucleotides of the generated primer collection (Table 5 of 
Annex I). H37Rv and GC1237 were used as external controls and HMS1301 as 
internal control as this strain presents the same RFLP as GC1237. The 8 
representative Beijing strains studied before by LMPCR and specific PCR were again 
included in this part of the study. The PCR products which might include an IS6110 
were sequenced with IS61 and IS62 primers (Table 5 of Annex I) and the flanking 
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regions were analyzed. The DRs were determined with the sequence analysis of the 
flanking regions of each copy of IS6110. 
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Results and Discussion 
The eight Beijing strains selected as representatives of this genotype share 
IS6110 points of insertion 
A first research of points of insertion of IS6110 in HCS was performed with the eight 
representative Beijing strains (NHN5, HM77, HM903, HM764, 990172, W4, N4 and 
CAM22) by LMPCR and PCR with the primers used previously in the study of IS-
locations of GC1237 strain (Chapter 1). Seventeen new genomic points of insertion of 
this element were obtained by LMPCR. Additional primers were designed to amplify 
these new IS6110 locations and used for checking whether they were also present in 
another strain of this group. As a result, a total of 45 different points of insertion of 
IS6110 were obtained (Table 5). 
With this first scrutiny, the IS6110 common locations in these Beijing strains also 
shared with GC1237, 210 and W (Beijing control strains) were obtained (Table 5 and 
figure 40). All these strains presented the three characteristic locations of IS6110 of 
Beijing strains: in the intergenic region of dnaA:dnaN, between Rv1754c-Rv1765c 
genes which correspond to the RD152 and in the Direct Repeat region. In the case of 
the strain CAM22, it was detected two copies of IS6110 in this region, both in the same 
orientation.  
Six more sites of insertion are stood out as IS6110 was present with high frequency: 
Rv1371, ctpD (Rv1469c), Rv2016, idsB (Rv3383c), between the two IS1532 and esxR-
esxS region. Six of the eight strains presented a copy of IS6110 in Rv2016 gene in the 
same point and orientation, whereas in the other two strains, IS6110 was also present 
in this gene but in different points. idsB and Rv1371 genes were disrupted by this 
element in seven strains and a copy of IS6110 was present in esxR-esxS region in six 
cases. Another highly preferred point of insertion was located in ctpD gene as five of 
the eight strains presented an IS6110 disrupting this gene. Finally, between the two 
IS1532, a copy of IS6110 was found in five strains (Table 5 and Figure 40). Due to the 
high frequency of all of these IS6110 locations, these regions could be specific hot-
spots for this element in Beijing strains (IS6110 Beijing-hot-spots).  
In some of these strains, a copy of IS6110 was observed in the ipl loci (red arrow, 
Figure 40), however, its frequency was fewer than that in the other regions described 
above. 
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Figure 40: Distribution of IS6110 insertion sequence throughout the genome of M. 
tuberculosis Beijing strains. The located copies of IS6110 in NHN5, HM77, HM903, HM764, 
990172, W4, N4 and CAM22 Beijing strains were plotted in H37Rv genome and represented in 
different concentric circles. IS6110 locations present either in all strains (blue arrows) or with 
high frequency (black arrows) are indicated; ipl hot-spots are pointed with red arrows. In this 
DNA plotter, the IS6110 locations of GC1237, W and 210 Beijing strains were also represented 
as IS6110 reference points of insertion. The unique insertion of IS6110 of GC1237 (within 
Rv2180c) is surrounded by a purple circle. 
 
Comparing these strains, unique locations were also observed. Some examples are: 
within papA4 and Rv2957 genes (N4 strain), interrupting mez and PPE49 genes 
(CAM22 strain) and in the intergenic region of Rv1542c:Rv1543 (W4 strain). It is noted 
that the location of IS6110 within Rv2180c in GC1237 strain, described in Chapter 1 
and analyzed in depth in Chapter 2 was unique (Figure 40 and Table 5). The high 
number of unique IS6110 among these strains indicates that although IS6110 has 
preferential genomic regions, its insertion is randomly and generates a high genomic 
plasticity among strains of the same family.  
As it was explained in Chapter 1, it is frequent to find at least a copy of IS6110 in the 
NTF region in Beijing family (26) and the absence of IS6110 in this locus is 
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characteristic of ancestral sublineages within the Beijing genotype (19). Following this 
classification, these eight strains are ancestral as the absence of IS6110 in this region. 
The majority of the IS6110 located copies were due to transposition mechanism 
The flanking regions of each copy of IS6110 of the eight Beijing strains were analyzed 
and with the exception of three locations of this element (indicated with minus in Table 
5), the presence of direct repeats (DR) was detected (Table 5). The absence of DRs in 
two of the other three locations, RD152 and RD207, is probably a consequence of 
recombination between two adjacent copies of IS6110 (36) as it was observed loss of 
these genomic regions. The last of the three IS6110 elements without DR, which was 
localized between Rv0794c:Rv0797, was identical to GC1237 (explained in Chapter 1) 
and could be explained by reorganization of this region. This event could be 
characteristic of Beijing genotype. 
As already mentioned in Chapter 1, due to the high number of copies of IS6110 per 
strain, it was possible to observe copies flanked by DR and other copies without DR 
indicating that the probability of rearrangement process between copies rises when the 
number of those increases. 
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Table 5: Locations of IS6110 of the eight representative Beijing strains, part 1 
Genes Points of insertion 
 
Direct Repeats 210 W GC1237 
Rv0001(dnaA):Rv0002(dnaN) 1594 ATT + + + 
Rv0794c:Rv0797 (IS1547) 889072 -   + 
Rv0840c (pip) 937116 ACG   + 
Rv1135c (PPE16) 1262963 AGC + +  
Rv1358:Rv1359 1530161 GCG    
Rv1359 1530203 CTC    
Rv1371 1543972 GAGG + + + 
Rv1469 (ctpD) 1657016 CGT + + + 
Rv1527c (pks5) 1724406 CCGA    
Rv1528c (papA4) 1729409 CTT    
Rv1542c(glbN):Rv1543 1745059 ACC    
Rv1754c 1986638 / + +  
Rv1754c-Rv1765c (RD152) 1986638-1998625  -   + 
Rv1798:Rv1799 (lppT) 2038898 / +   
Rv1800 (PPE28):Rv1801 (PPE29) 2041741 GCG    
Rv1917c (PPE34) 
2163392 TTA   ++ 
2163649 TCC +   
2167310 / + +  
Rv2016 
2263619 TCC    
2263627 AGG + + + 
2263778 CCT    
Rv2019 2266167 GAC    
MT2080 (Mb2047c):MT2081 (Mb2048c) 2268726-2268693 GAA   + 
Rv2077A:Rv2078 2334666 AGG    2334686 AGG   + 
Rv2104c:Rv2107 (PE22) 2366897 CAC +   - /  +  
Rv2107 (PE22):Rv2108 (PPE36) 2367679 CGA +   
Rv2180c 2442348 AGC   + 
Rv2282c 2555718 AAT    
Rv2286c 2559506 ATC   + 
Rv2332 (mez) 2605438 ATT    
Rv2349c (plcC) 2627829 CAG    
Rv2352c (PPE38) 2634022 / + +  
Rv2353c (PPE39):Rv2356c (PPE40) 2635592-2637688 CCG   + 
Rv2356c (PPE40):Rv2357c(glyS) 2639612     
Rv2813-Rv2820c (RD207) 3127927 - + + + 
Rv2957 3310163 GTT    
Rv3018A (PE27A):Rv3019c (esxR) 3378553 GCC + + + 
Rv3019c (esxR): Rv3020c (esxS) 3379027 CTG + +  
Rv3125c (PPE49) 3491592 CTC    
Rv3128c 3493908 CGA + +  
Rv3128c:Rv3129 - /  +  
Rv3178:Rv3179 3547342 ATG +   3549199 CGG + +  
Rv3184:Rv3187 - / + +  
Rv3190c 3555513 CGC    
Rv3324A:Rv3327 (IS1547) 3711737 GGC + + + 
Rv3382c (lytB1) 3796689 TGG    
Rv3383c (idsB) 3797823 ATC + + + 
Rv3427c (IS1532):Rv3428c (IS1532) 3844681 CGGG + + + 3844737 CCCG  +  
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Table 5: Locations of IS6110 of the eight representative Beijing strains, part 2 
Strains 
NHN5 HM764 990172 W4 N4 HM903 HM77 CAM22 
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Five of the eight Beijing strains have a possible IS-promoter 
The orientation and distance of each copy of IS6110 to the neighbouring genes was 
analyzed and in addition to the locations of IS6110 described in Chapter 1 where could 
act as a promoter, 5 new copies were located with the same orientation and close 
enough to neighbouring genes to act as a mobile promoter (Table 6). 
 
Table 6: New locations of IS6110 of the eight representative Beijing strains where 
IS6110 could act as a mobile promoter  
Strain Genes of IS6110 Distances to neighbouring genes 
NHN5 Rv1358:Rv1359 12 bp upstream Rv1359 
HM764 PPE40:glyS 77 bp upstream PPE40 
990172 Rv2077A:Rv2078 92 bp upstream Rv2077A 
W4 Rv1542c:Rv1543 5 bp upstream Rv1543 
N4 Rv2016 370 bp upstream Rv2017 
 
It is probably that the IS6110 located upstream Rv1359 gene in NHN5 and the copy 
located upstream Rv1543 in W4 do not act as a mobile promoter due to the distance to 
these gene is too short however, to confirm this, the effect of this element in these 
genes should be studied. Finally, it is noteworthy that these IS6110 were observed only 
in one strain and all of them were different from each indicating the genomic variability 
that IS6110 generates among strains of a same genotype.  
Randomly distribution of IS6110 in reference sequenced strains of GeneBank 
The analysis of the points of insertion of IS6110 of 43 reference sequenced strains of 
GenBank was carried out comparing their sequenced fragments with H37Rv genome. 
All the genomic locations of IS6110 of these strains were plotted on the H37Rv 
genome map (Figure 41). The IS-locations were grouped in two circles; the first one 
corresponds to Beijing strains and another one to non-Beijing strains. In this DNA 
plotter the locations of IS6110 of GC1237 (red circle) and of H37Rv (green circle) were 
also included.  
A randomly distribution of this element throughout the genome was observed among 
these strains (Figure 41). However, the presence of numerous preferential integration 
loci of IS6110 were also detected (some examples are indicated with black arrows in 
Figure 41). Beijing and no-Beijing strains presented copies of IS6110 in these hot-spots 
corroborating that preferential integration regions are common among M. tuberculosis 
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strains. In all the strains this element was found at an identical position within the DR 
region (with the exception of the Beijing strains which presented their characteristic 
deletion: RD207, so, characteristic point). Moreover, in all Beijing strains it was 
observed an identical copy of this element between dnaA:dnaN genes. In this region 
but in a different point, a copy of IS6110 in a non-Beijing strain (SUMu003) was 
observed indicating that the presence of an IS6110 in this intergenic region is 
characteristic of Beijing genotype but not exclusive of this family. This result is in 
agreement with studies which show different locations of IS6110 between these two 
genes (8, 20, 37). The detection of Beijing strain amplifying this entire intergenic region 
is a useful tool but it is necessary another genomic feature of this genotype if not, the 
result could be a Beijing false positive.  
 
 
Figure 41: Graphic representation of point of insertion of IS6110 in M. tuberculosis 
genome with Artemis DNA plotter. Distribution of insertion loci identified with the sequence 
analysis of genomic database in this work. The first circle (green) represents the genomic 
locations of IS6110 in H37Rv. The second concentric circle represents the distribution of this 
sequence in non-Beijing strains. The third circle represents the locations of IS6110 in Beijing 
strains and the fourth concentric circle (red) correspond to the genomic points of insertion of 
IS6110 in GC1237 strain. All the IS-locations were plotted on H37Rv genome. The hot-spots: 
IS1547, plcD region, DR region and dnaA:dnaN region are indicated by arrows. In addition, the 
unique IS6110 of GC1237 (upstream Rv2180c) is indicated. 
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The copy of IS6110 located upstream Rv2180c gene in GC1237 was also indicated in 
the M. tuberculosis map with an arrow (Figure 41) and, as it is observed, there was no 
strain with this location confirming again that this location is unique of this strain. 
It is noteworthy that this sequence was found inserted more often in some genomic 
regions, as the one from 1800000 to 2700000 (coordinates referred to H37Rv genomic 
map, Figure 41); whereas other regions lacked the presence of IS6110 as happens in 
the region around the OriC. Probably, these areas could be more abundant in essential 
genes. In fact, although an IS6110 transposes in these regions, if they are essential, 
the outcome of this event will not be observed. These findings are in agreement with 
previous studies of chromosomal distribution of IS6110 (29, 30, 41). 
It has been included a detailed table in Annex II with all the points of insertion of 
IS6110 of the analyzed reference strains of GeneBank. 
A primer collection which amplify locations of IS6110 in MTBC strains was 
generated in this study 
Available literature (1, 4, 10-12, 18, 20, 23-25, 28-30, 33, 39-41) was also reviewed 
and when a location of IS6110 in a Beijing strain was not included in the amplified 
regions of the primer collection new pair of primers were designs to amplify the area. In 
addition, as one of the objectives was to detect whether the preferred site of insertion 
of IS6110 in LCS were present or absent in the selected HCS, the DK regions (12) 
were analyzed and when necessary, primers were designed and included in the 
oligonucleotide collection. Moreover, the primers used to amplify preferred locations of 
IS6110 in M. bovis with human host (25) were included to check whether these 
locations are also detected in the selected M. tuberculosis clinical isolates as the host 
in both cases is the same. Finally, as one of the interesting IS6110 was the located 
upstream phoP gene in MBZ strain and it was quiet studied in Chapter 2, the primers 
BCG2A and BCG2B which amplify the promoter region of this gene (33) were included 
with the aim of checking the frequency with which IS6110 is inserted in this region. 
Figure 42 shows the distribution of the amplified regions with this collection and a 
detailed table has been included in Annex I (Table 5 of this Annex). 
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Figure 42: Distribution of the genomic regions which can be amplified with the primer 
collection generated in this work (Table 5 of Annex I) plotted in M. tuberculosis H37Rv 
genome. 
 
 
Mapping IS6110 locations in 61 clinical isolates of M. tuberculosis 
With the aim of obtaining a global view of the distribution of IS6110 throughout the 
genome of M. tuberculosis and compare them between Beijing and non-Beijing strains, 
a scrutiny of points of insertion of IS6110 was performed with 61 clinical isolates of M. 
tuberculosis. These strains were selected for its high copy number of IS6110 (HCS). 
Seventeen were Beijing strains and, as it has been explained above, eight of them 
were previously selected as representatives of this genotype. HMS1301, which 
presents identical RFLP as GC1237, was used as internal control and H37Rv and 
GC1237 strains were used as external controls. 
The study was carried out by PCR using all the primer collection (Figure 42 and Table 
5 of Annex I) and when a match was found, the fragment was sequenced with primers 
directed outwards (Table 5 of Annex I). By analysis of the sequences, it was obtained 
the point of insertion, the DR, the orientation and the distance to neighbouring genes of 
each copy of IS6110 (Table 7). After this analysis, all the locations were plotted in the 
H37Rv genomic map and represented with DNA plotter in two different circles, the red 
one corresponds to points of insertion of IS6110 in Beijing strains and the blue one to 
non-Beijing strains. The locations of IS6110 in GC1237 were included in a separated 
circle (green) as reference points of insertion (Figure 43).  
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A total of 160 different points of insertion of IS6110 were obtained (Table 7) with the 
primer collection (Table 5 of Annex I). It is stood out that several genes or intergenic 
regions were observed interrupted by this element in different points and in both 
orientations. Considering this fact, a total of 81 different regions were disrupted or 
altered by IS6110 (Table 7). By this method, the common locations of IS6110 of these 
strains were located; the fact that the number of copies of IS6110 located in the group 
of non-Beijing strains is much lower (1 to 4) than the group of Beijing strains (at least 
10) may indicate that Beijing genotype evolved separately from a common precursor at 
an early stage. Thus, the parental Beijing strains should carry low copy number of 
IS6110 (common with other lineages) and the descendants, more evolved, would carry 
high copy number. 
Copies of IS6110 were detected randomly around the genome of these strains with 
some exceptions. One of them is the region around OriC, which lacks this element, 
corroborating the importance of keeping this region intact. In both groups of strains 
(Beijing and non-Beijing), this element was observed inserted in the general hot-spots 
such as ipl loci or plc regions confirming again that IS6110 has preferential sites. All the 
strains presented one copy of IS6110 in the DR region and two copies were obtained in 
one of the Beijing strains (CAM22) as explained above in this Chapter. The 90.9% of 
the non-Beijing strains presented the same point of insertion in this region; however, it 
is noteworthy that in the remaining non-Beijing strains this copy is located in the DR 
region but in another point, different even among these four strains.  
The insertion of IS6110 in the possible IS6110 Beijing-hot-spot RD152 was also 
observed in non-Beijing strains (plcD region) indicating that this region is not exclusive 
of Beijing genotype (Figure 43 and Table 7). However, comparing these IS6110 points 
of insertion, it was observed that only Beijing strains presented the deletion of the 
region of difference RD152. IS-locations within Rv1371, Rv2016, ctpD, idsB genes and 
between the two IS1532, were only observed in Beijing strains (Figure 43 and 44 and 
Table 7) indicating again that these regions could be specific hot-spots of Beijing 
genotype (IS6110 Beijing-hot-spots). These locations could be the key of some 
advantages of the Beijing genotype and its study should be taken into account in 
further research. 
According to Fomukong et al. (12) and after the analysis done in this study, among the 
different Beijing strains analysed until now, no IS6110 has been detected in the DK1 
locus (mmpS1 gene). However, near to the 15% of the group non-Beijing strains 
presented a copy of IS6110 in this gene (Table 7). Specifying more, 6 of them 
presented an IS6110 at the exact DK1 point of insertion (12). This point is the preferred 
site of IS6110 in LCS and the authors defend the idea that its prevalence decreases in 
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HCS suggesting a separate lineage for HCS and LCS (12). The fact that the 15% of the 
studied HCS strains present this copy could indicate that the increment in number of 
copies of IS6110 is the result of the transposition of another IS6110 of their genomes. 
 
 
Figure 43: Distribution of IS6110 thorough the M. tuberculosis genome of the 61 clinical 
isolates. The obtained locations of IS6110 of each strain were plotted in M. tuberculosis H37Rv 
genome and represented in three concentric circles. The blue one corresponds to the IS-
locations in non-Beijing strains. The red one represents the IS-locations in Beijing strains and 
the green one corresponds to the locations of IS6110 in GC1237 strain. The general hot-spots 
of M. tuberculosis are indicated by blue arrows and with black arrows it has indicated the 
possible specific hot-spots of Beijing genotype. 
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Figure 44: IS6110 distribution of the 17 Beijing strains. The IS6110 obtained locations in the 
17 Beijing strains were plotted in M. tuberculosis H37Rv genome and represented each one in a 
concentric circle. The IS6110 locations of GC1237 were included as control. The general hot-
spots are indicated by blue arrows and with black arrows the IS6110-Beijing-hot-spots. 
 
 
Two of the sixty-one strains presented a copy of IS6110 in the promoter region of phoP 
gene (Table 7). One copy was located 132 bp upstream phoP gene (HSJ067 Beijing 
strain) but in opposite orientation to phoP, and the other one was located 196 bp 
upstream this gene (HMS2405 non-Beijing strain) and in the same orientation as phoP 
gene. Although this point is different of the present in MBZ, this last strain could be a 
possible candidate for studying the effect of IS6110 in phoP gene in a sensible M. 
tuberculosis strain.  
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Table 7: Points of insertion, DR, orientation and distance to neighboring genes of 
IS6110 located copies of the 61 studied strains 
GENE Point of Insertion DR 
Orientation 
5'→3' 
% 
Total % BS 
% 
NBS 
% In 
region 
Distance to 
neighbouring 
gene 
dnaA: dnaN 1594 ATT + 26,2 100 0 26,2 460 bp upstream dnaN 
Rv0403c 
(mmpS1),  
(DK1 region) 
483251 ACT + 1,6 0 2,2 
14,7 
726 bp upstream 
fadD30 
483298 CCT - 9,8 0 13,6 67 bp upstream mmpL1 
483310 TGA + 1,6 0 2,2 667 bp upstream fadD30 
483537 GTG + 1,6 0 2,2 440 bp upstream fadD30 
Rv0755c 
(PPE12): 
Rv0755A 
850087 TAA + 3,2 0 4,5 
4,9 
- 
850182 CTT - 1,6 0 2,2 142 bp upstream PPE12 
Rv0755A: thrV 
850539 TGTC + 4,9 0 6,8 
8,2 
- 
850592 - + 1,6 0 2,2 552 bp upstream PPE12 
850601 CCC - 1,6 0 2,2 561 bp upstream PPE12 
Rv0756c: 
Rv0757 (phoP) 
851412 CGAG + 1,6 0 2,2 
3,2 
196 bp upsttream 
phoP 
851479 GTA - 1,6 5,8 0 13 bp upstream Rv0756c 
Rv0794c: 
Rv0797 (IS1547) 
888768 TTG + 1,6 0 2,2 
16,3 
1620 bp upstream 
IS1547 
888789 CCG + 4,9 0 6,8 1599 bp upstream IS1547 
888846 CAC + 1,6 0 2,2 1542 bp upstream IS1547 
889072 - - 8,2 29,4 0 436 bp upstream Rv0794c 
Rv0835:Rv0836c 
932076 GTC - 3,2 11,7 0 
29,5 
- 
932203 GTT - 26,2 0 36,3 - 
Rv0840c (pip) 937116 ACG + 1,6 5,8 0 1,6 477 bp upstream Rv0841 
Rv1046c 1168966 GAG + 1,6 0 2,2 1,6 457 bp upstream Rv1047 (IS1081) 
Rv1135c (PPE16) 1262963 AGC - 18 64,7 0 18 - 
Rv1213 (glgC) 
1356403 GAC - 1,6 0 2,2 
3,2 
742 bp upstream 
Rv1212 (glgA) 
1357082 ATC - 1,6 0 2,2 1421 bp upstream Rv1212 (glgA) 
Rv1319c 1481531 GGC + 3,2 0 4,5 3,2 - 
Rv1358:Rv1359 1530161 GCG + 1,6 5,8 0 1,6 12 bp upstream Rv1359 
Rv1359 
1530203 CTC + 1,6 5,8 0 
3,2 
1145 bp upstream 
Rv1360 
1530907 GGG - 1,6 0 2,2 - 
Rv1360 1531507 - - 1,6 0 2,2 1,6 - 
Rv1371 1543972 GAGG - 26,2 94,1 0 26,2 - 
Rv1469 (ctpD) 1657016 CGT - 21,3 76,4 0 21,3 
295 bp upstream 
Rv1468 
(PE_PGRS29) 
Rv1527c (pks5) 1724406 CCGA - 3,2 11,7 0 3,2 2346 bp upstream Rv1526c 
 
% Total: % of the indicated location in the 61 studied strains.  
% BS: % of the indicated location in Beijing strains (17 strains).  
% NBS: % of the indicated location in Non-Beijing strains (44 strains).  
% In the Region: % of the indicated location in a gene or in an intergenic region in the 61 strains.  
DR: Direct Repeat of each copy of IS6110, the absence of DR is indicated by minus. 
Orientation 5'→3': the orientation of IS6110 is indicated by + or – direct or complementary chain respectively. 
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Table 7: Continuation, part 2 
GENE  Point of Insertion DR 
Orientation 
5'→3' 
% 
Total 
% 
BS 
% 
NBS 
% In 
region 
Distance to 
neighbouring gene 
Rv1528c (papA4) 1729409 CTT - 1,6 5,8 0 1,6 1000 bp upstream Rv1527c (pks5) 
Rv1542c (glbN): 
Rv1543 1745059 ACC + 1,6 5,8 0 1,6 
5 bp upstream 
Rv1543 
Rv1664 (pks9) 
1889068 CGG - 3,2 0 4,5 
4,9 
- 
1889623-
1889816 - + 1,6 0 2,2 
1410 bp upstream 
Rv1665 (pks11) 
Rv1669 1895860 - + 1,6 0 2,2 1,6 260 bp upstream Rv1670 
Rv1754c 
1986625 GTT - 8,2 0 11,3 
22,9 
1850 bp upstream 
Rv1753c (PPE24) 
1986626 TGTTC + 11,4 0 15,9 - 
1986726 ATC - 1,6 0 2,2 1951 bp upstream Rv1753c (PPE24) 
1986820 TAC - 1,6 0 5,8   
Rv1754-Rv1765c 
(RD152) 
1986638-
1998625 - - 27,8 100 0 27,8 - 
Rv1755c (plcD) 
1987008 CGG - 3,2 0 4,5 
13,1 
338 bp upstream 
Rv1754c 
1987018 CAG + 1,6 0 2,2 2024 bp upstream Rv1758 (cut1) 
1987129-
1987556 - - 1,6 0 2,2 
459 bp upstream 
Rv1754c 
1987211 GAAG + 1,6 0 2,2 1831 bp upstream Rv1758 (cut1) 
1987458-
1987544 - - 3,2 0 4,5 
788 bp upstream 
Rv1754c 
1987601 GAC + 1,6 0 2,2 1441 bp upstream Rv1758 (cut1) 
Rv1765c 1998278 - - 1,6 0 2,2 1,6 - 
Rv1765c:Rv1765A 
1998623 - - 3,2 11,7 0 
11,8 
108 bp upstream 
Rv1765c 
1998698 - - 1,6 0 2,2 183 bp upstream Rv1765c 
1998792 - - 3,2 0 4,5 277 bp upstream Rv1765c 
1998800 - - 1,6 0 2,2 285 bp upstream Rv1765c 
1998849 - - 1,6 0 2,2 334bp upsream Rv1765c 
Rv1777 (cyp144) 
2010924 CTC - 8,2 0 11,3 
9,8 
369 bp upstream 
Rv1776c 
2011104 -  - 1,6 0 2,2 549 bp upstream Rv1776c 
Rv1798 (eccA5) 2039012 CGGC - 1,6 0 2,2 1,6 - 
Rv1800 (PPE28): 
Rv1801(PPE29) 
2041428 TTT + 1,6 0 2,2 
6,5 
573 bp upstream 
PPE29 
2041741 GCG - 3,2 11,7 0 - 
2041820 CGCC - 1,6 0 2,2 - 
Rv1814 (erg3) 2057398 - - 1,6 0 2,2 1,6 - 
Rv1917c (PPE34) 
2163392 TTA + 1,6 5,8 0 
8,2 
- 
2163404 CCAG + 1,6 0 2,2 - 
2163461 TAA - 1,6 0 2,2 - 
2163473 CTG + 1,6 0 2,2 - 
2163649 TCC - 1,6 5,8 0 - 
 
% Total: % of the indicated location in the 61 studied strains.  
% BS: % of the indicated location in Beijing strains (17 strains).  
% NBS: % of the indicated location in Non-Beijing strains (44 strains).  
% In the Region: % of the indicated location in a gene or in an intergenic region in the 61 strains.  
DR: Direct Repeat of each copy of IS6110, the absence of DR is indicated by minus. 
Orientation 5'→3': the orientation of IS6110 is indicated by + or – direct or complementary chain respectively. 
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Table 7: Continuation, part 3 
GENE  Point of Insertion DR 
Orientation 
5'→3' 
% 
Total 
% 
BS 
% 
NBS 
% In 
region 
Distance to 
neighbouring gene 
Rv1922 2174919 - + 1,6 0 2,2 1,6 254 bp upstream Rv1923 (lipD) 
Rv1928c 2180845 AAG - 3,2 0 4,5 3,2 - 
Rv1947 2198330 - + 1,6 0 2,2 1,6 - 
Mb2048c 
(MT2081) 2248279 TGC + 1,6 0 2,2 1,6 - 
Rv2015c 2262185 ACG - 1,6 0 2,2 1,6 - 
Rv2016 
2263619 TCC + 1,6 5,8 0 
27,8 
370 bp upstream 
Rv2017 
2263627 AGG - 24,5 88,2 0 555 bp upstream Rv2015 
2263778 CCT - 1,6 5,8 0 706 bp upstream Rv2015 
Rv2019 
2266015 CGCC + 1,6 0 2,2 
3,2 
- 
2266167 GAC - 1,6 5,8 0 - 
Mb2047c: 
Mb2048c 
2268726-
2268693 GAA + 1,6 5,8 0 1,6 - 
Rv2077A:Rv2078 
2334686 AGG + 1,6 5,8 0 
3,2 
393 bp upstream 
Rv2078 
2334688 AGG - 1,6 5,8 0 92 bp upstream Rv2077A 
Rv2103c 2364232 - - 1,6 0 2,2 1,6 - 
Rv2104c:  
Rv2107 (PE22) 
2364548 - + 1,6 0 2,2 
27,8 
- 
2364912 - + 1,6 0 2,2 - 
2365243 - + 1,6 5,8 0 - 
2365414 - + 3,2 0 3,2 - 
2366894 CAC + 6,5 23,5 0 - 
2366896 CTA - 6,5 0 9,1 2376 bp upstream Rv2103c 
2366897 CAC - 4,9 17,6 0 2377 bp upstream Rv2103c 
2367158-
2367279 - - 1,6 0,00 2,2 
2638 bp upstream 
Rv2103c 
Rv2107 (PE22): 
Rv2108 (PPE36) 
2367672 CGA - 1,6 5,8 0 
3,2 
- 
2367679 CGAG + 1,6 5,8 0 32 bp upstream PPE36 
Rv2180c 2442348 AGC - 1,6 1,6 0 1,6 31 bp upstream Rv2179c 
Rv2282c 
2555228 AAG + 1,6 5,8 0 
3,2 
713 bp upstream 
Rv2283 
2555718 AAT - 1,6 5,8 0 - 
Rv2286c 
2559506 GAT - 1,6 5,8 0 
4,9 
- 
2559556 AAT + 1,6 0 2,2 147 bp upstream Rv2287 (yjcE) 
2559570 ATC - 1,6 0 2,2 - 
Rv2332 (mez) 2605438 AAT - 1,6 5,8 0 1,6 - 
Rv2336 2610861 GCC + 4,9 0 6,8 4,9 - 
Rv2349c (plcC) 
2627275 AAC - 1,6 0 2,2 
4,9 
295 bp upstream 
Rv2348c 
2627494 TCA + 1,6 0 2,2 - 
2627829 CAG - 1,6 5,8 0 849 bp upstream Rv2348c 
 
% Total: % of the indicated location in the 61 studied strains.  
% BS: % of the indicated location in Beijing strains (17 strains).  
% NBS: % of the indicated location in Non-Beijing strains (44 strains).  
% In the Region: % of the indicated location in a gene or in an intergenic region in the 61 strains.  
DR: Direct Repeat of each copy of IS6110, the absence of DR is indicated by minus. 
Orientation 5'→3': the orientation of IS6110 is indicated by + or – direct or complementary chain respectively. 
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Table 7: Continuation, part 4 
GENE Point of Insertion DR 
Orientation 
5'→3' 
% 
Total 
% 
BS 
% 
NBS 
% In 
region 
Distance to 
neighbouring gene 
Rv2352c (PPE38) 
2633979 CGC - 1,6 0 2,2 
8,2 
1904 bp upstream 
Rv2351c (plcA) 
2634022-
2634048 - + 6,5 23,5 0 - 
Rv2352c (PPE38): 
Rv2353c (PPE39) 2634148 TCC - 1,6 0 2,2 1,6 
50 bp upstream 
Rv2352c (PPE38) 
Rv2356c (PPE40) 2639543 CCC - 1,6 0 2,2 1,6 3951 bp upstream Rv2353c (PPE39) 
Rv2356c (PPE40): 
Rv2357c (glyS) 2639612 - - 1,6 5,8 0 1,6 
77 bp upstream 
Rv2356c (PPE40) 
Rv2435c 
2732535 TAGG + 1,6 5,8 0 
4,9 
695 bp upstream 
Rv2436 (rbsK) 
2732535-
2732670 - - 1,6 5,8 0 
1975 bp upstream 
Rv2434c 
2732604 CGA + 1,6 5,8 0 626 bp upstream Rv2436 (rbsK) 
Rv2664:Rv2665 2982432 TGGC - 1,6 0 2,2 1,6 - 
Rv2807 
3114403 TCA - 1,6 0 2,2 
4,9 
- 
3114442 CAC - 1,6 5,8 0 - 
3114795 GAT + 1,6 0 2,2 251 bp upstream Rv2808 
Rv2807:Rv2808 3114873 AGAT + 1,6 0 2,2 1,6 173 bp upstream Rv2808 
Rv2808 
3115131 CGA - 1,6 0 2,2 
3,2 
- 
3115231 CGA - 1,6 0 2,2 - 
Rv2809 3115489 GTC - 1,6 0 2,2 1,6 - 
Rv2813-Rv2820c, 
DR region and 
RD207 
3119420 TCC - 1,6 0 2,2 
100 
- 
3119936 - - 1,6 0 2,2 - 
3120515 GAC - 1,6 0 2,2 - 
3120523 GGG - 65,5 0 90,9 - 
3125228 GGTG - 1,6 0 2,2 - 
3125708 CGC + 1,6 0 2,2 - 
3125851 CTT - 1,6 0 2,2 - 
3127927 - + 27,8 100 0 - 
Rv2957 3310163 GTT - 1,6 5,8 0 1,6 - 
PE27A: 
Rv3019c (esxR) 3378553 GGC - 21,3 76,4 0 21,3 
310 bp upstream 
Rv3018c (PPE46) 
Rv3019c (esxR) 3378898 CTGC - 4,9 0 6,8 4,9 655 bp upstream Rv3018c (PPE46) 
Rv3019c (esxR): 
Rv3020c(esxS) 3379027 GCAG + 9,8 35,2 0 9,8 - 
Rv3113 3480373 CAG + 24,5 0 34 24,5 386 bp upstream Rv3114 
Rv3125c (PPE49) 3491592 CTC + 3,2 11,7 0 3,2 - 
Rv3128c 
3493192 CCT - 1,6 0 2,2 
19,6 
- 
3493843 AAC + 3,2 0 4,5 817 bp upstream Rv3129 
3493844-
3493908 CGA - 13,1 47,0 0 - 
3494114 ACC - 1,6 0 2,2 - 
 
% Total: % of the indicated location in the 61 studied strains.  
% BS: % of the indicated location in Beijing strains (17 strains).  
% NBS: % of the indicated location in Non-Beijing strains (44 strains).  
% In the Region: % of the indicated location in a gene or in an intergenic region in the 61 strains.  
DR: Direct Repeat of each copy of IS6110, the absence of DR is indicated by minus. 
Orientation 5'→3': the orientation of IS6110 is indicated by + or – direct or complementary chain respectively. 
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Table 7: continuation, part 5 
GENE Point of Insertion DR 
Orientation 
5'→3' 
% 
Total 
% 
BS 
% 
NBS 
% In 
region 
Distance to 
neighbouring gene 
Rv3128c:Rv3129 
3494372 AAG - 1,6 0 2,2 
3,2 
- 
3494395 TAC + 1,6 0 2,2 265 bp upstream Rv3129 
Rv3138 (pflA) 3504821 TAC + 1,6 0 2,2 1,6 542 bp upstream Rv3139 (fadE24) 
Rv3178:Rv3179 3547342 ATG + 3,2 11,7 0 3,2 276 bp upstream Rv3179 
Rv3179:Rv3180c 
3549051 GTCG - 1,6 0 2,2 
21,3 
- 
3549176 AAC + 1,6 0 2,2 - 
3549199 CGG - 18 64,7 0 - 
Rv3183 
3550960 ACC - 1,6 5,8 0 
6,5 
- 
3550962 - - 1,6 0 2,2 - 
3550996 CCTG - 1,6 0 2,2 - 
3551030 GTCG - 1,6 0 2,2 - 
Rv3183:Rv3188 
3551139 ATG - 1,6 0 2,2 
13,1 
- 
3551220 GAC + 1,6 0 2,2 - 
3551229 CTG + 1,6 0 2,2 - 
3551230 GAA - 1,6 0 2,2 - 
3552683 GCC + 1,6 5,8 0 - 
3552701 CGG + 1,6 0 2,2 - 
3554294 - - 1,6 0 2,2 - 
3559402 - + 1,6 0 2,2 - 
Rv3189 3555250 CGCG + 1,6 0 2,2 1,6 - 
Rv3190c 
3555513 CGC - 1,6 5,8 0 
3,2 
- 
3555753 TGT + 1,6 0 2,2 - 
Rv3323c (moaX) 
3709336 CTT - 1,6 0 2,2 
3,2 
284 bp upstream 
Rv3322c 
3709622 GCA - 1,6 0 2,2 570 pb upstream Rv3322c 
Rv3324A: 
Rv3327 (IS1547) 3711737 GGC - 3,2 11,7 0 3,2 - 
Rv3382c (lytB1) 3796689 TGG + 1,6 5,8 0 1,6 - 
Rv3383c (idsB) 3797823 ATC + 13,1 47 0 13,1 - 
Rv3427c:Rv3428c 
3844681 CGGG - 21,3 76,4 0 
22,9 
- 
3844737 CCCG - 1,6 0 2,2 - 
 
% Total: % of the indicated location in the 61 studied strains.  
% BS: % of the indicated location in Beijing strains (17 strains).  
% NBS: % of the indicated location in Non-Beijing strains (44 strains).  
% In the Region: % of the indicated location in a gene or in an intergenic region in the 61 strains.  
DR: Direct Repeat of each copy of IS6110, the absence of DR is indicated by minus. 
Orientation 5'→3': the orientation of IS6110 is indicated by + or – direct or complementary chain respectively. 
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The 20% of the located copies of IS6110 in the studied strains could act as 
mobile promoter 
As already mentioned in Chapter 1 and 2, different studies have indicated that when 
IS6110 is inserted in the same orientation as, and close enough to, a downstream gene 
could potentially function as a promoter (28, 33). The orientation of the located copies 
of IS6110 in the 61 strains and the distance to the close genes were analysed in order 
to test the promoter function of this element. 32 locations of IS6110 were located close 
enough (less than 400 bp) and with the same orientation as the neighbouring gene 
(Table 7). Among these 32 candidate locations to act as a mobile promoter, 4 of them 
were observed in two different strains and 23 in just one single strain. This result is 
indicating the enormous variability and genomic plasticity that IS6110 could generate 
among strains. The remaining 5 locations were observed in a higher number of strains; 
being 3 of these locations observed in non-Beijing strains and 2 in Beijing strains 
(Table 7).  It is noteworthy that one of the two frequent locations among Beijing strains 
corresponds to the copy located in ctpD gene and upstream Rv1468c gene and, as 
already explained in chapter 2, it was demonstrated that this copy is acting as a 
promoter inside monocytes (28). The fact that this location is quiet frequent in Beijing 
genotype and even is specific of this family could be one of the special features of 
Beijing family in terms of virulence and transmission. 
Analysis of the Direct Repeats of each IS6110 obtained copy in the 61 studied 
strains 
The DR generated by the mechanism of the transposition of IS6110 was determined 
with the sequence analysis of the flanking regions of each IS6110obtained copy of in 
the 61 strains. The DR of 3-4 nucleotides was detected 128 of the 160 located copies 
of IS6110 and the other 32 copies were not flanked by DRs. Genomic regions loss and 
genomic reorganizations were observed in these cases. It is stood out that in one copy 
of IS6110, located in, it was detected a Direct Repeat of 5 nucleotides.  
Although in some of the studied HCS the number of IS6110 located copies was less 
than 5, it was possible to observe some of them without DR corroborating the idea that 
the probability of rearrangement process between copies rises when the number of 
those increases producing more variability among strains. 
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Comparison among IS6110 locations and the distribution of the ORFs across the 
eleven functional categories of M. tuberculosis 
The 81 regions affected or altered for IS6110 were grouped in the eleven functional 
categories of M. tuberculosis. The 68% of the regions corresponded to interrupt ORFs 
and the remainder were intergenic regions. Comparing the current distribution of ORFs 
across the eleven functional categories and the 81 regions affected for IS6110 it is 
possible to observe similar proportions (Figure 45). 
 
 
Figure 45: Distribution of the genes and the IS6110 of M. tuberculosis across the eleven 
functional categories. The 81 obtained regions altered for the presence of IS6110 were 
classified in the 11 functional categories of M. tuberculosis. 
 
An accurate dendrogram of the 61 strains was obtained based on IS6110 points 
of insertion  
The informatic analysis of spoligotyping results is carried out by Bionumerics program 
and is based in presence/absence or numerical analysis 1/0 of a specific sequence of 
M. tuberculosis. Based on this idea, all the obtained IS-locations were arranged in 
columns of an excel sheet and the 61 strains, and the two controls, GC1237 and 
H37Rv, were arranged in rows. When a strain presented a point of insertion was given 
the number 1 and if not, was assigned with the number 0. After that, the document was 
introduced in SpolDB4 database as a new informatic event, included to the RFLP and 
the sopligotyping of each strain and analysed by Bionumerics program. The obtained 
dendrogram (Figure 47) shows that Beijing strains were grouped better than by RFLP 
(Figure 46). Furthermore, and despite having very few located copies of IS6110 in non-
Beijing strains, they were also grouped in families. However, in the case of non-Beijing 
strains the grouping was no perfect.  
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Comparing with spoligotyping and RFLP techniques, with this dendrogram it is possible 
to obtain information of each clone or strain, information not provided by the 
spoligotyping and provided by RFLP, and the families are also grouped. As Figure 45 
shows, although RFLP groups genotypes, if the RFLP of a Beijing strains is quite 
different from the others, this is not in the group. This method offers advantages over 
the other two as it is quickly and more economic. Moreover, as is based on PCR it is 
possible to complete in one day. 
 
 
Figure 46: Comparison of two Dendrogrames based on RFLP and dendrogram 
spolygotiping of the 61 strains used in this work. The RFLP/Spoligotyping of GC1237 and 
H37Rv strains were included in the dendrogram. The Beijing genotype is showed in both cases. 
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Figure 47: Dendrogram based on points of insertion of IS6110 of the 61 strains used in 
this work.  The points of insertion of GC1237 and H37Rv strains were included. 
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Conclusions 
• A primer collection, which amplifies locations of IS6110 in MTBC strains, was 
generated in this study. 
• 160 points of insertion of IS6110 were obtained. These points of insertion were 
grouped in 81 regions due to in some cases it was observed the interruption of a 
gene by IS6110 in different points. 
• Random distribution of IS6110 along the genome was observed both, in the 
reference M. tuberculosis strains of the database and in the 61 studied strains. 
• The common locations of IS6110 of Beijing strains were obtained. 
• The common locations of the group of used Beijing strains also common with the 
group of non-Beijing strains were obtained. 
• The hot-spots of IS6110: DR region, both ipl, and plcABC and plcD regions were 
observed in the two groups of HCS (Beijing and non-Beijing) being these general 
hot-spots of M. tuberculosis. 
• IS-locations within Rv1371, Rv2016, ctpD, idsB genes and between the two IS1532, 
were only observed in Beijing strains indicating that these regions could be specific 
hot-spots of Beijing genotype (IS6110 Beijing-hot-spots). 
• The 80% of the located copies have DR indicating that its presence was due to a 
transposition event. The remaining copies lack on DR and genomic reorganization 
was observed.  
• A dendrogram based on the points of insertion of IS6110 classifies more accurate 
the M. tuberculosis families and information of each clone is also obtained.  
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Conclusiones Generales 
 
• La cepa ancestral de M. tuberculosis GC1237 perteneciente a la familia Beijing 
tiene 19 copias de la secuencia de inserción IS6110. La localización de todas las 
copias de este elemento fue posible gracias a la combinación de varias técnicas 
como son LMPCR y PCR con el uso de la librería de BACs y del DNA genómico de 
la cepa de estudio GC1237. 
• Una de las copias de IS6110 de la cepa GC1237 se localizó a 31 nucleótidos del 
inicio del gen esencial Rv2179c. Mediante varios métodos se confirmó la actividad  
promotora de esta copia de IS6110. Además se observó que esta actividad se ve 
incrementada en el interior del macrófago y sólo está relacionada con la distancia 
de la IS al gen. 
• La copia de GC1237 delante del gen Rv2179c resultó ser única de esta cepa lo que 
permitió el diseño de un test rápido para su detección basada en un multiplex PCR. 
• Cuando IS6110 actúa como secuencia promotora lo hace de forma independiente al 
fondo genético. 
• La copia de IS entre los genes dnaA-dnaN (inserción A1), característica de todas 
las cepas Beijing, resultó no tener efecto en la expresión del gen dnaN tanto en 
cultivo líquido como en el interior del macrófago. 
• La copia de IS6110 localizada a 75 nucleótidos del gen phoP de MBZ actúa como 
una secuencia promotora de ese gen tanto en cultivo como en el interior del 
macrófago. 
• No se observaron diferencias en la replicación tanto en el interior del macrófago  
como en ratones de las cepas H37Rv ΔphoP pSO5k y H37Rv ΔphoP pSO7k. 
• Las cepas Beijing y las cepas no-Beijing comparten regiones donde IS6110 tiende a 
insertarse pero no comparten puntos de inserción. Concretamente las 
localizaciones de IS en los genes  ctpD, idsB, Rv1371, Rv2016, y entre las dos 
IS1532, son únicos de las cepas Beijing y podrían ser la clave de algunas 
características especiales de esta familia. 
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General Conclusions 
 
• M. tuberculosis Beijing GC1237 is an ancestral strain which contains 19 copies of 
the insertion sequence IS6110. The location of all its copies was possible with the 
complementation of different techniques, as LMPCR and PCR, and with the use of 
BACs library and genomic DNA of GC1237 strain. 
• One of the copies of IS6110 of GC1237 strain was located 31 bp upstream the 
essential gene Rv2179c. The promoter activity of this copy was demonstrated by 
several methods. In addition, this activity enhances inside macrophages and is only 
related to disposition of the sequence with respect to this gene. 
• The copy of IS6110 upstream Rv2179c gene is unique of GC1237 strain, and 
permitted the design a promising test for its rapid detection based on multiplex PCR.  
• When IS6110 acts as a promoter, acts regardless of the genetic background. 
• The well-known insertion A1, one of the genetic markers of all Beijing strains, 
causes minimal effect in dnaN gene expression both in broth and inside 
macrophages. 
• The copy of IS6110 located 75 bp upstream phoP gene of MBZ is acting as a 
promoter of this gene both in broth and inside macrophages. 
• No significant differences were observed in replication experiments both in 
macrophages and in mice between the strains H37Rv ΔphoP pSO5k y H37Rv 
ΔphoP pSO7k. 
• Beijing strains and non-Beijing strains share insertion regions of IS6110 but not 
points of insertion. Concretely, IS-locations within ctpD, idsB, Rv1371, Rv2016, 
genes and between the two IS1532, were only observed in Beijing strains and they 
could be the key of some advantages of the Beijing genotype.  
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Table 1: Primers used in the study of genomic deletions of Regions of Differences (RD) 
(Chapter 1) 
Name Sequence 5’-3’ Tm ºC Reference 
RD105d GGAGTCGTTGAGGGTGTTCATCAGCTCAGTC 77.3 Tsolaki et al. (8) 
RD105r CGCCAAGGCCGCATAGTCACGGTCG 81.6 Tsolaki et al. (8) 
RD105int GCAACACCCGCTTGTCTTTG 62 Hanekom et al.(2) 
RD108d CGCCGCGTCTGCCGCTCTT 77.1 Tsolaki et al. (8)
RD108r GACCAGGACACCGCGCAGATACG 75.4 Tsolaki et al. (8)
RD110ad GAACTGCCGCTGATCGAAGAATGG 73.3 Tsolaki et al. (8)
RD110ar GGTGTCGATGCCGTGCTATGTGC 74.5 Tsolaki et al. (8)
RD127d GACTCCGATCTGGAGGAGCTG 67.5 Tsolaki et al. (8)
RD127r CAGGCCGGCCAGAAAGTCCAG 74 Tsolaki et al. (8)
RD129d GAAAGCCGCTCGTGGTCAGGTTG 74.5 Tsolaki et al. (8)
RD129r GCTGCGGCCGGCTCCATC 75.9 Tsolaki et al. (8)
RD139BWd GATCCTGATCATCCCGTTCGCGCTGTGCTT 82 Tsolaki et al. (8)
RD139BWr AGGACCTCGACCTGACCGACCTGGTCAT 78.5 Tsolaki et al. (8)
RD142d TCCGCGACGACGAACAACGAC 74.7 Tsolaki et al. (8)
RD142r TCACTTCCATTTCCAGCGGCAACT 73.1 Tsolaki et al. (8)
RD142int GCTCGAGCATGATCAGCAAAG 62 Hanekom et al.(2) 
RD149d CATGTCACCCTGGCCCGACGGGTC 81.16 Tsolaki et al. (8)
RD149r CCAGGCGATCTTCGACCACGGCACAC 81.33 Tsolaki et al. (8)
RD150d TGTGGCGTGGCTCGGCAAATAG 74.7 Tsolaki et al. (8)
RD150r CGGGACGGCAAACGGGTGAT 75.1 Tsolaki et al. (8)
RD150int CACCGGCACTTACCATCTCG 62 Hanekom et al.(2) 
RD152d CCGGGTTGAGCAATGCGGATATCAGTGGAC 80.5 Tsolaki et al. (8)
RD152r TGGGATAGTTCAGGTGGCCATCGTGGGCAT 81.9 Tsolaki et al. (8)
RD165d GCCTTCGCTGCCCGTGTTCTG 75.1 Tsolaki et al. (8)
RD165r GCTCGCGGGGTGCTGGTGTTT 76.2 Tsolaki et al. (8)
RD166d CCAGGGTTGGCAGCCGTGCGTCTTGAA 77.7 Tsolaki et al. (8)
RD166r GTACTCGCTGTCGCCAAGCGCATAGAGAAGAT 77.8 Tsolaki et al. (8)
RD182ad CGGTGGGGCTCTGCGTGGTC 76.5 Tsolaki et al. (8)
RD182ar AGGCGTTCGGGGATGCGTCTT 74.6 Tsolaki et al. (8)
RD207d GACGAGTTCGCGCTCAAAATGT 69.4 Tsolaki et al. (8)
RD207r CCCCGGCGAGGAACAGAA 70.8 Tsolaki et al. (8)
RD181d CGCAACGGCCGCGGTGAACT 79.4 Tsolaki et al. (8)
RD181r CGGGCGGCTGCGGGAACCTT 79.6 Tsolaki et al. (8)
 
Table 2: Primers used in the study of pks15/1 polymorphism and in LMPCR technique (Chapter 
1) 
Name Sequence 5’-3’ Tm ºC Used for Reference 
Pks1l GCAGGCGATGCGTCATGGGG 77.2 pks15/1 
polymorphism 
Constant et al.(1) 
Pks1J TCTTGCCCACCGACCCTGGC 75.8 Constant et al.(1) 
SalGd TAGCTTATTCCTCAAGGCACGAGC 68.1 
LMPCR 
Prod’hom et al. (5) 
SalPt TCGAGCTCGTGC 49.2 Prod’hom et al. (5) 
Xmapt CCGGGCTCGTGC 59.3 Otal et al. (4) 
ISA1 CCTGACATGACCCCATCCTTTCC 71.4 Mendiola et al.(3) 
ISA3 GAGGCTGCCTACTACGCTCAACG 69.9 Mendiola et al.(3) 
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Table 3: Primers used for multiplex PCR designed to detect GC1237 strain (Chapter 1) 
Name Sequence 5’-3’ Tm ºC Reference 
dna II CCACCCACGACACCGCAT 70.8 This work 
dna III GGGCGGTTCAATTGGCTGT 69 This work 
Rv2179c fw CAATACGTGATCGCCGGGAC 69.6 This work 
Rv2179c rv CGAATTCCGTGGATACTGCGTAG 68.2 This work 
RD105 fw AGTCGTTGAGGGTGTTCATCAGC 68.5 This work 
RD105 rv CCAAGGCCGCATAGTCACG 68.8 This work 
 
Table 4: Primers used in the study of gene expression qRT-PCR and RT-PCR (Chapter 2) 
Name Sequence 5’-3’ Tm ºC Reference 
RT-rrnAP1 fw CCTATGGATATCTATGGATGACCGA 65.5 This work 
RT-rrnAP1 rv GGCGACCCTGCCAGTCTAA 63.2 This work 
RTRv0794c d CGGATCAAAGCGATCGATGT 67.2 This work 
RTRv0794c r CGCCCTGCCGGTGTATC 67.8 This work 
RTRv0841 d CTGGTCGATGACCCCTGTAGTT 66.2 This work 
RTRv0841 r CCAAGAGATGAGCACCATGAATC 66.7 This work 
RTRv2078 d CATTTCCTGTCGCCCAGACT 66.4 This work 
RTRv2078 r TTTCTCGCCCACCGTGAT 66.7 This work 
RT Rv2179c fw CTACGACCATGTAGCGCTGTGT 66.2 This work 
RT Rv2179c rv CAGTTCCCGGGTGAAACG 66.6 This work 
RT AroG fw TGCCAGCCATGAAGCTTTG 67.5 This work 
RT AroG rv CCGTCGGACAACCTCAACAT 67.2 This work 
RT Rv2280 fw H TCCTGGAGTACATTGACAACACTTC 65.1 This work 
RT Rv2280 rv H GGAATACCTAGCTCCAGGTTCTGA 65.4 This work 
RT ctpD F GTGGCGCTGCTGCTGTTTCT 70.1 This work 
RT ctpD R CGCGGCAATCATCAGCAGAT 70.6 This work 
RTdnaA F CCAGACACCACAACCGACAA 67.2 This work 
RTdnaA R TGGCCAACTGTGCTGGTTATC 67.1 This work 
RTdnaN d CGGTGAGACGGTGGTTTTG 66.6 This work 
RTdnaN r CGACGCCGACCACTTCAG 68.3 This work 
RT1371 F  GTATACCCAGAGCGAGGTG 59.7 This work 
RT1371 R TCGCTACGAATTGCAGTGCCC 71.3 This work 
RTPPE34 F ATCACCAGTTCCAAGGGTGTG 66.1 This work 
RTPPE34 R CGCCCATCTGTCCGAAGC 69.4 This work 
RTRv2016 F ACCACGCAGGTGACGAG 64 This work 
RTRv2016 R ACCGAAGTCGATGGACG 62.5 This work 
RTRv2077A F GGGTCGAATGAACTACAGGTTGTA 64.9 This work 
RTRv2077A R AATGGTTGGCCGGATTCTG 67 This work 
RTRv2077cF GCACCGAGCACCTTATCGAT 66.3 This work 
RTRv2077cR GCATCTGCAGAAACACGTCTTC 66 This work 
RTRv2286cF CCTGGTAGCGGGCAAGAAG 66.9 This work 
RTRv2286cR CCGATCCGCATCAACGA 67.3 This work 
AroGend1 GTCGTGTTCGCAGGTCAGTC 66.1 This work 
Rv2180cfw ACGCACTGATCCTGCATCTG 66.6 This work 
Rv2180crv GGCCACTGCGGCAAAG 67 This work 
Rv2179c fw CAATACGTGATCGCCGGGAC 69.6 This work 
Rv2179c rv CGAATTCCGTGGATACTGCGTAG 68.2 This work 
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Table 5: Primers used to amplify IS6110 insertion sequence of MTBC (Chapter 1 and 3) 
Name Sequence 5’-3’ Tm ºC Reference 
IS61 GACCGCGGATCTCTGCGACCATCC 78.8 This work 
IS62 ACCATCGCCGCCTCTACC 67.4 This work 
Gab1 CTGACCGAGCTGGGTGTGC 69.6 Samper et al. (6) 
Gab2 TCTGATCTGAGACCTCAGCC 62.2 Samper et al. (6) 
ISAcom ATGTCAGGTGGTTCATCGAGGAGG 71.2 This work 
NTFfw CGTGAGGCACCGAGGGTGTTTC 73.9 This work 
NTFrv CGGTAGTAACTGGGCGCGTTCG 73 This work 
dnaAI TCCGAGATGGCCGAGCGCCG 80.5 This work 
dnaAII CCACCCACGACACCGCAT 71 This work 
Rv0402cext GGTGCGCCTCATCACCCAG 71.6 This work 
Rv0403cext GTTCGGCGTTGCCAAACGC 73 This work 
Rv0594d ATGTCCGCTACACGCCGAACCC 74.7 This work 
Rv0594r GGCTCAGCCGGTTGGTGCC 74.5 This work 
Rv0756cint CCTCGTGGGTATTGCGA 63.5 This work 
Rv0782ext ACGAGAACGTCACGGCCC 68.8 This work 
BCG2A GCCGTCCATCCCGGGCATC 76.2 Soto et al.(7) 
BCG2B CCATGTTCAAACCGGTGTC 63.9 Soto et al.(7) 
Rv0783cext AAACCAACTTCGCGGCCC 69.4 This work 
0795F CCTATCGCCCACCAGACGC 70 This work 
0795R ACACCGTGCGCCTCTACCTGC 72.7 This work 
Rv0795d AGGCTTTGCTGGGCACACAGG 72.6 This work 
Rv0795r GTCCTTCTCACCTAGTGCCG 63.7 This work 
Rv0835d TTGCTCCACTGCTGCCAAGTCGG 76.2 This work 
Rv0836cd AACAATTGGGACCACTTCGAGG 68 This work 
pipF ACGAATGGCTGAAGATGTGAA 64.5 This work 
pipR AATCGGAGGTCAAGTGGA 60.6 This work 
Rv0920cr GCAGCATCCATGCCCTTGAG 70.3 This work 
Rv0921r AATCCGCCAGATTCACGCCG 73.3 This work 
Rv1032c out AGCACAACGGTAACGACC 61.3 This work 
Rv1033c int GGGGTACACGCGCAGTCAA 69.5 This work 
Rv1046d CGTAACTGCTGATATTATCGAGG 66.5 This work 
Rv1046r ACGACGAATGGAATCGCCC 69.4 This work 
Rv1051c out CGATGTCGCGAACCACC 66.8 This work 
Rv1052out AACTTGGCTGAGGCCCTTG 66.5 This work 
PPE12out CCGCCGCGTGCAACTC 70.9 This work 
PPE16d ACAACATGATCGGCATCGGC 69.3 This work 
PPE16r GAAACCGAAGTTGCCGCTGCCC 76 This work 
PPE16end1 GCGTATTCAGCCAGCGGAGG 71.1 This work 
PPE16end2 CGAAGGATCTCGCGCGG 70.7 This work 
glgCd CATGAGAGAAGTGCCGCACG 69.4 This work 
glgCr AACCACCGCGATGCTGGC 72 This work 
Rv1234d CTCATGCAGGTTGAACGGGTC 68.9 This work 
Rv1235r TACCTCTGATTGTGCTGGTCACG 68.2 This work 
Rv1301d GAGCAGCGTTCGCGTGG 69.8 This work 
Rv1301r CTGGCCGCGTCCACACC 71.9 This work 
Rv1319cd GAGACCGTGACACTTCGCGGG 73.3 This work 
Rv1319cr TACCCGTCGGCGCCGTTGG 77.2 This work 
Rv1359d TTTCGTCTCACCGCGTACCGTG 73.1 This work 
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Table 5: Continuation 
Name Sequence 5’-3’ Tm ºC Reference 
Rv1359r GCAGGACGATCGGGGACAACG 75 This work 
Rv1359ext CGTCGCCGCGTTCGCCC 78 This work 
Rv1360ext GACGAATTCACGCATCCGACG 71.9 This work 
Rv1368ext GACAATCCAGGGACGTGAC 63.2 This work 
Rv1371ext TTGGAAATCCACTCACTCAGG 64 This work 
Rv1371d ATCGTTGCAGTACTGGCCGTGGG 74.5 This work 
Rv1371r TATACGGGTGGTGCAGCAGGGTG 73.5 This work 
Rv1468cext GCTAATCATCGAACCGAGGCG 69.7 This work 
Rv1469cext CACGGAGACTACCGACCACAG 67 This work 
CtpDF ACCCCGCCAGAATGGTTAATCC 70.4 This work 
CtpDR TTGTTCCGCAACGCTTGTGC 71.5 This work 
CtpDbIS GAGGCTCCTTTCGACCG 68 This work 
Rv1506d ATCTATCGTCTCCACGCTTCC 64.3 This work 
Rv1506r TAGCCGAGAGCCTTAGCGGC 69.7 This work 
FadD25d GGTCGAATCCTCTCTTCCTGG 66.1 This work 
FadD25r CCAATAGCCGATGGCGACG 70.8 This work 
Rv1528cd ATGTAGGTGATGGCCGC 66 This work 
Rv1528cr GCCAATTGGTGCCCG 64 This work 
Rv1541cd GAGGCCTACCAGACCCG 63.4 This work 
Rv1541cr CGACCATACCGGGCGCCAC 75 This work 
Rv1541cf GCACCAGTCTGAGCCCTG 65 This work 
Rv1541ci ATCCCAAGCTAGCGAAGAGG 65.4 This work 
Rv1543d CAGATCCTTGGTCGCCGCAC 72.4 This work 
Rv1543r GTTGAGCTGCATCGTTCGC 67.2 This work 
cyar TTGGCGGTCAGACCCCTGC 73.1 This work 
LeuVd GGCGATTTCGGATGCGGCG 76.8 This work 
Rv1664d GCCAGCTTTTTGCCATCCTCG 71 This work 
Rv1664r GCATAATTTGAGCCTGCCAGGAC 69.4 This work 
Rv1669d GGTGTTTGAACATTTCGTGGG 66.2 This work 
Rv1669r GGTAGTACCAGGCAGCGTCC 65.8 This work 
Rv1728cext GGTTTCTGAGCCGTAGTCCG 65.9 This work 
Rv1729cext GGGTTTGACTCGGCAGCACC 71.3 This work 
Rv1754cd AGGAACTCAAATCCGGTCAGG 66.2 This work 
Rv1754cr GAACCATGAGTCCAATAGCGGC 68.5 This work 
1765 CGGTTCCAACTTGAGCGCGGTC 75.5 Otal et al. (4) 
1765-ISA1 GTTGGTGCATCATTCCGACC 67.5 Otal et al. (4) 
plcDd GTCAGCTGGAAGGTGTATCGC 65.8 This work 
plcDr GGATTTGAGTTCCTCGAGCC 64.8 This work 
Rv1758d ATTGGCGAGAAGTCTATGGGC 66.2 This work 
Rv17589d TTGGTGCCGGCGGCAT 72.6 This work 
Rv1761cext GCGTTGATGTTCGGGATCAC 67.7 This work 
Rv1762cint TCGCTCGATCCAGTAGCC 64.2 This work 
Rv1777d GAGACGTTCGCCGAAAGGC 69.3 This work 
Rv1777r CTGCCTCAATTACCGAGG 60.8 This work 
Rv1798d GTTTGGCACAAGTATCGGT 60 This work 
Rv1798r TCTCATGTTTCGATATATTTGGC 61.5 This work 
PPE28d GGAGGGCATCCAGCAAGCG 72.5 This work 
PPE28r CTTAATCCCTAATCGCGTGGC 66.4 This work 
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Table 5: Continuation 
Name Sequence 5’-3’ Tm ºC Reference 
Rv1879d AAACGACCGTAGACCCGAC 63.9 This work 
Rv1879r ATAGATGCGTGCGGCAGTGC 70.7 This work 
1883-ISA1 ACGATAATGCCAATTGTTCACCG 68.3 Otal et al. (4)
1883-ISA3 GTTGCCAATCGGGTTCTCGCC 73.6 Otal et al. (4)
PPE34d TATTTCCCGCATCCCCCTTACG 71 This work 
PPE34r ATGCCAGACTCCAGGGTGCC 71 This work 
PPE34a AACGTCGCTGGTATCTTCACGG 69 This work 
PPE34t TGCCCGACGTTGTAGATTCCC 70 This work 
Rv1917cd TCGATTCCTAAAGCGGCT 62.4 This work 
Rv1917cr CGAATATGAGGGCCGAG 61.8 This work 
Rv1928cd ATTCCATCAGGTATCGGCCC 66.8 This work 
Rv1928cr CCGTGTGTCGTTCAGTGACG 68 This work 
Rv1929d GATTCAGCTGGCGATCGAG 66.1 This work 
Rv1929r TCACATCGCAGCAGACGGGC 74.4 This work 
1947-Rv1948c GTGCTGGAGCAAGACCTCGC 69.7 Otal et al. (4)
1947-ISA3 ACTGCGGATATGGAACTGGG 66 Otal et al. (4)
Rv2015rev AATCCTTGATGCCCCAAACC 66.8 This work 
Rv2016d ATGCATAGCCGGTGTCTGTCC 68.3 This work 
Rv2016r AATGCGAACCTCTTCCAGCC 67.5 This work 
Rv2017rev AATTCGATCTGGGTGAGTCC 62.8 This work 
Rv2019d AGCCTGATCGGAATCTCCTCGCC 74.2 This work 
Rv2019r TCGCCGGCGGTTAACG 69.5 This work 
Rv2078d ATCGAGACCACGCAGAGGGC 71.1 This work 
Rv2078r AGTCCTCATGATGCGCACG 67.6 This work 
Rv2088d TGACCTCGATTTTCGGGC 66.2 This work 
Rv2088r TCGTCGATTGTCAACCCG 66 This work 
Rv2102fw CGTGGCCGCAGCTATGC 69.3 This work 
Rv2103fw TGATCCCAGCGCACCCCT 71.6 This work 
Rv2106d GTCCACATTTTGTACACGAAATACC 64 This work 
Rv2106r TCCTCCTCGAAACTCAAAGAA 62.7 This work 
PE22d ACATGGCGGTAAGCAATGC 66 This work 
PE22r ATCGCGGTCTTATGGGC 63.6 This work 
Rv2166cext CCGATCACCACACAGTCC 62.9 This work 
Rv2169cext TCTCTACGCCGAAGATCCCAAG 68.5 This work 
Rv2179cd AATACGTGATCGCCGGGAC 67 This work 
Rv2179cr TTCCGTGGATACTGCG 59.2 This work 
Rv2277c AAGTCCCTCCCAAGGCG 65.27 This work 
Rv2280r TGTCATTTCACTCATCGGAGGC 68.3 This work 
Rv2282cd TTCTGGCCATCGCTGAGGC 72 This work 
Rv2282cr GCAGGTCTCGTATCGCACCC 74 This work 
Rv2286cd ATCAGCTGGAGGACTCAGG 62 This work 
Rv2286cr AATCGCCGCATTGACGCC 71.6 This work 
mezd GCACCAAGTCTCAACCGTG 64.5 This work 
mezr ATCGTTGAACACGCAGTAATCCG 68.8 This work 
Rv2336d TCGCCGAATTCACCTCGGGC 75.5 This work 
Rv2336r CCGCCCATTACCGCTTCCAG 72.5 This work 
Rv2348cd ATGGTTCAGACGTAACGGTTG 63.7 This work 
Rv2348cr GAGAATGCGGAATCACG 60.4 This work 
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Table 5: Continuation 
Name Sequence 5’-3’ Tm ºC Reference 
plcCd TTCTCGTCGCTTCTTGGC 64.4 This work 
plcCr ATTGCAGCTGCGATGTGTGG 69.7 This work 
plcBd AATTCGTCACGGTCCCC 63.5 This work 
plcBr CAGGAATGCTCGGCGTGAC 69.4 This work 
plcAd TGCAGGAAGGCAGGGC 68 This work 
plcAr TTTCAGCTGCACAGCCCG 69 This work 
PPE38d AAGTGCGGATTTTCGGTGTGG 70 This work 
PPE38r ATCAAACGAGGACGCCGAGG 70.5 This work 
PPE39int1 ATGCCGGGGCGGTTCAGAAA 74.6 This work 
PPE39int2 GAAGAAACCCGAAAGCCC 63.5 This work 
PPE39R AAGCCTGTGTTGCCGGCGCCG 80.4 This work 
PPE40-3’ ACTCCGGGTTCTTCAACACAGGC 71.2 This work 
PPE40F CGGATGTTTTTTGGTGCG 65 This work 
PPE40R GGCGTTGGAGAAGCCCG 69.3 This work 
Rv2345d ATGCGTCTCGTTCGCCTGC 71 This work 
Rv2345r AACTTCCCGGCGCGTTCG 72.6 This work 
Rv2356cf CCGGCAGCTGGCTTGACC 71.8 This work 
Rv2356crev CAACTGCACAAACGCACTGC 68 This work 
PPE40d AAGGGTGGGATGGATAAGCG 67 This work 
PPE40r ATAGGTGGCCTCAGCAGCGG 70.6 This work 
GlyS-3’ AATGCCGTCACCGTGCGGGAG 77.2 This work 
Rv2390cd AAAACTACGCAACAAGCCTGG 65.1 This work 
Rv2390cr ATTGCGCGATGGCGTCCC 73.9 This work 
2407-ISA1 ATCCATCGCATTGAGCAGGC 66 Otal et al. (4) 
2407 AGCTATGACCAACCAGCCC 64 Otal et al. (4) 
Rv2435cr ATGATCGCTCCGACAATCGG 69.4 This work 
Rv2435cd AAACGCGATGATCGTGGGC 70 This work 
Rv2478cext GCCGATATGGGCAGGGGG 71.9 This work 
Rv2481cext GCGTAGACGCCATGAGCC 67.1 This work 
Rv2664d GTTCTACGACTACCTGAGGTG 57.9 This work 
Rv2664r CCAACTGGTGTTGCTGTCAG 64.5 This work 
Rv2807int TGACGATGACTGATCTGGTG 62.5 This work 
Rv2809int GCACCGCCTGGTCAGCC 70.9 This work 
Rv2809d TTAGAGAATCGTAATCCCGC 60.6 This work 
Rv2809r AACGGACGACTGGAAGCCC 68.7 This work 
Rv2813d CAAGCCGAGCGCGGACGC 77 This work 
DR-ISA1 GGGACGGAAACCTTGAATAACG 67 Otal et al. (4) 
DR-ISA3 CCTGTATTTCGCTGGTTTCCGTC 69 Otal et al. (4) 
Rv2818cd TTTGTCACCGACCAAGACGAC 67.3 This work 
Rv2818cr TTGCGCACCTGTTAGCCCAG 70.5 This work 
Rv2957d TTTCCGCTGGGGTGG 64 This work 
Rv2957r AAGATCACGCCGCCCAAG 69 This work 
Rv2986cd CCCCCTGAGGCGTAGAACCG 71.9 This work 
Rv2986cr TCGAGCAAGTAGGCACACCC 67.6 This work 
esxQrev GTGCTGACATTTCCACCAC 61.7 This work 
PPE46d ATGTGGTCGGCGAGGAGC 69 This work 
PPE46r TTCCTTAGGCGCCTTCCC 66.3 This work 
PPE46rev CCTTTCAAATATTCCGGGCA 65.5 This work 
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Table 5: Continuation 
Name Sequence 5’-3’ Tm ºC Reference 
esxRd TTTCAGGGTGCGCATGCC 70.7 This work 
esxRr TGTTGGACTCATGGGTGCC 67.2 This work 
PPE47rev CCTCTGTAAATGCTTGGGC 62.2 This work 
Rv3113d CAATTCATCGCGCCGCTGT 71 This work 
Rv3113r AAAATAGGTGTTGCCACCCG 65.6 This work 
Rv3124d GTGCATGAAACCCGGAG 62.9 This work 
Rv3124r CTCCAATGAGAAGGCGT 58.9 This work 
3126-ISA1 GGTCGATGAGCTGAGCGC 67.5 Otal et al. (4)
3126-ISA3 CCAACGCGGCCTCAAACG 72.2 Otal et al. (4)
Rv3128cd GACATGGTGACCGTCGTGAGGC 73.3 This work 
Rv3128cr GAGAAAGGGCGTAATGCCTC 64.8 This work 
Rv3179d AAGAACCGCCTGCTCGAATCTGC 73.2 This work 
Rv3179r TTGTGGCTGTAGTCGACCTTCCAGG 72.7 This work 
Rv3180cd TAGTCGCCGTTTGGGACCG 70.3 This work 
Rv3180cr AACGATGGGCGGCTCTAGCG 72.4 This work 
Rv3186d AACCAGTCGCAATCTCTCCCA 68 This work 
Rv3186r AATAGAGGCTGATCTGGACG 60.8 This work 
Rv3190cd ACTACCAGTCCGCACTTCG 63 This work 
Rv3190cr ACGAACACATGCCCGAC 63.5 This work 
moaxd ATCGGGTCATTACCGGCGGC 73.8 This work 
moaxr CCAGTCGACGCGGTTGGGG 75.4 This work 
Rv3324Ad TTCAGTGTCCATAACAAGCGG 64.9 This work 
Rv3324Ar TAAACCGTGAGCGCTGTCACC 69.4 This work 
3326F TGAGCGCTGTCACCGTAACG 69.6 This work 
3326R ACTTGTGCGCATCGGTTCC 68.5 This work 
Rv3328cd AAGTTCACCGGCTCTCCGCTG 71.8 This work 
Rv3327-SigJ CGCACAAGTACAGCCACACC 66.8 This work 
SigJd TTTCCGAATTCGAGGCAC 63.8 This work 
dsx2ext GATAGGTTTGGTGCCCGGTG 72 This work 
lytBext TACTTGATTGACGGGCCTG 68 This work 
lytB1d GAACCTGCCCGAGGGTACCCAG 73.5 This work 
lytB1r AAGGCCGAATCGCACCGTCTC 73.5 This work 
IdsBd TTTGAGGATTGTTTATTGGAGGG 64.6 This work 
IdsBr AACGCAAGACCCAACTCATGGC 71.2 This work 
Rv3427cd TATCGCACCATCAAGGGC 64.7 This work 
Rv3427cr AATTCCAGATGCCCCAGG 64.8 This work 
Rv3346cr CCCCAACGGGTCAATGGTGG 73.5 This work 
Rv3347cd CCAGCACGCTGCCGCTTGGG 79 This work 
Rv3347cr AAGCGGCAGCGTGCTGGTG 74 This work 
Rv3347cint ATCCTGATCCATACCGGTCCC 67.9 This work 
PPE56d GAATGGCATCAGTGCTCCC 65.8 This work 
PPE56r GAATTGGGAGATCGTGGGC 66.7 This work 
rmlB2-ISA1 AACACATGCAGCCACCATGAGAG 70.4 Otal et al. (4)
rmlB2-ISA3 CTGCGCGGCGTTGAGGTG 74 Otal et al. (4)
Mb2047cd TGTTCTCAAGTGTCCCCAA 61.8 This work 
Mb2047cr CCTAAAAGGATAGCGTTGAA 58.4 This work 
Mb3109d TGATGGGGGTCTCTCAGG 63.9 This work 
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Table 6: Primers used in the construction of integrative plasmids and replicative plasmids 
(Chapter 2) 
Name Sequence 5’-3’ Tm ºC Reference 
Rv2179c-Eco TCGAGAACCCGAATTCACCATAGC 70.6 This work 
Rv2179c-Kpn GTGTCGTAGAGGTACCGCACCG 69.7 This work 
ISA4-Eco CTCGAATTCTCGACTGGTTCAACCATCG 74.9 Previous work 
dnaN-KpnI GAGCACCGGTACCGCGGG 76 This work 
dnaN-EcoRI ACCGCCGAATTCTTCGACACTACC 76 This work 
BCG2B-Eco CTCGAATTCCCATGTTCAAACCGGTGTC 76 Previous work 
PhoBO3.1-Kpn CTCGGTACCAACTTGAGGCTCACCGACAG 77 Previous work 
Hygfw CTGCGGAACGACCAGGAATTC 69.9 This work 
Hygrv GACCTCGGAATGGGGGG 67.9 This work 
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Table 1. Obtained Points of insertion of IS6110 of the 61 studied strains. 
Name of the 
strain 1594 483251 483298 483310 483537 850087 850182 850539 850592 
a H37Rv 0 b 0 0 0 0 0 0 0 0 
HMS 1301 1c 0 0 0 0 0 0 0 0 
HMS 1356  1 0 0 0 0 0 0 0 0 
HMS 1470  1 0 0 0 0 0 0 0 0 
HMS 1480  1 0 0 0 0 0 0 0 0 
HMS 1834 0 0 0 0 0 0 0 0 0 
HMS 2103 0 0 0 0 0 0 0 0 0 
HMS 2193 0 0 0 0 0 0 0 0 0 
HMS 2200 0 0 0 0 1 0 0 1 0 
HMS 2206 0 0 0 0 0 0 0 0 0 
HMS 2208 0 0 0 0 0 0 0 0 0 
HMS 2224 0 0 1 0 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 0 
HMS 2258 0 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 0 
HMS 2271 0 1 0 0 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 0 
HMS 2281 0 0 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 1 0 0 
HMS 2355 0 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 0 0 0 0 
HMS 2394 0 0 1 0 0 0 0 0 0 
HMS 2400 1 0 0 0 0 0 0 0 0 
HMS 2405 0 0 0 0 0 0 0 0 1 
HMS 2414 0 0 1 0 0 0 0 0 0 
HMS 2513 0 0 1 0 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 1 0 
HMS 2580 1 0 0 0 0 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 0 0 
HCU 2398  1 0 0 0 0 0 0 0 0 
HCU 2613 0 0 0 0 0 0 0 0 0 
HCU 2617  1 0 0 0 0 0 0 0 0 
HCU 2633 0 0 0 0 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 0 
HCU 2654 0 0 0 0 0 0 0 0 0 
HCU 2663 0 0 0 0 0 0 0 0 0 
HCU 2671 0 0 0 0 0 0 0 1 0 
HCU 2703 0 0 0 0 0 0 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 0 
HCU 2821 0 0 1 0 0 0 0 0 0 
HCU 2864 0 0 1 0 0 0 0 0 0 
HCU 2886 0 0 0 0 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 1 0 0 0 
HSJ 025 0 0 0 0 0 1 0 0 0 
HSJ 029 0 0 0 1 0 0 0 0 0 
HSJ 067 1 0 0 0 0 0 0 0 0 
NHN5 1 0 0 0 0 0 0 0 0 
HM77 1 0 0 0 0 0 0 0 0 
HM764 1 0 0 0 0 0 0 0 0 
HM903 1 0 0 0 0 0 0 0 0 
N4 1 0 0 0 0 0 0 0 0 
W4 1 0 0 0 0 0 0 0 0 
990172 1 0 0 0 0 0 0 0 0 
CAM22 1 0 0 0 0 0 0 0 0 
a The points of insertion of IS6110 of H37Rv strain were included 
b The absence of a point of insertion of IS6110 in a strain was indicated by the number 0. 
c The presence of a point of insertion of IS6110 in a strain was indicated by the number 1. 
Mª Henar Alonso Ezcurra 
180 
Name of the 
strain 850601 851412 851479 888768 888789 888846 889072 932076 932203 
a H37Rv 0 0 0 0 0 0 1 0 0 
HMS 1301 0 0 0 0 0 0 1 0 0 
HMS 1356  0 0 0 0 0 0 0 0 0 
HMS 1470  0 0 0 0 0 0 0 1 0 
HMS 1480  0 0 0 0 0 0 0 1 0 
HMS 1834 0 0 0 0 0 0 0 0 1 
HMS 2103 0 0 0 0 1 0 0 0 0 
HMS 2193 0 0 0 0 0 0 0 0 1 
HMS 2200 0 0 0 0 1 0 0 0 0 
HMS 2206 0 0 0 0 0 0 0 0 1 
HMS 2208 0 0 0 0 0 0 0 0 1 
HMS 2224 0 0 0 0 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 0 
HMS 2258 0 0 0 1 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 1 
HMS 2271 0 0 0 0 0 0 0 0 1 
HMS 2280 0 0 0 0 0 0 0 0 1 
HMS 2281 0 0 0 0 0 1 0 0 1 
HMS 2296 0 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 0 0 0 1 
HMS 2394 0 0 0 0 0 0 0 0 0 
HMS 2400 1 0 0 0 0 0 0 0 0 
HMS 2405 0 1 0 0 0 0 0 0 0 
HMS 2414 0 0 0 0 0 0 0 0 0 
HMS 2513 0 0 0 0 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 0 0 
HMS 2580 0 0 0 0 0 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 0 0 
HCU 2398  0 0 0 0 0 0 0 0 0 
HCU 2613 0 0 0 0 0 0 0 0 1 
HCU 2617  0 0 0 0 0 0 0 0 0 
HCU 2633 0 0 0 0 0 0 0 0 1 
HCU 2647 0 0 0 0 0 0 0 0 1 
HCU 2654 0 0 0 0 0 0 0 0 1 
HCU 2663 0 0 0 0 0 0 0 0 1 
HCU 2671 0 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 1 0 0 0 1 
HCU 2706 0 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 0 0 
HCU 2886 0 0 0 0 0 0 0 0 1 
HCU 2875 0 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 0 0 
HSJ 029 0 0 0 0 0 0 0 0 0 
HSJ 067 0 0 1 0 0 0 0 0 0 
NHN5 0 0 0 0 0 0 0 0 0 
HM77 0 0 0 0 0 0 1 0 0 
HM764 0 0 0 0 0 0 1 0 0 
HM903 0 0 0 0 0 0 0 0 0 
N4 0 0 0 0 0 0 0 0 0 
W4 0 0 0 0 0 0 1 0 0 
990172 0 0 0 0 0 0 0 0 0 
CAM22 0 0 0 0 0 0 1 0 0 
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Name of the 
strain 937116 1168966 1262963 1356403 1357082 1481531 1530161 1530203 1530907 
a H37Rv 0 0 0 0 0 0 0 0 0 
HMS 1301 1 0 0 0 0 0 0 0 0 
HMS 1356  0 0 1 0 0 0 0 0 0 
HMS 1470  0 0 1 0 0 0 0 0 0 
HMS 1480  0 0 1 0 0 0 0 0 0 
HMS 1834 0 0 0 0 0 0 0 0 0 
HMS 2103 0 0 0 0 0 0 0 0 0 
HMS 2193 0 0 0 0 0 0 0 0 0 
HMS 2200 0 0 0 0 0 0 0 0 0 
HMS 2206 0 0 0 0 0 0 0 0 0 
HMS 2208 0 0 0 0 0 0 0 0 0 
HMS 2224 0 0 0 0 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 0 
HMS 2258 0 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 0 
HMS 2271 0 0 0 1 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 0 
HMS 2281 0 0 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 0 0 0 0 
HMS 2394 0 0 0 0 0 0 0 0 0 
HMS 2400 0 0 0 0 0 0 0 0 0 
HMS 2405 0 0 0 0 0 0 0 0 0 
HMS 2414 0 0 0 0 0 0 0 0 0 
HMS 2513 0 0 0 0 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 0 0 
HMS 2580 0 0 1 0 0 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 0 0 
HCU 2398  0 0 1 0 0 0 0 0 0 
HCU 2613 0 0 0 0 0 0 0 0 0 
HCU 2617  0 0 1 0 0 0 0 0 0 
HCU 2633 0 0 0 0 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 1 
HCU 2654 0 0 0 0 0 1 0 0 0 
HCU 2663 0 1 0 0 0 0 0 0 0 
HCU 2671 0 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 0 1 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 1 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 0 0 
HCU 2886 0 0 0 0 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 0 0 
HSJ 029 0 0 0 0 0 0 0 0 0 
HSJ 067 0 0 1 0 0 0 0 0 0 
NHN5 0 0 0 0 0 0 1 0 0 
HM77 0 0 1 0 0 0 0 0 0 
HM764 0 0 1 0 0 0 0 0 0 
HM903 0 0 0 0 0 0 0 0 0 
N4 0 0 0 0 0 0 0 1 0 
W4 0 0 1 0 0 0 0 0 0 
990172 0 0 0 0 0 0 0 0 0 
CAM22 0 0 1 0 0 0 0 0 0 
 
 
 
Mª Henar Alonso Ezcurra 
182 
Name of the 
strain 1531507 1541994 1543972 1657016 1724406 1729409 1745059 1889068 
1889623
-
1889816 
a H37Rv 0 1 0 0 0 0 0 0 0 
HMS 1301 0 0 1 1 0 0 0 0 0 
HMS 1356  0 0 1 1 0 0 0 0 0 
HMS 1470  0 0 1 1 0 0 0 0 0 
HMS 1480  0 0 1 1 0 0 0 0 0 
HMS 1834 0 0 0 0 0 0 0 0 0 
HMS 2103 0 0 0 0 0 0 0 0 0 
HMS 2193 0 0 0 0 0 0 0 0 0 
HMS 2200 0 0 0 0 0 0 0 0 0 
HMS 2206 0 0 0 0 0 0 0 0 0 
HMS 2208 0 0 0 0 0 0 0 0 0 
HMS 2224 0 0 0 0 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 0 
HMS 2258 0 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 0 
HMS 2271 0 0 0 0 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 0 
HMS 2281 0 0 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 0 0 0 0 
HMS 2394 0 0 0 0 0 0 0 0 0 
HMS 2400 0 0 1 0 0 0 0 0 0 
HMS 2405 0 0 0 0 0 0 0 0 0 
HMS 2414 0 0 0 0 0 0 0 0 0 
HMS 2513 0 0 0 0 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 0 0 
HMS 2580 0 0 1 1 0 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 1 0 
HCU 2398  0 0 1 1 0 0 0 0 0 
HCU 2613 0 0 0 0 0 0 0 0 0 
HCU 2617  0 0 1 1 0 0 0 0 0 
HCU 2633 0 0 0 0 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 0 
HCU 2654 0 0 0 0 0 0 0 0 0 
HCU 2663 0 0 0 0 0 0 0 0 0 
HCU 2671 0 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 0 0 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 0 0 
HCU 2886 0 0 0 0 0 0 0 0 0 
HCU 2875 1 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 1 0 
HCU 3151 0 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 0 1 
HSJ 029 0 0 0 0 0 0 0 0 0 
HSJ 067 0 0 1 1 0 0 0 0 0 
NHN5 0 0 1 0 1 0 0 0 0 
HM77 0 0 1 1 0 0 0 0 0 
HM764 0 0 1 1 0 0 0 0 0 
HM903 0 0 1 1 0 0 0 0 0 
N4 0 0 1 0 1 1 0 0 0 
W4 0 0 1 1 0 0 1 0 0 
990172 0 0 0 0 0 0 0 0 0 
CAM22 0 0 1 1 0 0 0 0 0 
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Name of the 
strain 1895860 1986625 1986626 1986726 1986820 
1986638-
1998625 1987008 1987018 
a H37Rv 0 0 0 0 0 0 0 0 
HMS 1301 0 0 0 0 0 1 0 0 
HMS 1356  0 0 0 0 0 1 0 0 
HMS 1470  0 0 0 0 0 1 0 0 
HMS 1480  0 0 0 0 0 1 0 0 
HMS 1834 0 1 0 0 0 0 0 1 
HMS 2103 0 0 0 0 0 0 0 0 
HMS 2193 0 0 0 0 0 0 0 0 
HMS 2200 0 0 0 1 0 0 0 0 
HMS 2206 0 0 0 0 1 0 0 0 
HMS 2208 0 1 0 0 0 0 0 0 
HMS 2224 0 0 1 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 
HMS 2237 0 0 1 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 
HMS 2258 0 0 1 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 
HMS 2271 0 0 0 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 
HMS 2281 0 1 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 1 0 
HMS 2391 0 1 0 0 0 0 0 0 
HMS 2394 0 0 1 0 0 0 0 0 
HMS 2400 0 0 0 0 0 1 0 0 
HMS 2405 0 0 0 0 0 0 0 0 
HMS 2414 0 0 1 0 0 0 0 0 
HMS 2513 0 0 1 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 0 
HMS 2580 0 0 0 0 0 1 0 0 
HMS 2584 0 0 0 0 0 0 0 0 
HCU 2398  0 0 0 0 0 1 0 0 
HCU 2613 0 0 0 0 0 0 0 0 
HCU 2617  0 0 0 0 0 1 0 0 
HCU 2633 0 0 0 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 
HCU 2654 0 0 0 0 0 0 0 0 
HCU 2663 1 0 0 0 0 0 0 0 
HCU 2671 0 0 0 0 0 0 0 0 
HCU 2703 0 1 0 0 0 0 0 0 
HCU 2706 0 0 0 0 0 0 1 0 
HCU 2728 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 
HCU 2864 0 0 1 0 0 0 0 0 
HCU 2886 0 0 0 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 0 
HSJ 029 0 0 0 0 0 0 0 0 
HSJ 067 0 0 0 0 0 1 0 0 
NHN5 0 0 0 0 0 1 0 0 
HM77 0 0 0 0 0 1 0 0 
HM764 0 0 0 0 0 1 0 0 
HM903 0 0 0 0 0 1 0 0 
N4 0 0 0 0 0 1 0 0 
W4 0 0 0 0 0 1 0 0 
990172 0 0 0 0 0 1 0 0 
CAM22 0 0 0 0 0 1 0 0 
 
 
 
Mª Henar Alonso Ezcurra 
184 
 
Name of the 
strain 
1987129-
1987556 1987211 
1987458-
1987544 1987556 1987601 1987745 1996152 1998278 
a H37Rv 0 0 0 0 0 1 1 0 
HMS 1301 0 0 0 0 0 0 0 0 
HMS 1356 0 0 0 0 0 0 0 0 
HMS 1470 0 0 0 0 0 0 0 0 
HMS 1480 0 0 0 0 0 0 0 0 
HMS 1834 0 0 0 0 0 0 0 0 
HMS 2103 1 0 0 1 0 0 0 0 
HMS 2193 0 0 0 0 0 0 0 0 
HMS 2200 0 0 0 0 0 0 0 0 
HMS 2206 0 1 0 0 0 0 0 0 
HMS 2208 0 0 0 0 0 0 0 0 
HMS 2224 0 0 0 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 
HMS 2258 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 
HMS 2271 0 0 0 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 
HMS 2281 0 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 0 0 0 
HMS 2394 0 0 0 0 0 0 0 0 
HMS 2400 0 0 0 0 0 0 0 0 
HMS 2405 0 0 0 0 0 0 0 0 
HMS 2414 0 0 0 0 1 0 0 0 
HMS 2513 0 0 0 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 0 
HMS 2580 0 0 0 0 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 0 
HCU 2398 0 0 0 0 0 0 0 0 
HCU 2613 0 0 0 0 0 0 0 0 
HCU 2617 0 0 0 0 0 0 0 0 
HCU 2633 0 0 0 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 
HCU 2654 0 0 0 0 0 0 0 0 
HCU 2663 0 0 0 0 0 0 0 0 
HCU 2671 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 0 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 1 
HCU 2777 0 0 0 0 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 0 
HCU 2886 0 0 0 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 
HCU 3151 0 0 1 0 0 0 0 0 
HSJ 025 0 0 1 0 0 0 0 0 
HSJ 029 0 0 0 0 0 0 0 0 
HSJ 067 0 0 0 0 0 0 0 0 
NHN5 0 0 0 0 0 0 0 0 
HM77 0 0 0 0 0 0 0 0 
HM764 0 0 0 0 0 0 0 0 
HM903 0 0 0 0 0 0 0 0 
N4 0 0 0 0 0 0 0 0 
W4 0 0 0 0 0 0 0 0 
990172 0 0 0 0 0 0 0 0 
CAM22 0 0 0 0 0 0 0 0 
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Name of the 
strain 1998623 1998698 1998792 1998800 1998849 2010924 2011104 2011114 2039012 
a H37Rv 0 0 0 0 0 0 0 0 0 
HMS 1301 0 0 0 0 0 0 0 0 0 
HMS 1356 0 0 0 0 0 0 0 0 0 
HMS 1470 0 0 0 0 0 0 0 0 0 
HMS 1480 0 0 0 0 0 0 0 0 0 
HMS 1834 0 0 0 0 0 1 0 0 0 
HMS 2103 0 0 0 0 0 0 0 0 0 
HMS 2193 0 0 0 0 0 0 0 0 0 
HMS 2200 0 0 0 0 0 0 0 0 0 
HMS 2206 0 0 0 0 0 0 0 0 0 
HMS 2208 0 0 0 0 0 1 0 0 0 
HMS 2224 0 0 0 0 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 0 
HMS 2237 0 0 1 0 0 0 0 0 0 
HMS 2241 0 0 0 1 0 0 0 0 0 
HMS 2258 0 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 0 
HMS 2271 0 0 0 0 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 0 
HMS 2281 0 0 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 1 1 0 0 
HMS 2394 0 0 0 0 0 0 0 0 0 
HMS 2400 1 0 0 0 0 0 0 0 0 
HMS 2405 0 0 1 0 0 0 0 0 0 
HMS 2414 0 0 0 0 0 0 0 0 0 
HMS 2513 0 0 0 0 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 0 0 
HMS 2580 1 0 0 0 0 0 0 0 0 
HMS 2584 0 0 0 0 1 0 0 0 0 
HCU 2398 0 0 0 0 0 0 0 0 0 
HCU 2613 0 0 0 0 0 0 0 0 0 
HCU 2617 0 0 0 0 0 0 0 0 0 
HCU 2633 0 0 0 0 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 0 
HCU 2654 0 0 0 0 0 1 0 1 0 
HCU 2663 0 0 0 0 0 0 0 0 0 
HCU 2671 0 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 0 1 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 1 
HCU 2821 0 0 0 0 0 0 0 0 0 
HCU 2864 0 1 0 0 0 0 0 0 0 
HCU 2886 0 0 0 0 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 0 0 
HSJ 029 0 0 0 0 0 0 0 0 0 
HSJ 067 0 0 0 0 0 0 0 0 0 
NHN5 0 0 0 0 0 0 0 0 0 
HM77 0 0 0 0 0 0 0 0 0 
HM764 0 0 0 0 0 0 0 0 0 
HM903 0 0 0 0 0 0 0 0 0 
N4 0 0 0 0 0 0 0 0 0 
W4 0 0 0 0 0 0 0 0 0 
990172 0 0 0 0 0 0 0 0 0 
CAM22 0 0 0 0 0 0 0 0 0 
 
 
 
Mª Henar Alonso Ezcurra 
186 
 
Name of the 
strain 2041428 2041741 2041820 2057398 2163392 2163404 2163461 2163473 
a H37Rv 0 0 0 0 0 0 0 0 
HMS 1301 0 0 0 0 2 0 0 0 
HMS 1356 0 0 0 0 0 0 0 0 
HMS 1470 0 0 0 0 0 0 0 0 
HMS 1480 0 0 0 0 0 0 0 0 
HMS 1834 0 0 0 0 0 1 0 0 
HMS 2103 0 0 0 1 0 0 0 0 
HMS 2193 0 0 0 0 0 0 1 0 
HMS 2200 0 0 0 0 0 0 0 0 
HMS 2206 0 0 0 0 0 0 0 0 
HMS 2208 0 0 0 0 0 0 0 0 
HMS 2224 0 0 0 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 
HMS 2258 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 
HMS 2271 1 0 0 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 
HMS 2281 0 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 0 0 0 
HMS 2394 0 0 1 0 0 0 0 0 
HMS 2400 0 0 0 0 0 0 0 0 
HMS 2405 0 0 0 0 0 0 0 0 
HMS 2414 0 0 0 0 0 0 0 0 
HMS 2513 0 0 0 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 0 
HMS 2580 0 0 0 0 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 0 
HCU 2398 0 0 0 0 0 0 0 0 
HCU 2613 0 0 0 0 0 0 0 0 
HCU 2617 0 0 0 0 0 0 0 0 
HCU 2633 0 0 0 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 
HCU 2654 0 0 0 0 0 0 0 0 
HCU 2663 0 0 0 0 0 0 0 0 
HCU 2671 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 0 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 1 
HCU 2886 0 0 0 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 0 
HSJ 029 0 0 0 0 0 0 0 0 
HSJ 067 0 0 0 0 0 0 0 0 
NHN5 0 1 0 0 0 0 0 0 
HM77 0 0 0 0 0 0 0 0 
HM764 0 0 0 0 0 0 0 0 
HM903 0 0 0 0 0 0 0 0 
N4 0 1 0 0 0 0 0 0 
W4 0 0 0 0 0 0 0 0 
990172 0 0 0 0 0 0 0 0 
CAM22 0 0 0 0 0 0 0 0 
 
 
 
Annex II 
187 
 
Name of the 
strain 2163649 2174919 2180845 2198330 2248279 2262185 2263619 2263627 
a H37Rv 0 0 0 0 0 0 0 0 
HMS 1301 0 0 0 0 0 0 0 1 
HMS 1356 0 0 0 0 0 0 0 1 
HMS 1470 0 0 0 0 0 0 0 1 
HMS 1480 0 0 0 0 0 0 0 1 
HMS 1834 0 0 0 0 0 0 0 0 
HMS 2103 0 0 0 0 1 0 0 0 
HMS 2193 0 1 0 0 0 0 0 0 
HMS 2200 0 0 0 0 0 0 0 0 
HMS 2206 0 0 0 0 0 0 0 0 
HMS 2208 0 0 0 0 0 0 0 0 
HMS 2224 0 0 0 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 
HMS 2258 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 
HMS 2271 0 0 0 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 
HMS 2281 0 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 1 0 0 
HMS 2394 0 0 0 0 0 0 0 0 
HMS 2400 0 0 0 0 0 0 0 1 
HMS 2405 0 0 0 0 0 0 0 0 
HMS 2414 0 0 0 0 0 0 0 0 
HMS 2513 0 0 0 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 0 
HMS 2580 0 0 0 0 0 0 0 1 
HMS 2584 0 0 0 0 0 0 0 0 
HCU 2398 0 0 0 0 0 0 0 1 
HCU 2613 0 0 0 0 0 0 0 0 
HCU 2617 0 0 0 0 0 0 0 1 
HCU 2633 0 0 1 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 
HCU 2654 0 0 0 0 0 0 0 0 
HCU 2663 0 0 0 0 0 0 0 0 
HCU 2671 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 0 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 1 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 0 
HCU 2886 0 0 1 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 0 
HSJ 029 0 0 0 0 0 0 0 0 
HSJ 067 0 0 0 0 0 0 0 1 
NHN5 1 0 0 0 0 0 0 1 
HM77 0 0 0 0 0 0 0 1 
HM764 0 0 0 0 0 0 0 1 
HM903 0 0 0 0 0 0 0 1 
N4 0 0 0 0 0 0 1 0 
W4 0 0 0 0 0 0 0 1 
990172 0 0 0 0 0 0 0 0 
CAM22 0 0 0 0 0 0 0 1 
 
 
 
Mª Henar Alonso Ezcurra 
188 
 
Name of the 
strain 2263778 2266015 2266167 
2268726-
2268693 2334666 2334686 2364232 2364548 
a H37Rv 0 0 0 0 0 0 0 0 
HMS 1301 0 0 0 1 0 1 0 0 
HMS 1356 0 0 0 0 0 0 0 0 
HMS 1470 0 0 0 0 0 0 0 0 
HMS 1480 0 0 0 0 0 0 0 0 
HMS 1834 0 0 0 0 0 0 0 0 
HMS 2103 0 0 0 0 0 0 0 0 
HMS 2193 0 0 0 0 0 0 0 0 
HMS 2200 0 0 0 0 0 0 0 0 
HMS 2206 0 0 0 0 0 0 0 1 
HMS 2208 0 0 0 0 0 0 0 0 
HMS 2224 0 0 0 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 
HMS 2258 0 1 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 
HMS 2271 0 0 0 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 
HMS 2281 0 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 0 0 0 
HMS 2394 0 0 0 0 0 0 0 0 
HMS 2400 0 0 0 0 0 0 0 0 
HMS 2405 0 0 0 0 0 0 0 0 
HMS 2414 0 0 0 0 0 0 0 0 
HMS 2513 0 0 0 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 0 
HMS 2580 0 0 0 0 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 0 
HCU 2398 0 0 0 0 0 0 0 0 
HCU 2613 0 0 0 0 0 0 0 0 
HCU 2617 0 0 0 0 0 0 0 0 
HCU 2633 0 0 0 0 0 0 1 0 
HCU 2647 0 0 0 0 0 0 0 0 
HCU 2654 0 0 0 0 0 0 0 0 
HCU 2663 0 0 0 0 0 0 0 0 
HCU 2671 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 0 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 0 
HCU 2886 0 0 0 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 0 
HSJ 029 0 0 0 0 0 0 0 0 
HSJ 067 0 0 0 0 0 0 0 0 
NHN5 0 0 0 0 0 0 0 0 
HM77 0 0 0 0 0 0 0 0 
HM764 0 0 0 0 0 0 0 0 
HM903 0 0 0 0 0 0 0 0 
N4 0 0 0 0 0 0 0 0 
W4 0 0 0 0 0 0 0 0 
990172 1 0 1 0 1 0 0 0 
CAM22 0 0 0 0 0 0 0 0 
 
 
 
Annex II 
189 
 
Name of the 
strain 2364912 2365243 2365414 2365465 2366894 2366896 2366897 
2367158-
2367279 
a H37Rv 0 0 0 1 0 0 0 0 
HMS 1301 0 0 0 0 0 0 0 0 
HMS 1356 0 0 0 0 0 0 0 0 
HMS 1470 0 0 0 0 1 0 0 0 
HMS 1480 0 0 0 0 1 0 0 0 
HMS 1834 0 0 0 0 0 0 0 0 
HMS 2103 0 0 0 0 0 0 0 0 
HMS 2193 0 0 0 0 0 0 0 0 
HMS 2200 0 0 0 0 0 0 0 0 
HMS 2206 0 0 0 0 0 0 0 0 
HMS 2208 0 0 0 0 0 0 0 0 
HMS 2224 0 0 0 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 
HMS 2258 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 1 0 0 
HMS 2271 0 0 0 0 0 0 0 0 
HMS 2280 0 0 0 0 0 1 0 0 
HMS 2281 0 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 
HMS 2370 0 0 1 0 0 0 0 0 
HMS 2391 0 0 0 0 0 0 0 0 
HMS 2394 0 0 1 0 0 0 0 0 
HMS 2400 0 0 0 0 0 0 0 0 
HMS 2405 0 0 0 0 0 0 0 0 
HMS 2414 0 0 0 0 0 0 0 0 
HMS 2513 0 0 0 0 0 0 0 0 
HMS 2536 1 0 0 0 0 0 0 0 
HMS 2580 0 0 0 0 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 0 
HCU 2398 0 0 0 0 1 0 0 0 
HCU 2613 0 0 0 0 0 0 0 0 
HCU 2617 0 0 0 0 1 0 0 0 
HCU 2633 0 0 0 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 
HCU 2654 0 0 0 0 0 0 0 0 
HCU 2663 0 0 0 0 0 1 0 0 
HCU 2671 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 0 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 0 
HCU 2886 0 0 0 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 1 
HSJ 029 0 0 0 0 0 1 0 0 
HSJ 067 0 1 0 0 0 0 0 0 
NHN5 0 0 0 0 0 0 0 0 
HM77 0 0 0 0 0 0 0 0 
HM764 0 0 0 0 0 0 1 0 
HM903 0 0 0 0 0 0 0 0 
N4 0 0 0 0 0 0 0 0 
W4 0 0 0 0 0 0 1 0 
990172 0 0 0 0 0 0 0 0 
CAM22 0 0 0 0 0 0 1 0 
 
 
 
Mª Henar Alonso Ezcurra 
190 
 
Name of the 
strain 2367679 2430159 2442348 2550065 2555228 2555718 2559506 2559556 
a H37Rv 0 1 0 1 0 0 0 0 
HMS 1301 0 0 1 0 0 0 1 0 
HMS 1356 0 0 0 0 0 0 0 0 
HMS 1470 0 0 0 0 0 0 0 0 
HMS 1480 0 0 0 0 0 0 0 0 
HMS 1834 0 0 0 0 0 0 0 0 
HMS 2103 0 0 0 0 0 0 0 1 
HMS 2193 0 0 0 0 0 0 0 0 
HMS 2200 0 0 0 0 0 0 0 0 
HMS 2206 0 0 0 0 0 0 0 0 
HMS 2208 0 0 0 0 0 0 0 0 
HMS 2224 0 0 0 0 0 0 0 0 
HMS 2227 1 0 0 0 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 
HMS 2258 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 
HMS 2271 0 0 0 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 
HMS 2281 0 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 0 0 0 
HMS 2394 0 0 0 0 0 0 0 0 
HMS 2400 0 0 0 0 0 0 0 0 
HMS 2405 0 0 0 0 0 0 0 0 
HMS 2414 0 0 0 0 0 0 0 0 
HMS 2513 0 0 0 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 0 
HMS 2580 0 0 0 0 1 0 0 0 
HMS 2584 0 0 0 0 0 0 0 0 
HCU 2398 0 0 0 0 0 0 0 0 
HCU 2613 0 0 0 0 0 0 0 0 
HCU 2617 0 0 0 0 0 0 0 0 
HCU 2633 0 0 0 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 
HCU 2654 0 0 0 0 0 0 0 0 
HCU 2663 0 0 0 0 0 0 0 0 
HCU 2671 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 0 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 0 
HCU 2886 0 0 0 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 0 
HSJ 029 0 0 0 0 0 0 0 0 
HSJ 067 0 0 0 0 0 0 0 0 
NHN5 0 0 0 0 0 0 0 0 
HM77 0 0 0 0 0 1 0 0 
HM764 0 0 0 0 0 0 0 0 
HM903 0 0 0 0 0 0 0 0 
N4 0 0 0 0 0 0 0 0 
W4 1 0 0 0 0 0 0 0 
990172 0 0 0 0 0 0 0 0 
CAM22 0 0 0 0 0 0 0 0 
 
 
 
Annex II 
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Name of the 
strain 2559570 2605438 2610861 2627275 2627494 2627829 2633979 
2634022-
2634048 
a H37Rv 0 0 0 0 0 0 0 0 
HMS 1301 0 0 0 0 0 0 0 0 
HMS 1356 0 0 0 0 0 0 0 1 
HMS 1470 0 0 0 0 0 0 0 1 
HMS 1480 0 0 0 0 0 0 0 0 
HMS 1834 0 0 0 0 0 0 0 0 
HMS 2103 0 0 0 0 0 0 0 0 
HMS 2193 0 0 0 0 0 0 0 0 
HMS 2200 0 0 0 0 0 0 0 0 
HMS 2206 0 0 0 0 0 0 0 0 
HMS 2208 0 0 0 0 0 0 0 0 
HMS 2224 0 0 1 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 
HMS 2258 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 
HMS 2271 0 0 0 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 
HMS 2281 0 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 0 0 0 
HMS 2394 0 0 0 0 0 0 0 0 
HMS 2400 0 0 0 0 0 0 0 0 
HMS 2405 0 0 0 0 0 0 0 0 
HMS 2414 0 0 0 0 0 0 0 0 
HMS 2513 0 0 1 1 0 0 0 0 
HMS 2536 1 0 0 0 1 0 1 0 
HMS 2580 0 0 0 0 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 0 
HCU 2398 0 0 0 0 0 0 0 1 
HCU 2613 0 0 0 0 0 0 0 0 
HCU 2617 0 0 0 0 0 0 0 1 
HCU 2633 0 0 0 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 
HCU 2654 0 0 0 0 0 0 0 0 
HCU 2663 0 0 0 0 0 0 0 0 
HCU 2671 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 0 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 
HCU 2821 0 0 1 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 0 
HCU 2886 0 0 0 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 0 
HSJ 029 0 0 0 0 0 0 0 0 
HSJ 067 0 0 0 0 0 0 0 0 
NHN5 0 0 0 0 0 0 0 0 
HM77 0 0 0 0 0 0 0 0 
HM764 0 0 0 0 0 1 0 0 
HM903 0 0 0 0 0 0 0 0 
N4 0 0 0 0 0 0 0 0 
W4 0 0 0 0 0 0 0 0 
990172 0 0 0 0 0 0 0 0 
CAM22 0 1 0 0 0 0 0 0 
 
 
 
Mª Henar Alonso Ezcurra 
192 
 
Name of the 
strain 2634148 2635628 
2635592-
2637688 2639543 2639612 2732535 
2732535-
2732670 2732604 
a H37Rv 0 1 0 0 0 0 0 0 
HMS 1301 0 0 1 0 0 0 0 0 
HMS 1356 0 0 0 0 0 0 0 0 
HMS 1470 0 0 0 0 0 0 0 0 
HMS 1480 0 0 0 0 0 0 0 0 
HMS 1834 0 0 0 0 0 0 0 0 
HMS 2103 0 0 0 0 0 0 0 0 
HMS 2193 0 0 0 0 0 0 0 0 
HMS 2200 0 0 0 0 0 0 0 0 
HMS 2206 0 0 0 0 0 0 0 0 
HMS 2208 0 0 0 0 0 0 0 0 
HMS 2224 0 0 0 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 
HMS 2258 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 
HMS 2271 0 0 0 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 
HMS 2281 1 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 0 0 0 
HMS 2394 0 0 0 0 0 0 0 0 
HMS 2400 0 0 0 0 0 0 1 0 
HMS 2405 0 0 0 0 0 0 0 0 
HMS 2414 0 0 0 0 0 0 0 0 
HMS 2513 0 0 0 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 0 
HMS 2580 0 0 0 0 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 0 
HCU 2398 0 0 0 0 0 1 0 0 
HCU 2613 0 0 0 0 0 0 0 0 
HCU 2617 0 0 0 0 0 0 0 1 
HCU 2633 0 0 0 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 
HCU 2654 0 0 0 0 0 0 0 0 
HCU 2663 0 0 0 1 0 0 0 0 
HCU 2671 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 0 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 0 
HCU 2886 0 0 0 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 0 
HSJ 029 0 0 0 0 0 0 0 0 
HSJ 067 0 0 0 0 0 0 0 0 
NHN5 0 0 0 0 0 0 0 0 
HM77 0 0 0 0 0 0 0 0 
HM764 0 0 0 0 1 0 0 0 
HM903 0 0 0 0 0 0 0 0 
N4 0 0 0 0 0 0 0 0 
W4 0 0 0 0 0 0 0 0 
990172 0 0 0 0 0 0 0 0 
CAM22 0 0 0 0 0 0 0 0 
 
 
 
Annex II 
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Name of the 
strain 2784657 2972160 2982432 3114403 3114442 3114795 3114873 3115131 
a H37Rv 1 1 0 0 0 0 0 0 
HMS 1301 0 0 0 0 0 0 0 0 
HMS 1356 0 0 0 0 1 0 0 0 
HMS 1470 0 0 0 0 0 0 0 0 
HMS 1480 0 0 0 0 0 0 0 0 
HMS 1834 0 0 0 0 0 0 0 0 
HMS 2103 0 0 0 0 0 0 0 0 
HMS 2193 0 0 0 0 0 0 0 0 
HMS 2200 0 0 0 0 0 0 0 0 
HMS 2206 0 0 0 0 0 0 0 0 
HMS 2208 0 0 0 0 0 0 0 0 
HMS 2224 0 0 0 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 1 0 
HMS 2258 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 
HMS 2271 0 0 1 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 
HMS 2281 0 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 1 0 0 0 0 
HMS 2391 0 0 0 0 0 0 0 0 
HMS 2394 0 0 0 0 0 0 0 0 
HMS 2400 0 0 0 0 0 0 0 0 
HMS 2405 0 0 0 0 0 0 0 1 
HMS 2414 0 0 0 0 0 0 0 0 
HMS 2513 0 0 0 0 0 1 0 0 
HMS 2536 0 0 0 0 0 0 0 0 
HMS 2580 0 0 0 0 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 0 
HCU 2398 0 0 0 0 0 0 0 0 
HCU 2613 0 0 0 0 0 0 0 0 
HCU 2617 0 0 0 0 0 0 0 0 
HCU 2633 0 0 0 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 
HCU 2654 0 0 0 0 0 0 0 0 
HCU 2663 0 0 0 0 0 0 0 0 
HCU 2671 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 0 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 0 
HCU 2886 0 0 0 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 0 
HSJ 029 0 0 0 0 0 0 0 0 
HSJ 067 0 0 0 0 0 0 0 0 
NHN5 0 0 0 0 0 0 0 0 
HM77 0 0 0 0 0 0 0 0 
HM764 0 0 0 0 0 0 0 0 
HM903 0 0 0 0 0 0 0 0 
N4 0 0 0 0 0 0 0 0 
W4 0 0 0 0 0 0 0 0 
990172 0 0 0 0 0 0 0 0 
CAM22 0 0 0 0 0 0 0 0 
 
 
 
Mª Henar Alonso Ezcurra 
194 
 
Name of the 
strain 3115231 3115489 3120523 3120566 3125228 3125708 3125851 3127417 
a H37Rv 0 0 0 1 0 0 0 0 
HMS 1301 0 0 0 0 0 0 0 0 
HMS 1356 0 0 0 0 0 0 0 0 
HMS 1470 0 0 0 0 0 0 0 0 
HMS 1480 0 0 0 0 0 0 0 0 
HMS 1834 0 0 1 0 0 0 0 0 
HMS 2103 0 0 1 0 0 0 0 0 
HMS 2193 0 0 1 0 0 0 0 0 
HMS 2200 0 0 1 0 0 0 0 0 
HMS 2206 0 0 1 0 0 0 0 0 
HMS 2208 1 0 1 0 0 0 0 0 
HMS 2224 0 0 1 0 0 0 0 0 
HMS 2227 0 0 1 0 0 0 1 0 
HMS 2237 0 0 1 0 0 0 0 0 
HMS 2241 0 0 1 0 0 0 0 0 
HMS 2258 0 0 1 0 0 0 0 0 
HMS 2268 0 0 1 0 0 0 0 0 
HMS 2271 0 0 1 0 0 0 0 0 
HMS 2280 0 0 1 0 0 0 0 0 
HMS 2281 0 0 1 0 0 0 0 0 
HMS 2296 0 1 1 0 0 0 0 0 
HMS 2310 0 0 1 0 0 0 0 0 
HMS 2355 0 0 1 0 0 0 0 0 
HMS 2370 0 0 1 0 0 0 0 0 
HMS 2391 0 0 1 0 0 0 0 0 
HMS 2394 0 0 1 0 0 0 0 0 
HMS 2400 0 0 0 0 0 0 0 0 
HMS 2405 0 0 1 0 0 0 0 0 
HMS 2414 0 0 1 0 0 0 0 0 
HMS 2513 0 0 1 0 0 0 0 0 
HMS 2536 0 0 1 0 0 0 0 0 
HMS 2580 0 0 0 0 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 1 
HCU 2398 0 0 0 0 0 0 0 0 
HCU 2613 0 0 1 0 1 0 0 0 
HCU 2617 0 0 0 0 0 0 0 0 
HCU 2633 0 0 1 0 0 0 0 0 
HCU 2647 0 0 1 0 0 0 0 0 
HCU 2654 0 0 1 0 0 0 0 0 
HCU 2663 0 0 1 0 0 0 0 0 
HCU 2671 0 0 1 0 0 0 0 0 
HCU 2703 0 0 1 0 0 0 0 0 
HCU 2706 0 0 1 0 0 0 0 0 
HCU 2728 0 0 1 0 0 0 0 0 
HCU 2777 0 0 1 0 0 0 0 0 
HCU 2821 0 0 1 0 0 0 0 0 
HCU 2864 0 0 1 0 0 0 0 0 
HCU 2886 0 0 1 0 0 0 0 0 
HCU 2875 0 0 1 0 0 0 0 0 
HCU 2942 0 0 1 0 0 1 0 0 
HCU 3151 0 0 1 0 0 0 0 0 
HSJ 025 0 0 1 0 0 0 0 0 
HSJ 029 0 0 1 0 0 0 0 0 
HSJ 067 0 0 0 0 0 0 0 0 
NHN5 0 0 0 0 0 0 0 0 
HM77 0 0 0 0 0 0 0 0 
HM764 0 0 0 0 0 0 0 0 
HM903 0 0 0 0 0 0 0 0 
N4 0 0 0 0 0 0 0 0 
W4 0 0 0 0 0 0 0 0 
990172 0 0 0 0 0 0 0 0 
CAM22 0 0 0 0 0 0 0 0 
 
 
 
Annex II 
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Name of the 
strain 3127927 3310163 3378553 3378898 3379027 3480373 3491592 3493192 
a H37Rv 0 0 0 0 0 0 0 0 
HMS 1301 1 0 1 0 0 0 0 0 
HMS 1356 1 0 0 0 0 0 0 0 
HMS 1470 1 0 1 0 1 0 0 0 
HMS 1480 1 0 1 0 1 0 1 0 
HMS 1834 0 0 0 0 0 1 0 0 
HMS 2103 0 0 0 0 0 0 0 0 
HMS 2193 0 0 0 0 0 1 0 0 
HMS 2200 0 0 0 0 0 0 0 0 
HMS 2206 0 0 0 0 0 0 0 0 
HMS 2208 0 0 0 0 0 1 0 0 
HMS 2224 0 0 0 0 0 0 0 0 
HMS 2227 0 0 0 1 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 1 0 0 0 0 
HMS 2258 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 1 0 0 
HMS 2271 0 0 0 0 0 1 0 0 
HMS 2280 0 0 0 0 0 1 0 0 
HMS 2281 0 0 0 0 0 1 0 0 
HMS 2296 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 1 0 0 
HMS 2394 0 0 0 0 0 0 0 0 
HMS 2400 1 0 1 0 0 0 0 0 
HMS 2405 0 0 0 0 0 0 0 0 
HMS 2414 0 0 0 0 0 0 0 0 
HMS 2513 0 0 0 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 0 
HMS 2580 1 0 0 0 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 0 
HCU 2398 1 0 1 0 1 0 0 0 
HCU 2613 0 0 0 0 0 1 0 0 
HCU 2617 1 0 1 0 1 0 0 0 
HCU 2633 0 0 0 0 0 1 0 0 
HCU 2647 0 0 0 0 0 1 0 0 
HCU 2654 0 0 0 0 0 1 0 0 
HCU 2663 0 0 0 0 0 0 0 0 
HCU 2671 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 0 1 0 0 
HCU 2706 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 1 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 0 
HCU 2886 0 0 0 0 0 1 0 0 
HCU 2875 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 0 
HSJ 029 0 0 0 0 0 1 0 1 
HSJ 067 1 0 1 0 1 0 0 0 
NHN5 1 0 1 0 0 0 0 0 
HM77 1 0 1 0 0 0 0 0 
HM764 1 0 0 0 0 0 0 0 
HM903 1 0 1 0 0 0 0 0 
N4 1 1 1 0 0 0 0 0 
W4 1 0 1 0 1 0 0 0 
990172 1 0 1 0 0 0 0 0 
CAM22 2 0 0 0 0 0 1 0 
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Name of the 
strain 3493843 
3493844-
3493908 3494114 3494372 3494395 3504821 3547342 3549051 
a H37Rv 0 0 0 0 0 0 0 0 
HMS 1301 0 0 0 0 0 0 0 0 
HMS 1356 0 1 0 0 0 0 0 0 
HMS 1470 0 1 0 0 0 0 0 0 
HMS 1480 0 1 0 0 0 0 0 0 
HMS 1834 0 0 0 0 0 0 0 0 
HMS 2103 0 0 0 0 0 0 0 0 
HMS 2193 0 0 0 0 0 0 0 0 
HMS 2200 0 0 0 0 1 0 0 0 
HMS 2206 0 0 0 0 0 0 0 0 
HMS 2208 0 0 0 0 0 0 0 0 
HMS 2224 0 0 1 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 
HMS 2258 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 
HMS 2271 0 0 0 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 
HMS 2281 0 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 1 0 0 
HMS 2394 0 0 0 0 0 0 0 0 
HMS 2400 0 0 0 0 0 0 0 0 
HMS 2405 0 0 0 0 0 0 0 0 
HMS 2414 0 0 0 0 0 0 0 0 
HMS 2513 0 0 0 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 0 
HMS 2580 0 0 0 0 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 0 
HCU 2398 0 1 0 0 0 0 0 0 
HCU 2613 0 0 0 0 0 0 0 0 
HCU 2617 0 1 0 0 0 0 0 0 
HCU 2633 1 0 0 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 
HCU 2654 0 0 0 0 0 0 0 0 
HCU 2663 0 0 0 0 0 0 0 1 
HCU 2671 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 0 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 1 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 0 
HCU 2886 1 0 0 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 0 
HSJ 029 0 0 0 0 0 0 0 0 
HSJ 067 0 0 0 0 0 0 0 0 
NHN5 0 0 0 0 0 0 0 0 
HM77 0 0 0 0 0 0 0 0 
HM764 0 1 0 0 0 0 1 0 
HM903 0 0 0 0 0 0 0 0 
N4 0 0 0 0 0 0 0 0 
W4 0 1 0 0 0 0 1 0 
990172 0 0 0 0 0 0 0 0 
CAM22 0 1 0 0 0 0 0 0 
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Name of the 
strain 3549176 3549199 3550960 3550962 3550996 3551030 3551139 3551220 
a H37Rv 0 0 0 0 0 0 0 0 
HMS 1301 0 0 0 0 0 0 0 0 
HMS 1356 0 1 0 0 0 0 0 0 
HMS 1470 0 1 0 0 0 0 0 0 
HMS 1480 0 1 0 0 0 0 0 0 
HMS 1834 0 0 0 0 0 0 0 0 
HMS 2103 0 0 0 0 0 0 0 0 
HMS 2193 0 0 0 0 0 0 1 0 
HMS 2200 0 0 0 0 0 0 0 0 
HMS 2206 0 0 0 1 0 0 0 0 
HMS 2208 0 0 0 0 0 0 0 0 
HMS 2224 0 0 0 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 
HMS 2258 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 
HMS 2271 0 0 0 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 
HMS 2281 0 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 1 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 0 0 1 
HMS 2394 0 0 0 0 0 0 0 0 
HMS 2400 0 0 0 0 0 0 0 0 
HMS 2405 0 0 0 0 0 0 0 0 
HMS 2414 0 0 0 0 0 0 0 0 
HMS 2513 0 0 0 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 0 
HMS 2580 0 1 0 0 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 0 
HCU 2398 0 1 0 0 0 0 0 0 
HCU 2613 0 0 0 0 0 0 0 0 
HCU 2617 0 1 1 0 0 0 0 0 
HCU 2633 0 0 0 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 
HCU 2654 1 0 0 0 0 0 0 0 
HCU 2663 0 0 0 0 0 0 0 0 
HCU 2671 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 0 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 0 
HCU 2886 0 0 0 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 1 0 0 
HSJ 029 0 0 0 0 0 0 0 0 
HSJ 067 0 1 0 0 0 0 0 0 
NHN5 0 0 0 0 0 0 0 0 
HM77 0 1 0 0 0 0 0 0 
HM764 0 1 0 0 0 0 0 0 
HM903 0 0 0 0 0 0 0 0 
N4 0 0 0 0 0 0 0 0 
W4 0 1 0 0 0 0 0 0 
990172 0 0 0 0 0 0 0 0 
CAM22 0 1 0 0 0 0 0 0 
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Name of the 
strain 3551229 3551230 3551281 3552683 3552701 3552764 3554294 3559402 
a H37Rv 0 0 1 0 0 1 0 0 
HMS 1301 0 0 0 0 0 0 0 0 
HMS 1356 0 0 0 0 0 0 0 0 
HMS 1470 0 0 0 0 0 0 0 0 
HMS 1480 0 0 0 0 0 0 0 0 
HMS 1834 0 0 0 0 0 0 0 0 
HMS 2103 0 0 0 0 0 0 0 0 
HMS 2193 0 0 0 0 0 0 0 0 
HMS 2200 0 0 0 0 0 0 0 0 
HMS 2206 0 0 0 0 0 0 0 0 
HMS 2208 0 0 0 0 0 0 0 0 
HMS 2224 0 1 0 0 0 0 1 0 
HMS 2227 0 0 0 0 0 0 0 0 
HMS 2237 0 0 0 0 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 
HMS 2258 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 
HMS 2271 0 0 0 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 
HMS 2281 0 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 0 0 0 
HMS 2394 0 0 0 0 0 0 0 0 
HMS 2400 0 0 0 0 0 0 0 0 
HMS 2405 0 0 0 0 0 0 0 0 
HMS 2414 0 0 0 0 0 0 0 0 
HMS 2513 0 0 0 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 0 
HMS 2580 0 0 0 1 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 0 
HCU 2398 0 0 0 0 0 0 0 0 
HCU 2613 0 0 0 0 1 0 0 0 
HCU 2617 0 0 0 0 0 0 0 0 
HCU 2633 0 0 0 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 
HCU 2654 0 0 0 0 0 0 0 0 
HCU 2663 0 0 0 0 0 0 0 0 
HCU 2671 1 0 0 0 0 0 0 1 
HCU 2703 0 0 0 0 0 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 0 
HCU 2886 0 0 0 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 
HCU 2942 0 0 0 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 0 
HSJ 029 0 0 0 0 0 0 0 0 
HSJ 067 0 0 0 0 0 0 0 0 
NHN5 0 0 0 0 0 0 0 0 
HM77 0 0 0 0 0 0 0 0 
HM764 0 0 0 0 0 0 0 0 
HM903 0 0 0 0 0 0 0 0 
N4 0 0 0 0 0 0 0 0 
W4 0 0 0 0 0 0 0 0 
990172 0 0 0 0 0 0 0 0 
CAM22 0 0 0 0 0 0 0 0 
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Name of the 
strain 3555250 3555513 3555753 3709336 3709622 3710433 3711737 3795100 
a H37Rv 0 0 0 0 0 1 0 1 
HMS 1301 0 0 0 0 0 0 1 0 
HMS 1356 0 0 0 0 0 0 0 0 
HMS 1470 0 0 0 0 0 0 0 0 
HMS 1480 0 0 0 0 0 0 0 0 
HMS 1834 0 0 0 0 0 0 0 0 
HMS 2103 0 0 0 0 0 0 0 0 
HMS 2193 0 0 0 0 0 0 0 0 
HMS 2200 0 0 0 0 0 0 0 0 
HMS 2206 0 0 0 0 0 0 0 0 
HMS 2208 0 0 0 0 0 0 0 0 
HMS 2224 0 0 0 0 0 0 0 0 
HMS 2227 0 0 0 0 0 0 0 0 
HMS 2237 0 0 0 1 0 0 0 0 
HMS 2241 0 0 0 0 0 0 0 0 
HMS 2258 0 0 0 0 0 0 0 0 
HMS 2268 0 0 0 0 0 0 0 0 
HMS 2271 0 0 0 0 0 0 0 0 
HMS 2280 0 0 0 0 0 0 0 0 
HMS 2281 0 0 0 0 0 0 0 0 
HMS 2296 0 0 0 0 0 0 0 0 
HMS 2310 0 0 0 0 0 0 0 0 
HMS 2355 0 0 0 0 0 0 0 0 
HMS 2370 0 0 0 0 0 0 0 0 
HMS 2391 0 0 0 0 0 0 0 0 
HMS 2394 0 0 0 0 1 0 0 0 
HMS 2400 0 0 0 0 0 0 0 0 
HMS 2405 0 0 0 0 0 0 0 0 
HMS 2414 0 0 0 0 0 0 0 0 
HMS 2513 1 0 0 0 0 0 0 0 
HMS 2536 0 0 0 0 0 0 0 0 
HMS 2580 0 0 0 0 0 0 0 0 
HMS 2584 0 0 0 0 0 0 0 0 
HCU 2398 0 0 0 0 0 0 0 0 
HCU 2613 0 0 0 0 0 0 0 0 
HCU 2617 0 0 0 0 0 0 0 0 
HCU 2633 0 0 0 0 0 0 0 0 
HCU 2647 0 0 0 0 0 0 0 0 
HCU 2654 0 0 0 0 0 0 0 0 
HCU 2663 0 0 0 0 0 0 0 0 
HCU 2671 0 0 0 0 0 0 0 0 
HCU 2703 0 0 0 0 0 0 0 0 
HCU 2706 0 0 0 0 0 0 0 0 
HCU 2728 0 0 0 0 0 0 0 0 
HCU 2777 0 0 0 0 0 0 0 0 
HCU 2821 0 0 0 0 0 0 0 0 
HCU 2864 0 0 0 0 0 0 0 0 
HCU 2886 0 0 0 0 0 0 0 0 
HCU 2875 0 0 0 0 0 0 0 0 
HCU 2942 0 0 1 0 0 0 0 0 
HCU 3151 0 0 0 0 0 0 0 0 
HSJ 025 0 0 0 0 0 0 0 0 
HSJ 029 0 0 0 0 0 0 0 0 
HSJ 067 0 0 0 0 0 0 0 0 
NHN5 0 0 0 0 0 0 0 0 
HM77 0 0 0 0 0 0 0 0 
HM764 0 1 0 0 0 0 1 0 
HM903 0 0 0 0 0 0 0 0 
N4 0 0 0 0 0 0 0 0 
W4 0 0 0 0 0 0 0 0 
990172 0 0 0 0 0 0 0 0 
CAM22 0 0 0 0 0 0 0 0 
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Name of the 
strain 3796689 3797823 3844681 3844737 3890830 
a H37Rv 0 0 0 0 1 
HMS 1301 0 1 1 0 0 
HMS 1356 0 0 1 0 0 
HMS 1470 0 0 1 0 0 
HMS 1480 0 0 1 0 0 
HMS 1834 0 0 0 0 0 
HMS 2103 0 0 0 0 0 
HMS 2193 0 0 0 0 0 
HMS 2200 0 0 0 0 0 
HMS 2206 0 0 0 0 0 
HMS 2208 0 0 0 0 0 
HMS 2224 0 0 0 0 0 
HMS 2227 0 0 0 0 0 
HMS 2237 0 0 0 0 0 
HMS 2241 0 0 0 0 0 
HMS 2258 0 0 0 0 0 
HMS 2268 0 0 0 0 0 
HMS 2271 0 0 0 0 0 
HMS 2280 0 0 0 0 0 
HMS 2281 0 0 0 0 0 
HMS 2296 0 0 0 0 0 
HMS 2310 0 0 0 0 0 
HMS 2355 0 0 0 0 0 
HMS 2370 0 0 0 0 0 
HMS 2391 0 0 0 0 0 
HMS 2394 0 0 0 0 0 
HMS 2400 0 0 0 0 0 
HMS 2405 0 0 0 0 0 
HMS 2414 0 0 0 0 0 
HMS 2513 0 0 0 0 0 
HMS 2536 0 0 0 0 0 
HMS 2580 0 0 1 0 0 
HMS 2584 0 0 0 0 0 
HCU 2398 0 0 1 0 0 
HCU 2613 0 0 0 0 0 
HCU 2617 0 0 1 0 0 
HCU 2633 0 0 0 0 0 
HCU 2647 0 0 0 0 0 
HCU 2654 0 0 0 0 0 
HCU 2663 0 0 0 0 0 
HCU 2671 0 0 0 0 0 
HCU 2703 0 0 0 0 0 
HCU 2706 0 0 0 0 0 
HCU 2728 0 0 0 0 0 
HCU 2777 0 0 0 0 0 
HCU 2821 0 0 0 0 0 
HCU 2864 0 0 0 0 0 
HCU 2886 0 0 0 0 0 
HCU 2875 0 0 0 0 0 
HCU 2942 0 0 0 0 0 
HCU 3151 0 0 0 0 0 
HSJ 025 0 0 0 0 0 
HSJ 029 0 0 0 0 0 
HSJ 067 0 0 1 0 0 
NHN5 0 1 0 0 0 
HM77 0 1 1 0 0 
HM764 0 1 1 1 0 
HM903 0 1 1 0 0 
N4 0 1 0 0 0 
W4 1 1 1 0 0 
990172 0 0 0 0 0 
CAM22 0 1 1 0 0 
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s u m m a r y
The capacity of infection and the ability of Mycobacterium tuberculosis strains belonging to the Beijing
family to spread rapidly probably result from genetic advantages and unidentified mechanisms of
virulence not yet thoroughly investigated. Among the mechanisms proposed to be responsible for the
varying virulence phenotypes ofM. tuberculosis strains we find IS6110 insertions, genetic reorganizations
and deletions, which have strong influences on fitness.
Beijing family is one of the lineages with the highest number of copies of IS6110. By studying genetic
markers characteristic for this lineage, here we have characterized the clinical isolate M. tuberculosis
GC1237 strain responsible for important epidemic outbreaks in the Gran Canary Island. We have iden-
tified and analyzed each point of insertion of IS6110 using a bacterial artificial chromosome (BAC) library
of this strain, in addition to the use of other approximations.
Nineteen copies of IS6110 have been localized in GC1237 genome of which, four copies of IS6110 can act
as a promoter and we have focused in the characterization of one copy located 31 bp upstream of the
essential gene Rv2179c and compared to the reference strain H37Rv.
 2010 Elsevier Ltd. All rights reserved.
1. Introduction
Strains of the Beijing genotype were first described in China and
neighboring countries in 1995.1 They are widespread in many
regions of the world and frequently cause epidemic outbreaks.
Different studies have indicated that one-third of global tubercu-
losis (TB) cases is caused by Beijing family strains assigning this
lineage to one of the most successful mycobacterial families in
terms of morbidity andmortality.2 The predominance of the Beijing
lineage probably results from genetic advantages, including
unidentified virulence factors and the modulation of specific host
responses not yet thoroughly investigated. There are some studies
that relate hypervirulence of W-Beijing strains with production of
phenolic glycolipid PGL,3,4 which is a putative virulence factor that
attenuates the host’s innate immune response and ability to control
infection.4 The pks15/1 locus, described to be polymorphic among
members of the Mycobacterium tuberculosis complex,5 is involved
in the biosynthesis of the glycolipid PGL and although it is char-
acteristic of Beijing strains to have an intact pks15/1, not all
members of this family are producers of PGL.5e7
Nowadays, Beijing strains are currently attracting considerable
worldwide attention because they display important pathogenic
features.8,9 These strains are often associated with multi-drug
resistance as the well-known case in New York in the 1990s caused
by the W strain.10e12 The clinical isolate M. tuberculosis GC1237
which belongs to the Beijing family has been responsible for
epidemic outbreaks in the Gran Canary Island since its first intro-
duction in the community in 1993.13 Nowadays, this strain continues
being predominant in the area due to its rapid and successful
dissemination within the community. The increased capacity of
infection and the high success rate of the Beijing family to spread
rapidly could be a consequence of genetic advantages and uniden-
tified mechanisms of virulence not yet thoroughly investigated.
* Corresponding author. Departamento de Microbiología, Medicina Preventiva y
Salud Pública, Facultad de Medicina, Universidad de Zaragoza, C/Domingo Miral sn,
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IS6110 insertions, genetic reorganizations and deletions are some of
the mechanisms proposed to be responsible for differences in the
virulence phenotypes ofM. tuberculosis.
It has been demonstrated that IS6110 may increase the expres-
sion of neighboring virulence genes by generating new promoter
sequences capable of driving their expression.14,15 IS6110 can upre-
gulate downstreamgenes through anoutward-directedpromoter in
its 30 end. This activity has been demonstrated for upregulation of
the two-component system PhoP/PhoR.15 Promoter activity was
orientation dependent and was localized within 110-bp fragment
adjacent to the right terminal inverted repeat.14 The fact that the
Beijing lineage contains a larger number of IS6110 copies than other
lineages16 could be related with the special characteristics of this
family in terms of virulence and capacity for rapid dissemination.
In this studywehave classified theM. tuberculosisGC1237within
the Beijing family.6,17 We also identified the locations of IS6110
insertions in this strain and compared them to the IS6110 insertions
in two Beijing strains, 210 and W.18 We studied the orientation and
distance toneighboring genes of each copy focusingour study in one
copy of IS6110 that is acting as a promoter located 31 bp upstream
the hypothetical essential gene Rv2179c.
2. Material and methods
2.1. Bacterial strains, culture media, and growth conditions
The clinical isolate M. tuberculosis GC1237 and the reference
M. tuberculosis H37Rv strains were used. Mycobacterial strains were
grown in Middlebrook 7H9 broth supplemented with albumin-
dextrose-catalase and 0.05% Tween 80 or in Middlebrook 7H10
mediumBacto agar supplementedwitholeic acid-albumin-dextrose-
catalase (Difco Laboratories, Detroit, Mich.) and 0.05% Tween 80.19
Liquid cultures were grown to logarithmic phase to be used for
macrophage infection in vitro and for mycobacterial RNA extraction.
Escherichia coli DH10B cultures were grown in Lurina-Bertani (LB)
medium supplemented with chloramphenicol (12.5 mg/ml) in order
to isolate the BACs. All of the strainswere grown at 37 C pBeloBAC11
plasmid was used for the construction of the BAC library of
M. tuberculosisGC1237. pFPV27-int, derived frompFPV27,20was used
for the construction of the GFP strains.
2.2. Cell culture and infections
MH-S murine alveolar macrophages were obtained from HPA
culture collections. Cells were grown in Dulbecco’s modified Eagle
medium (DMEM) supplemented with 10% fetal bovine serum (FBS)
and 4 mM L-glutamine. Infections were performed during 4 h at
a multiplicity of infection (MOI) of 10 bacteria per cell. After incu-
bating with bacteria, cells were washed three times with PBS, and
cultured in complete medium during the time indicated for each
experiment.
2.3. Isolation of genomic DNA
Genomic DNA of mycobacterial strains was isolated using the
CTAB method as previously described by van Soolingen et al.21
2.4. Construction and characterization of BAC library of M.
tuberculosis GC1237 strain
The construction of BACs was carried out as previously
described by Brosch et al.22 Briefly, the M. tuberculosis GC1237
library was constructed by ligation of partially digested HindIII
fragments (50e125 Kb) into pBeloBAC11 plasmid. From almost
10,000 clones obtained 2000 were placed into 96-well plates and
stored at 80 C. Plasmid preparations of recombinant clones for
sequencing reactions were prepared in 96-well plates containing
an overnight culture in 250 ml of 2X yeast-tryptone medium with
12.5 mg/ml of chloramphenicol.
BAC DNA extraction was done as previously described by Birn-
boim et al.23 with minor modifications. Briefly, 100 ml of BAC-
transformed E. coli was prepared in LB medium containing 12.5
mg/ml chloramphenicol, and the cultures were grown overnight at
37 C with vigorous and continuous agitation. Then, the bacterial
cells were collected by centrifugation. The bacterial pellet was
softly resuspended in a solution of 5 ml of 50 mM glucose 10 mM
EDTA, 25mMTris pH 8, 200mg lysozimewas added to the tube and
a solution of 4 ml of ice-cold NaAc pH 4.8 was added to the mixture.
The tube was placed on ice and the precipitated debris was
removed by centrifugation. Then, 14 ml of chloroform/isoamilic
alcohol (24/1) were added to the supernatant and after centrifu-
gation the aqueous phase was transferred to a newmicrofuge tube.
DNA of the BACs was precipitated adding isopropanol and finally
obtained by centrifugation.
End-sequencing reactions were performed with Taq DyeDeoxy
Terminator cycle sequencing kit (Applied Biosystems) by using
a mixture of 13 ml of BAC DNA solution, 2 ml of primer SP6-BAC1 or
T7-BAC1 (supplementary material), 2.5 ml of Big Dye, and 2.5 ml of
a 5X buffer (50 mM MgCl2, 50 mM Tris). Thermal cycling was per-
formed on a thermocycler (MJ Research Inc.) with an initial dena-
turation stepof 60 s at 95 C, followedby26cyclesof 15 s at 96 C,15 s
at 56 C, and 4 min at 60 C. DNAwas precipitated with 70 ml of 70%
ethanol, centrifuged, rinsed with 70% ethanol, dried and resus-
pended in 2 ml of formamide-EDTA buffer. The sequencing was
performed on a model 373A automatic DNA sequencer (Applied
Biosistems) for 12e16 h. Sequence data were transferred to Digital
workstations and edited with TED software from the Staden
package.24 Edited sequences were compared using BLAST programs
to theM. tuberculosis H37Rv sequence database.
2.5. Identificationof genomicdeletions andanalysis of pks15/1 region
The study of the genomic deletions of the regions of difference
RD105, RD142, RD150, RD181 and RD207 inM. tuberculosis GC1237
strain, which identify and phylogenetically sub-classify the Beij-
ing lineage, was performed by PCR. Other genomic deletions
(RD108, RD110a, RD127, RD129, RD139BW, RD149, RD152, RD165,
RD166 and RD182a) also were analyzed. The primers used in these
amplifications were as described elsewhere.6 The PCR was carried
out in a total volume of 50 ml, containing 0.5 mg of DNA, 5 ml of
10x PCR buffer, 200 mM dNTPs, 12.5 pmol of each primer and 1 U
Taq Gold polymerase (Roche). Before the amplification, the
template was initially denatured by incubation at 94 C for 9 min
then the amplification was performed for 35 cycles of 94 C for
30 s, corresponding annealing temperature for 30 s, and 72 C for
1e2 min depending on the amplified product. After the last cycle,
the samples were incubated at 72 C for 10 min. The RD deletions
were confirmed by DNA sequencing using H37Rv as reference
genome.
The pks15/1 polymorphism in this strain was determined by
PCR and sequencing as previously described in Ref.6
2.6. Location of the copies of IS6110 insertion sequence
The study of the presence of IS6110 insertion sequence in
GC1237 BACs library was carried out by PCR as previously described
in this study with the specific primers of this sequence, Gab 1 and
Gab 2 (supplementary material).
We used Ligation-mediated PCR (LMPCR) to locate the copies of
IS6110 in GC1237 strain as described by Prod’hom et al.25 This
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technique amplifies both ends of each copy of IS6110. Briefly,
genomic DNA and BACs were digested with SalI or with SmaI and
ligated to a linker containing a SalI restriction site or a SmaI restric-
tion site. The resulting template was then digested by SalI or with
SmaI. PCR was performed using ISA1 and ISA3, specific primers for
IS6110 directed outwards26 and the common linker primer Salgd
(supplementary material). PCR products were purified using GFX
PCR DNA gel band purification kit (Amersham Pharmacia Biotech)
and the restriction enzyme ExoSAP-IT (Affymetrix).
The amplified products were sequenced with the corresponding
oligonucleotides and when a match was found for a flanking region
in the databases, additional primers were designed to verify the
point of insertion (supplementary material). PCR amplification was
carried out as previously described in this study. PCR products
included the complete sequence of IS6110 and approximately
100e200 bp of both flanking sequences.
Each amplified PCR product was sequenced using CNIO service
and analyzed for homology with Tuberculist (http://genolist.
pasteur.fr/TubercuList), Bovilist (http://genolist.pasteur.fr/BoviList)
and NCBI (http://www.ncbi.nlm.nih.gov/) database Blast analysis.
In addition, we designed primers (supplementary material) to
amplify the different regions that might include IS6110 based in
genome known locations of IS6110 in 210 and W-Beijing strains.18
2.7. Construction of FPV79c and FPVIS79c strains
To construct pFPV79cplasmid, primersRv2179c-Eco andRv2179c-
Kpn were used to amplify a 670 bp fragment from H37Rv strain.
To construct pFPVIS79c plasmid, primers ISA4-Eco and Rv2179c-
Kpnwere used to amplify a 210 bp segment from GC1237 strain. The
PCR products were inserted in pFPV27-int that had been cut with
EcoRI and KpnI enzimes. To verify the constructions, pFPV79c and
pFPVIS79c plasmidswere sequencedwith the corresponding primers
(supplementary material).
The two newplasmidswere electroporated into H37Rv to obtain
FPV79c and FPVIS79c strains.
2.8. Analysis of GFP expression
To study the expression of the GFP protein in FPV79c and
FPVIS79c strains, the fluorescence was measured by fluorometric
method (SynergyHT, BioTek) during the bacterial growth and
normalized with OD600. Fluorescence median intensity (FMI) of the
different GFP expressing strains was measured by FACS.
To compare GFP expression under intracellular conditions, MH-S
cellswere infectedwithdifferentGFP expressing strains; H37Rvwas
used as reference. Infections were carried out in 24-well plates,
where cells were seeded at 105 cells per well. Cells were collected at
0, 24, 48 and 72 h post-infection and they were analyzed by FACS.
Previously, cellswere labeledwith annexinV to discern between live
and dead cells. Briefly, after washing collected cells once with
AnnexinV binding buffer (ABB) (BD Biosciences), they were incu-
bated for 15 min at room temperature with annexinV APC-conju-
gated diluted in ABB, and then fixed with paraformaldehide 4% in
calcium-containing buffer. The cytometer used in this work was
a FACSaria (BDBiosciences) and the analysiswas performedwith the
software Weasel.
2.9. Isolation of RNA from mycobacteria
2.9.1. Extracellular conditions
M. tuberculosis strainsweregrownat37 Cuntil thedesiredOD600
under aerobic conditions. The RNA from bacterial pellet was stabi-
lized using the RNAprotect Bacteria Reagent (QIAGEN) following
manufacturer’s recommendations. Cells were resuspended in 1 ml
acid phenol:chloroform (5:1) and 0.4 ml lysis buffer (0.5% SDS,
20 mMNaAc, 0.1 mM EDTA) and transferred to 2 ml Lysing Matrix B
screw-cap tubes containing 0.1 mm silica spheres (Q-BIOgene). Cells
were disrupted by three 30 s pulses in a FastPrep homogenizer
(Q-BIOgene). After centrifugation, RNA from the supernatant was
further extracted with 0.9 ml chloroform:isoamyl alcohol (24:1).
Total RNAwas precipitatedwithNaAc/isopropanol andwashedwith
70% ethanol. RNA pellet was treated with RNase-free DNase
(Ambion), and theDNA free RNAwas then further purified using and
RNeasy kit (Qiagen). DNA contamination was ruled out by lack of
amplification products after 35 cycles of PCR and the integrity of
the RNA from the different strains were checked by gel electropho-
resis on a 1% agarose gel. Purified RNA was kept at 80 C until
further use.
2.9.2. Intracellular conditions
Intracellular mycobacteria RNA extraction was performed with
a modified protocol based on the one described by Fontan et al.27
Briefly, 12.106 MH-S cells per flask were seeded in 150 cm2 flasks.
An appropriate volume of liquid mycobacteria culture was sus-
pended in complete medium and added to each flask containing
cells. After incubation, cells were washed with phosphate buffered
saline (PBS) to remove extracellular bacteria, and cultured in
complete medium for 0 and 48 h post-infection, when they were
treated to extract intracellular mycobacteria. With this aim, cells
were lysed and homogeneized during 5 min adding 10 ml per flask
of GTC buffer (25 mM sodium citrate, 4 M guanidine thiocyanate,
0.5% N-lauryl sarcosine, 0.125 M 2-mercaptoethanol and 0.5%
Tween 80, pH 7.0). Next, samples were collected in 15-ml centrifuge
tubes and centrifuged for 1 h at 4000 rpm. Bacterial pellets were
washed with GTC buffer and centrifuged again for 1 h at 4000 rpm.
After that, dry bacterial pellets were treated as described above to
extract mycobacterial RNA.
2.10. RT-PCR
Reverse transcription-PCR (RT-PCR) was carried out in two
steps. RT was carried out with Expand Reverse Transcriptase
(Roche) using 1 mg RNA as the template and the appropriate reverse
primer. Reaction mixtures were incubated at 42 C for 90 min. RT
products were the subjected to PCR amplification, using Taq Gold
polymerase (Roche) as we previously described with the appro-
priate primers. Samples were analyzed by electrophoresis on a 1%
agarose gel.
2.11. qRT-PCR
cDNA libraries from M. tuberculosis H37Rv and GC1237 strains
were constructed as follows. One mm of RNA was mixed with
25 pmol of random hexanucleotides primers (Sigma) and 50 units
of Expand Reverse Trancriptase (Roche) in a final volume of 20 ml.
Reaction mixtures were incubated at 65 C for 10 min and then at
42 C for 90 min. Expression of Rv2179c was measured and
normalized with respect to the levels of rrnaP1 mRNA by quanti-
tative real-time PCR (qRT-PCR). qRT-PCR was carried out in a Ste-
pOne Plus (Applied Biosystems) instrument, using the cDNA
generated by RT from 25 ng of RNA as a template, 1X Power SYBER
green PCR master mix (Applied Biosystems), and the appropriated
primers (supplementary material), each at a concentration of
250 nM. The PCR program involved an initial denaturation step for
10 min at 95 C, followed by 40 cycles at 95 C for 15 s and 60 C for
1min. The specificity of the PCR products was confirmed by the loss
of fluorescence at a single temperature, when the double-stranded
DNA melted to single-stranded DNA.
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3. Results
3.1. Analysis and representativity of the pBeloBAC11 library of M.
tuberculosis GC1237 strain
We have constructed a BAC library of GC1237 strain. To char-
acterize the BAC clones, we systematically subjected them to end-
sequencing reactions. The sequence of the clones provided us the
exact BAC positions on the physical map of the reference chromo-
some H37Rv. A total of 59 BACs named A1e12 to H1e12 were selected
covering different regions of the genome of GC1237. These BACs
represented around 75% of the chromosome of the studied strain
(Figure 1A).
3.2. Characterization of GC1237 strain: study of RD and pks15/1
region and analysis of extra regions
We studied the regions RD105, RD207, RD181, RD150 and RD142
in order to classify GC1237 strain within one of the four subgroups
of the Beijing family.6 The results indicated that GC1237 has deleted
RD181 and RD105, a robust marker for strains pertaining to the
Beijing family, and RD207 concerning the Direct Repeat Locus. The
findings regarding these deletions indicate that the studied strain
belongs to subgroup four of the seven groups of M. tuberculosis
described by Kong et al.28 We further found the deletions of RD149
and RD152, associated with mobile genetic elements such as
IS61106 (Figure 1B). GC1237 presents a copy of IS6110 in place of
RD152. Finally, the studied strain presented intact regions in the
rest of the analyzed regions including RD110a, RD127, RD129,
RD139BW, RD165, RD166 and RD182a.
We observed two extra regions in GC1237 absent in H37Rv.
Whenwe compared the findings in Bovilist database, we found that
the extra regions corresponded toMb3356-Mb3359c andMb2047c-
Mb2048c. A copy of IS6110 was detected between the genes corre-
sponding to Mb2047c-Mb2048c (Figure 1B).
The study of pks15/1 region revealed an intact gene in GC1237
(data not shown) indicating that this strain could retain the ability
to produce functional glycolipid PGL in contrast to the reference
strain H37Rv.
3.3. Different strategies to localize all copies of IS6110 insertion
sequence in GC1237 strain
We localized 19 different copies of IS6110 in GC1237 applying
two main strategies: LMPCR technique with BAC library and
genomic DNA of the studied strain and PCR with designed primers
based on the known points of the insertion sequence in the two
reference Beijing strains 210 and W.18 The presence of IS6110 in the
representative GC1237 BAC library was detected using PCRwith the
specific oligonucleotides Gab 1 and Gab 2 and ten of total of 59
BACs were positive for IS6110 (data not shown). Using LMPCR the
ten different copies were localized in GC1237 and this technique
was further utilized with genomic DNA to detect the rest of the
copies present in GC1237 by amplifying one or both ends of each
copy of IS6110 and its flanking sequences. As a second strategy,
based on genome known locations of IS6110 in 210 andW strains,18
we designed primers to amplify the different regions that might
include IS6110 in the studied strain. This design was realized using
M. tuberculosis H37Rv as genome reference. As a result of the two
different strategies followed in this study we determined the exact
location of the 19 copies of IS6110 in GC1237 strain (Table 1).
The three Beijing strains share nine IS6110 positions, these
include the two insertions characteristic of the Beijing family,
between dnaA:dnaN, and in the Direct Repeat Locus (Figure 1C).
GC1237 strain contains eight copies of IS6110 in intergenic regions
and eleven in intragenic regions (Table 1). Of the eleven interrup-
ted genes, pip, ctpD, idsB and Rv2180c are involved in bacterial
metabolism and respiration, four correspond to genes with no
predicted function and three are members of the PE and PPE family.
We investigated the location of IS6110 within Rv2180c in other
M. tuberculosis strains including other Beijing strains (data not
shown) and this point of insertion is unique to GC1237 strain.
Two IS6110 within the PPE34 were consecutive and in the same
orientation but the second one lacks 60 bp at the 50 end. One of the
Figure 1. Circular plot of GC1237 genome prepared with DNAplotter. Graphic repre-
sentation of M. tuberculosis GC1237 genome. (A) BACs regions. (B) Genomic regions
absent in M. tuberculosis H37Rv (RvDs), lacking regions of difference (RD) and extra
regions in GC1237 strain. (C) Location of IS6110 in different Beijing strains GC1237, 210
and W. The DR locus and dnaA:dnaN region are marked.
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intergenic copies in GC1237, localized between PPE39 and PPE40
genes, is also present in H37Rv but the region is longer in the
studied strain. Within the two ipl regions two copies of IS6110were
located: one between Rv0794c and Rv0797, which is in the opposite
orientation in H37Rv and other studied Beijing strains (data no
shown), and the second onewas located between Rv3324A:Rv3327
in the same orientation as reference H37Rv.
The NTF region of GC1237 does not contain any copies of IS6110
which is an indication of being an ancestral strain different to 210
and W.29,30
3.4. Analysis of direct repeats of each copy of IS6110 in GC1237
genome
We analyzed the flanking regions of each of the nineteen copies
of IS6110 in GC1237 genome and detected the presence of direct
repeats (DR) of 3e4 nucleotides at the extremities of sixteen IS6110
sequences as result of IS6110 transposition (Table 2). The other three
copies analyzed were not flanked by DRs. Genomic reorganization
was observed in two of these locations (RD152 and RD207), and this
is probably a consequence of recombination between two adjacent
copies of IS6110.6 The last of the three IS6110 elements without DR,
which was localized between Rv0794c:Rv0797 was in the opposite
orientation with respect to the IS6110 in the reference genome
H37Rv. The IS6110 in H37Rv contains DR and the lack of DR in the
studied IS6110 could be explained by reorganization in this region in
GC1237 genome. The two copies localized in PPE34 are flanked by
the direct repeat sequence TTA. These DRs were located in the 50
end of the first IS6110 and the 30 end of the second one, probably due
to simultaneous transposition of the two copies. The DR sequen-
ces differ among each other indicating the lack of transposition
specificity.
3.5. Study of the orientation and distance of IS6110 to the
neighboring genes
Different studies have indicated that IS6110 could upregulate the
expression of downstream genes. Previous studies have shown that
when IS6110 is inserted in the same orientation as, and close
enough to, a downstream gene, IS6110 could potentially function as
a promoter.14 We analyzed the orientation of each copy of the
IS6110 insertion sequence in GC1237 strain and the distance to the
close gene in order to test the promoter function of IS6110 and we
observed that IS6110 could act as a mobile promoter in four loca-
tions (Table 1). One of them is located 297 bp upstream of the
Rv1468c gene, another 138 bp upstream of PE27A gene, the third
one 41 bp upstream Rv3427c gene and the last one is located 31 bp
upstream of the essential gene Rv2179c. We focused our study in
the last one as this location is specific for GC1237 and the distance
to the downstream gene is the shortest.
3.6. Detection of a transcript from IS6110 to aroG in GC1237 strain
and from Rv2180c to aroG in H37Rv strain
To determine if a transcript extended from IS6110 or Rv2180c
into downstream genes Rv2179c and aroG, we extracted RNA from
broth cultures of GC1237 and H37Rv strains and RT-PCR was per-
formed using the corresponding oligonucleotides as previously
described in this work. We obtained amplification products from
Rv2180c to aroG in H37Rv (Figure 2A and C). These results indicate
that the three genes are cotranscribed in an operon. In the case of
GC1237, amplification products were obtained from 30 end of IS6110
to aroG suggesting that the 30 end of IS6110, Rv2179c and aroG
genes are cotranscribed (Figure 2B and D). All the RT-PCR products
were sequenced and the Blast results verified their specificity. Our
results indicated that the three genes are cotranscribed in an
Table 1
Insertion sites of IS6110 in M. tuberculosis GC1237, 210 and W.
GENESa GC1237 210d Wd
GC1237
genomeb
BAC
regionc
Rv0001(dnaA):Rv0002(dnaN) þ e þ þ
Rv0794c:Rv0797 (IS1547) þ B4
Rv0840c (pip) þ e
Rv1135c B11 þ þ
Rv1371 þ C7 þ þ
*Rv1469 (ctpD) þ C10 þ þ
Rv1754c D4 þ þ
Rv1754c-Rv1765c (RD152) þ D4
Rv1798:Rv1799 (lppT) D6 þ
Rv1917c (PPE34) D9 þ þ
Rv1917c (PPE34) þþ D9
Rv2016 þ D12 þ þ
MT2080 (Mb2047c):MT2081 (Mb2048c) þ D12
Rv2077A:Rv2078 þ E1
Rv2104c:Rv2107 (PE22) E1 þ
Rv2104c:Rv2107 (PE22) E1 þ
Rv2107 (PE22):Rv2108 (PPE36) E1 þ
*Rv2180c þ e
Rv2286c þ E7
Rv2352c (PPE38) E8 þ þ
Rv2353c (PPE39):Rv2356c (PPE40) þ E8
Rv2813-Rv2820c (RD207) þ e þ þ
*Rv3018A (PE27A):Rv3019c (esxR) þ e þ þ
Rv3019c (esxR):Rv3020c (esxS) e þ þ
Rv3128c G1 þ þ
Rv3128c:Rv3129 G1 þ
Rv3178:Rv3179 e þ
Rv3179:Rv3180c e þ þ
Rv3184:Rv3187 e þ þ
Rv3324A:Rv3327 (IS1547) þ e þ þ
Rv3383c (idsB) þ G7 þ þ
*Rv3427c (IS1532):Rv3428c (IS1532) þ G8 þ þ
*Candidate locations to act as a promoter.
a Gene names come from the M. tuberculosis H37Rv genome map. One gene is
listed when the location of insertion is in that gene and two genes are listed when
the insertion of IS6110 is between both.
b Sites are in order of appearance on the M. tuberculosis H37Rv genome map.
c Name of BAC.
d The plus sign indicates that the M. tuberculosis 210 and W contain a copy of
IS6110 in those regions.18
Table 2
Direct repeats of IS6110 insertion sequence in GC1237 strain.
Genes of IS6110 in GC1237 genome Direct Repeat (DR)a
Rv0001 (dnaA):Rv0002 (dnaN) ATT
Rv0794c:Rv0797 
Rv0840c (pip) ACG
Rv1371 GAGG
Rv1469 (ctpD) CGT
Rv1754c-Rv1765c (RD152) 
Rv1917c (PPE34) TTA
Rv1917c (PPE34) TTA
Rv2016 AGG
MT2080 (Mb2047c):MT2081 (Mb2048c) GAA
Rv2077A:Rv2078 AGG
Rv2179c:Rv2180c AGC
Rv2286c ATC
Rv2353 (PPE39):Rv2356c (PPE40) CCG
Rv2813-Rv2820c (RD207) 
Rv3018A (PE27A):Rv3019c (esxR) GCC
Rv3324A:Rv3327 (IS1547) GGC
Rv3383c (idsB) ATC
Rv3427c (IS1532):Rv3428c (IS1532) CCCG
a The absence of Direct Repeat is indicated by minus.
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operon, but these results do not exclude the possibility of inde-
pendent promoters for each gene.
3.7. IS6110 is acting as a promoter of Rv2179c gene both under
extracellular and intracellular conditions
Toverify that IS6110 locatedupstreamRv2179c inGC1237genome
was functional as a promoter, we constructed the recombinant
plasmids pFPV79c and pFPVIS79c containing the promoterless gfp
gene preceded by the region upstreamRv2179c in H37Rv strain or in
GC1237 strain, respectively. They were transformed into H37Rv
obtaining FPV79c and FPVIS79c strains to compare GFP expression of
both constructions in the same genetic background. As control, we
used H37Rv transformed with pFPV27 which contains gfp gene
without promoter (FPV27 strain). GFP expressionwasmeasured both
by fluorometry and flow cytometry. Results of both techniques
showed that the fluorescence of FPVIS79c strain is about 5-fold
higher than theobserved inFPV79c strain (Figure3A).Moreover, data
obtained by fluorometry during the growth curve indicated that the
effect of IS6110 on the regulation of GFP in this casewas independent
of bacterial growth phase (Figure 3B). Therefore, this result suggests
that in GC1237, IS6110 is acting as a promoter of Rv2179c gene.
We decided to study the promoter activity of IS6110 upstream
Rv2179c under intracellular conditions. For that issue, we infected
murine immortalized alveolar macrophages (MH-S cell line) with
the different GFP expressing strains and infected cells FMI was
measured by FACS. Thus, to exclude non-infected cells, we also
infected with non-fluorescent H37Rv, considering their FMI as
negative fluorescence level (R1 in Figure 4A). On the other hand,
cells contained in the region with a higher fluorescence level were
established as the infected ones (R2 in Figure 4A). Moreover, data
were referred to annexinV-negative cells, in order to analyze only
live cells. As it is observed in Figure 4B cells infected with FPVIS79c
strain showed a clear increase of their FMI values regarding the
control at all times studied. These results are in agreement with the
obtained data under extracellular conditions. Furthermore, GFP
expression of FPVIS79c-infected cells tended to increase during the
experiment, being this risemore dramatic at 72 h. In contrast, in the
absence of IS6110 this event failed to happen (Figure 4B).
Figure 2. RT-PCR analysis of Rv2179c region from M. tuberculosis H37Rv and GC1237 strains. (A) Schematic diagram of Rv2179c region in H37Rv strain. (B) Schematic diagram of
Rv2179c region in GC1237 strain. In both diagrams, the primers used for RT-PCR (Table 1) and the sizes of the fragments obtained with each pair of primers are indicated. The
direction of transcription for Rv2179c is indicated by arrows. (C) RT-PCR analysis of this region in H37Rv. (D) RT-PCR analysis of this region in GC1237. In both RT-PCR the
combination of primers is indicated above each set of reaction. Each set of the three reaction consists of a positive control PCR assay with genomic DNA as the template (þ), an RT-
PCR (*), and a negative control assay without reverse transcriptase ().
Figure 3. GFP expression in FPV79c and FPVIS79c strains. (A) Fluorescence median
intensity (FMI) of FPV27, FPV79c and FPVIS79c strains was measured by flow cytom-
etry at logarithmic phase. (B) Time course the evolution of the fluorescence of FPV27,
FPV79c and FPVIS79c strains during the bacterial growth normalized with O.D600.
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3.8. Rv2179c gene expression is increased in GC1237 strain both in
broth and intracellular conditions
As it had been previously described that IS6110 can act as
a promoter of downstream genes inM. tuberculosis,14 we compared
the expression of Rv2179c gene in GC1237 and H37Rv strains. Thus,
both strains were cultured to mid-exponential growth phase and
RNAs were extracted to generate cDNAs. The expression of Rv2179c
was measured by qRT-PCR and normalized to rrnAP1 expression
levels. Results demonstrated that Rv2179c expression was about 6-
fold higher in GC1237 than in H37Rv (Figure 5A), which suggests
that IS6110 in this location is up-regulating gene expression.
To determine the effect of IS6110 on Rv2179c expression during
infection, bacterial RNA was obtained both from intracellular and
broth growth conditions. The results showed that Rv2179c expres-
sion rose dramatically in GC1237 infected macrophages, being 6
and 10-fold higher at 0 h and 48 h post-infection, respectively
(Figure 5B). On the contrary, lower increasewas observed in the case
of H37Rv, confirming that the presence of IS6110 correlated with
higher expression of Rv2179c in the studied strain both under
intracellular and extracellular conditions.
As part of the three genes forming an operon we analyzed the
expression of aroG by qRT-PCR, but we could not observed signif-
icant increment of this gene (data no shown). This result does not
exclude the possibility of another regulation of aroG.
4. Discussion
The M. tuberculosis GC1237 strain has demonstrated an
enhanced capacity to spread and transmit within a community.
This strain belongs to one of the most virulent families, Beijing. The
capacity of infection and the ability of this family to spread rapidly
probably result from genetic advantages and unidentified mecha-
nisms of virulence not yet thoroughly investigated.
Several reports have strongly suggested that the severity and
clinical manifestations of TB depend on the immunogenicity and
pathogenicity of the infecting M. tuberculosis strain; these proper-
ties vary considerably among strains.31 The notion that some
M. tuberculosis lineages, such as the W-Beijing genotype, are more
virulent than others is supported by results obtained with animal
and cellular models. Studies in both show that among the Beijing
family strains there are hyper-virulent phenotypes that are asso-
ciated with relapse and treatment failure in humans and distinct
immune responses in animal models.32 Furthermore, different
studies have demonstrated that some W-Beijing strains can escape
the immunoprotective efficacy of the current TB vaccine and thus
act as “escape variants” of Mycobacterium bovis BCG vaccination.33
We decided to study most extensively the GC1237 strain
because it has been responsible for a high number of TB cases since
its introduction in the Gran Canary Island in 1990s.
Beijing strains are genetically homogeneous and conserved. They
share some genetic markers, such as similar spoligotypes1,29 char-
acterized by the deletions of spacers 1e34 in theDirect Repeat Locus
ofM. tuberculosis; a copy of IS6110 between dnaA:dnaN genes; and it
is frequent to find at least a copy of IS6110 in the NTF region in the
strains belonging to Beijing family34 and some members of this
familymayhave a second insertionwithin this locus.35However, the
absence of IS6110 in NTF locus is characteristic of ancestral sub-
lineages within the Beijing genotype.29 Due to the course of evolu-
tion, some strains (“modern” sublineages) have acquired the
insertion of IS6110 in this region.35 The clinical strain GC1237
presents an intact NTF locus indicating that GC1237 is an ancestral
Beijing strain.
Comparative whole-genome hybridization of Beijing strains
showed large sequencepolymorphisms (LSPs) also knownas regions
of difference (RD), which subdivide the Beijing family into at least
four phylogenetic subgroups, raising the possibility that there are
phenotypic differences within the Beijing family. The subdivisions
Figure 4. GFP expression in FPV79c and FPVIS79c strains in murine macrophages. (A) Histograms of H37Rv and FPVIS79c-infected cells. R1 indicates the non-fluorescent cells and
R2 represents the fluorescent cells. (B) Time course of FMI of cells gated in R2, infected with FPV79c and FPVIS79c strains. The percentage of increment was calculated with respect
to FMI values of FPV27 strain. Figure shows a representative experiment of three performed.
H. Alonso et al. / Tuberculosis xxx (2011) 1e10 7
Please cite this article in press as: Alonso H, et al., Deciphering the role of IS6110 in a highly transmissible Mycobacterium tuberculosis Beijing
strain, GC1237, Tuberculosis (2011), doi:10.1016/j.tube.2010.12.007
are made on the basis of RD105 and RD207, and the variable
appearance of RD181, RD150 and RD142 deletions.6 Some authors
haveproposedanevolutionarypathwayof theBeijing lineages based
on the RD deletions and on the IS6110 insertions in the NTF region
indicating that ancient strains have neither deletion of RD181 nor
insertion of IS6110 in NTF region.36 However, our results are in
disagreement with this classification because GC1237 presents
RD181 deleted but lacks IS6110 in NTF locus. A recent study supports
the view that genomic deletion of RD181 has occurred during the
evolutionary process from ancient tomodern strains proposing four
genetic sublineages. According to this view, GC1237 falls in the
genetic subgroup “ancient with deleted RD181”, being the ancient
subgroup the most predominant in Japan.37 When we analyzed the
RD152 in GC1237, we detected a copy of IS6110without flanking DR
confirming a recombination event of two previous copies of IS6110
resulting in the loss of this region. This finding is in agreement with
different studies indicating that strainswith a high number of IS6110
copies (>14) have lost genomic regionsmore often than strains with
only few copies,38 as is in the case of GC1237. RD149 has also been
associated with recombinations between mobile genetic elements6
but IS6110 is not implicated in the deletion of this region as we
show the absence of IS6110 in this region in GC1237. The two
phenomenons regarding RD152 and RD149 have been observed in
other Beijing strains studied in our laboratory. We also studied the
deletion of other RD observed in clinical strains belonging to Beijing
family from East Asia clade6; GC1237 has these RD intact. However,
we do not rule out the possibility of the presence of specific deleted
regions in GC1237. The high number of different combinations of
deleted RD that we can find in Beijing strains shows that although
the Beijing family is awell-defined group, there is genetic variability
among these strains.
Another feature of GC1237 is the presence of two extra regions,
Mb2047c-Mb2048c and Mb3356-Mb3357, with respect to H37Rv.
These regions, present in other sequenced strains ofM. tuberculosis
and M. bovis, do not correspond exactly to the described RvD1 and
RvD5, respectively. The two IS6110 localized in these regions suggest
possible implication in new genomic reorganizations with loss of
these regions. By studying the flanking regions of IS6110 compared
with H37Rv, we have detected as many new regions as loss of other
ones. These findings confirm the implication of IS6110 in genomic
reorganizations and its capacity to generate genomic plasticity.
The pks15/1 gene, which is implicated in M. tuberculosis viru-
lence4 is intact in GC1237 as well as the rest of the Beijing strains.
This strain presents a single point mutation in Rv2952 gene
implicated in the biosynthetic pathway of PGL as previously
described by Huet et al.39 In spite of this mutation the structural
variants of PGL have no major impact on virulence.
When a strain ofM. tuberculosis presents a high level of copies of
IS6110 insertion sequence the probability to localize all the copies by
LMPCR technique is low. This techniquewas useful to determine the
points of insertion of this sequence in M. bovis.40 However, the
number of copies of IS6110 inM. bovis is verymuchminor (1e5) than
the observed in M. tuberculosis. In this regard, the construction of
BAC libraryofGC1237 strainhas been a successful tool. Theuse of the
different molecular strategies has allowed us to localize all IS6110
copies inside the GC1237 genome. Except for some sequenced
strains, to our knowledge this is the first time to localize all IS6110
copies in a strain ofM. tuberculosis containing a high number of this
insertion sequence. Previous studies supported the idea that some
insertion sites were prevalent in the low-copy number strains and
suggested a separate evolutionary lineage for the low and the high-
copy number strains of M. tuberculosis.41 According to this, GC1237
does not have any copy of IS6110 inserted at the same genomic
position described for low-copyM. tuberculosis strains.
In sixteen of the nineteen copies, we observed DR of 3e4
nucleotides in the flanking regions. These DR indicate that the
presence of IS6110was due to transposition events and the absence
of DR in the other copies suggests rearrangements between IS6110
elements. There are very few studies where authors report DR
flanking IS6110.26,40 In these studies the number of copies is low
(<6) and all of themwereflanked byDR, indicating that these IS6110
are consequence of transposition. In our study, because of the high
number of copies of IS6110we observed some copies flanked by DR
and other copies without DR suggesting that the probability of
rearrangement process between copies rises when the number of
those increases producing more variability among strains.
Numerous studies indicate that IS6110 insertion sequence has
some preferential points of insertion (hot-spots) in the genome.
The IS1547 (ipl locus) is a site of intensive insertion of IS611042,43
and the studied strain corroborates this hot-spot with the inser-
tion of a copy of IS6110 in each ipl locus. On the other hand,
mapping of IS6110 insertion points in M. tuberculosis GC1237 has
shown that no consensus target sequence was detected in the
immediate vicinity of the nineteen analyzed copies. Obviously, the
DR flanking IS6110 also were different except for the sequence ATC
that was found in two cases. All these support the lack of trans-
position specificity for IS6110, according with other authors.44,45
The open reading frames represent 91% of M. tuberculosis
genome46 but in GC1237 the insertion of IS6110 into coding regions
occurred in 42% of the cases, suggesting that the transposition is
Figure 5. Quantification of Rv2179c in M. tuberculosis GC1237 and H37Rv by qRT-PCR.
(A) Relative quantification (RQ) of Rv2179c expression in GC1237 with respect to
H37Rv at logarithmic phase. (B) RQ of Rv2179c expression in intracellular conditions at
0 h and 48 h post-infection in GC1237 or H37Rv with respect to extracellular condi-
tions. In both cases, the expression of Rv2179c was normalized to the levels of rrnAP1
mRNA. Results are the means of three independent experiments; error bars indicate
the standard deviations of the means.
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relatively more frequent in intergenic regions. Our results agreed
with other studies that found that 58% of discrete IS6110 insertion
sites occurred within coding regions in M. tuberculosis47 and in
M. bovis strains.40 In this context, because of the insertion of IS6110
in possible promoter regions the probability of IS6110 influencing
the expression of the neighboring genes could be increased. It is
necessary to take into account that the locations of IS6110 observed
in the different genomes are the result of transposition events and
the natural selection of viable mycobacteria because when inser-
tion occurs in a necessary gene it could affect survival and we
cannot observe it. In case of the interruption of a non-essential
gene, the phenotype of the mycobacteria could be affected. It has
been demonstrated the potential for intra- and inter-genic IS6110
insertions to add plasticity toM. tuberculosis genome and influence
fitness of the mycobacterium.
With the exception of the copy of IS6110 located between dnaA
and dnaN genes, we have not found any copy of IS6110 in the
quarter of M. tuberculosis GC1237 circular genome surrounding
these genes (Figure 1C). Also, we observed the same in the two
Beijing strains 210 and W. This result is in agreement with other
authors when they have characterized IS6110 integration loci.47
This finding could indicate that in this part of the genome there
are no specific sequences or regions recognized by the sequence or
that these genes have an important role in M. tuberculosis and the
interruption or modulation of their expression could result in no
advantage for the bacteria.
The IS6110 insertion sequence varies in number and position
within the genome generating a high level of DNA polymorphism
among strains. It is known that the insertion of IS6110 can alter
bacterial gene expression. Depending on the location, IS6110 may
cause loss of gene activity or can also upregulate the expression of
downstream genes by acting as a mobile promoter. When IS6110 is
inserted in the same orientation as, and close enough to, a down-
stream gene it could potentially function as a promoter.14,15 Accord-
ing to these previous studies we analyzed the orientation and the
distance to the closest gene of each copy of IS6110 in GC1237 strain.
Thus, we obtained eight genes with an IS6110 inserted upstream, in
the right orientation and at a reasonable distance to work as
apromoter thesegenes.However,whenwecompared the expression
of these genes in GC1237 with reference to H37Rv strain, we only
founda clear increase in thecaseof the geneRv2179c,whose IS6110 is
located 31 bp upstream of it. To discern that Rv2179c upregulation
observed in GC1237 strain was really due to the presence of IS6110
andnot to the different genetic background,we constructedpFPV79c
andpFPVIS79c plasmids andwe transformed them intoH37Rv. Thus,
we observed thatGFP expressionwas clearly higherwhen IS6110was
located upstream as we observed in GC1237 strain, showing the
IS6110 promoter activity at this location. Moreover, we infected
macrophages with the GFP-expressing H37Rv strains explained
above, finding that GFP fluorescence from cells infected with
FPVIS79c strain was more likely to increase across the experiment,
confirming that IS6110 promoter activity results enforced inside host
cells. Furthermore, we also studied mRNA from GC1237 and H37Rv
strains both under intra and extracellular conditions, detecting in the
caseofGC1237adramatic increaseofRv2179cgeneexpressionunder
intracellular conditions regarding to broth ones. Curiously, although
far lower than in GC1237, Rv2179c gene was also upregulated in
H37Rv intracellular bacteria, which could indicate that this gene has
some role during infection process. A previous work showed a rein-
forcement of IS6110 promoter activity under intracellular condi-
tions.14 However, in that work authors studied the expression of
different genes and the presence or not of IS6110 upstream in two
different strains. Nevertheless, authors did not discern thepossibility
of a regulation due to the different genetic background of the strains
studied. Our results clearly show that the promoter activity of IS6110
onRV2179c is only related todispositionof the sequencewith respect
to this gene. We also quantified the Rv2179c expression in macro-
phages by qRT-PCR demonstrating that the expression of this gene in
GC1237 was about 6-fold higher than in extracellular conditions.
When we compared Rv2179c expression in both strains in broth
culture, we observed higher expression in GC1237 than in H37Rv.
These results confirmthepromoteractivityof IS6110 andsuggest that
this activity is upregulated inside macrophages.
On the other hand, the RT-PCR results indicated that in H37Rv
strain the Rv2180c, Rv2179c and Rv2178c (aroG) genes are cotran-
scribed. Differently, in GC1237 we could not detect the cotranscript
between Rv2180c and Rv2179c genes due to the insertion of IS6110
in Rv2180c, but we detected the cotranscript from the 30 end of
IS6110 to aroG indicating that this sequence acts as a new promoter
for the Rv2179c gene and also for aroG gene which is an essential
gene involved in biosynthesis of chorismate precursor of the three
aromatic amino acids in M. tuberculosis.48 There are no available
data about the function of the protein encoded by Rv2179c gene.
In fact, according to Tuberculist database, the product of this gene
is a conserved essential hypothical protein and it is conserved
in different mycobacterial strains.49 From our results we can
hypothesize that the over-expression of this gene could be advan-
tageous for GC1237 at least in certain environments such as
infecting macrophages but we do not rule out the possibility of not
having an effect. Providing that this insertion is unique in this strain
we do not discard its implication in specific fitness advantages
in GC1237 and on the other hand, this point of insertion can be
a useful tool in epidemiological studies because it allows us to
identify and differentiate this strain among Beijing strains.
In summary, this study facilitates the location of all the copies of
IS6110 in GC1237 which will enable the search of the common
locations of IS6110 in Beijing strains that would be characteristic of
this family. Knowledge on distribution of IS insertion sites in Beijing
strains sheds more light in evolutionary processes involving this
family. The location of all the copies will allow studying the
implication of each one in the different strain properties. Some of
the detected copies are interrupting genes, others are implicated in
recombination events and we have demonstrated that IS6110 is
acting as a promoter in Rv2179c.
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tuberculosis Beijing Strain of Sub-Saharan Origin
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The development of a rapid test to identifyMycobacterium tuberculosis Beijing isolates and specifically strain GC1237, coming
from a sub-Saharan country, is needed due to its alarming wide spread on Gran Canaria Island (Spain). A rapid test that detects
IS6110 present between dnaA and dnaN in the Beijing strains and in a specific site for GC1237 (Rv2180c) has been developed.
This test would be a useful tool in the surveillance of subsequent cases.
Beijing is a lineage of Mycobacterium tuberculosis that is dis-persed worldwide predominating throughout East Asia and
the former Soviet Union. This lineage may have a selective advan-
tage either with higher virulence or transmissibility that led to
clonal expansion. The prevalence of this family is low in Spain,
and its presence in the population has been associated with the
recent increase in the number of tuberculosis (TB) cases among
immigrants (5, 9, 11, 16).
The introduction of a Beijing strain, strain GC1237, in Gran
Canaria Island, Spain, by an African refugee (from Liberia), and
its explosive spread in this community (27.1% of TB cases) over
the next few years were reported in 2001 (6). Through review of
the literature, an identical restriction fragment length polymor-
phism (RFLP) pattern of strain GC1237 was found in four isolates
from Somalia, Ethiopia, Sierra Leone, and Liberia (6). Three Bei-
jing isolates sharing the RFLP genotype and MIRU-VNTR were
identified in Sweden frompatients fromEthiopia and Eritrea (12).
An M. tuberculosis Beijing strain responsible for an outbreak of
streptomycin-resistant TB in Benin that affected at least 17 pa-
tients shared an identical mycobacterial interspersed repetitive-
unit–variable-number tandem-repeat (MIRU-VNTR) pattern,
except for two loci that authors failed to amplify (1). All these
findings suggest that this clone originated in sub-Saharan Africa
and that it is being introduced in countries with a low incidence of
TB through immigration.
The purpose of this study was to develop a rapid diagnostic
method based on multiplex PCR to identify the Beijing isolates
and specifically the GC1237 genotype which could be applied in
the laboratories located in the country of origin. The test could
help in the subsequent prospective epidemiological studies to bet-
ter control of the cases.
In order to carry this out, all the isolates from 2007 to 2008
collected in the threemain hospitals of the Province of Las Palmas
(Gran Canaria Island) were genotyped at the University of Zara-
goza. One stored isolate of the original Beijing GC1237 strain was
used as a control of the different techniques. First, all 292 isolates
were screened by spoligotyping with a commercially available kit
(Ocimum Biosolutions Ltd., Hyderabad, India) by the method of
Kamerbeek et al. (14). Seventy of the 292 isolates belonged to the
Beijing family. Second, IS6110RFLPwas performed on the Beijing
isolates detected by spoligotyping, if enough DNA were available
(32 of the 70 isolates) according to the standardized protocol (19).
Twenty-nine isolates (90.6%) had RFLP patterns similar to the
pattern of GC1237, four of which presented an additional band.
The other 3 isolates showed a clearly different Beijing pattern.
Besides, genotyping based on 15-locus MIRU-VNTR for 3 dif-
ferent isolates of the GC1237 genotype was conducted as pre-
viously described (18). The three isolates showed the pattern
442333464465372 (MIRU-VNTR loci ordered according to their
position on theM. tuberculosis H37Rv genome).
Subsequently, a multiplex PCR detecting two different loca-
tions of IS6110 was designed for a rapid identification of isolates
related to the GC1237 genotype. The first target recognizes the
point of insertion of IS6110 between dnaA and dnaN, which is a
characteristic feature of all Beijing strains (15). To accomplish
this, primer dnaA3 (5=-GGGCGGTTCAATTGGCTGT), was de-
signed to anneal in the 3= end of IS6110 and the following se-
quence of the genome and used together with primer dnaA2
(5=-CCACCCACGACACCGCAT)which had been previously de-
scribed (10). The second target detected a specific IS6110 of strain
GC1237. This target was chosen among the 19 copies of IS6110
recently localized in the genome of GC1237 (3). Eleven of the
insertion sites were shared with 210 strains, 2 were located in the
variable PPE regions, which could present difficulties in the spec-
ificity of the PCR. The other 5 were in hot spots, detected in other
non-Beijing clinical isolates or its flanking region was not pre-
sented in the reference strain H37Rv. Finally, the copy inserted
into the Rv2180c gene was selected as the specific target for rapid
diagnosis. To detect this target, primers Rv2179c-fw (fw stands for
forward) (5=-CAATACGTGATCGCCGGGAC) and Rv2179c-rv
(rv stands for reverse) (5=-CGAATTCCGTGGATACTGCTAG)
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were designed (3). For this assay, a rapid DNA extraction was
made as previously described (2). As a result of themultiplex PCR,
two amplicons were expected for isolates with GC1237 genotypes
of 1,626 bp and 550 bp, respectively. Two 550-bp fragments and a
261-bp fragment were expected for other Beijing isolates. A non-
Beijing isolate was expected to produce only one fragment of 261
bp for the wild-type Rv2180c gene (Fig. 1).
To validate this technique, all 58 isolates of M. tuberculosis
from one of the hospitals reported between 2007 and 2008 were
tested. Nine isolates were found to belong to the Beijing lineage,
and eight of these isolates exhibited the GC1237 pattern. Subse-
quently, the IS6110 RFLP patterns of the Beijing isolates (9 iso-
lates) were compared. The other 49 isolates presented a non-
Beijing genotype. Of the isolates with a non-Beijing genotype, 8
isolates showed a high similarity to strain GC1237, and one had a
different pattern, validating the diagnostic test, which showed
100% specificity (Fig. 2).
Finally, the multiplex PCR was used to identify the GC1237
genotype among 66 Beijing isolates. All the isolates amplified the
specific target of Beijing family. Fifty-six presented the GC1237
genotype, and 10 presented a genotype of a different Beijing strain
(Table 1). We confirmed these results by comparison with RFLP
in 32 of the 66 isolates supporting the specificity of the test. A
group of 50 “non-Beijing” isolates of TB patients diagnosed in the
same period previously analyzed by spoligotyping were further
analyzed, and all presented a non-Beijing genotype.
Due to the high incidence of this strain in the population stud-
ied, a rapid diagnostic method to discriminate non-Beijing sub-
types from strain GC1237 would be useful for better control of TB
on Gran Canaria island. Considering that the RFLP, spoligotyp-
ing, and MIRU methods are difficult to implement in the clinical
setting, the describedmultiplex PCR could bring the possibility of
in situ identification of GC1237 genotype isolates.
Until now, the incidence of this strain was retrospectively
screened by spoligotyping in reference laboratories. This tech-
nique is a good method to detect those isolates of the Beijing
lineage; however, information about clonality in this group was
not provided. In addition, the spoligotypingmethod is better used
for the study of 40 isolates at a time (13). RFLP analysis based on
IS6110 gives us this information, but a larger amount of DNA is
required, it is time-consuming and technically demanding, and
the results among laboratories are difficult to compare (19). The
rapid proposed technique 24-locus MIRU-VNTR could be also a
tool for detecting this genotype, but it requires 24 single PCRs or 8
multiplex PCRs. Several PCR-based methods for the identifica-
tion of Beijing strains have also been developed targeting different
FIG 1 (A) Results of multiplex PCR visualized with agarose gel electrophoresis. Lane 1, molecular size markers (100-bp DNA ladder); lane 2, Beijing GC1237
genotype (1,626 bp and 550 bp); lane 3, a Beijing genotype different from strain GC1237 (550 bp and 261 bp); lane 4, strainH37Rv (261 bp); lane 5, negative PCR
control; lanes 6, 7, and 8, different clinical isolates of M. tuberculosis. (B and C) Schematic representations of the positions and orientations of the two IS6110
insertions used for the diagnostic test, the dnaA-dnaN region in the Beijing strains (B) and the Rv2180c region in strain GC1237 (C). The IS6110 element is
represented by the white arrow, with the arrowhead indicating the direction of transcription of the putative transposase. The primers are represented by the small
black arrows above the schematic representations.
FIG 2 Dendrogram showing the IS6110 RFLP fingerprints patterns of M.
tuberculosis Beijing isolates used to verify the multiplex PCR technique. Iso-
lates 1 to 8 shows high similarity to strain GC1237, and isolate 9 had a different
pattern.
TABLE 1 Results of the multiplex PCR (validating and applying the
method) for detection of the isolates with the GC1237 genotype
Purpose and method
No. of isolates with the following
genotype: Total no. of
isolates
tested by
method
Beijing
GC1237
Beijing
but not
GC1237
Not
Beijing
Validation
Spoligotyping 9a 9a 49 58
Multiplex PCR 8 1 49 58
RFLP 8 1 9
Test use
Spoligotyping 66a 66a 50 116
Multiplex PCR 56 10 50 116
a Because spoligotyping does not discriminate between the Beijing GC1237 genotype
and Beijing but not GC1237 genotype, these data correspond to the same isolates.
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MIRU loci, specific deletions, or single-nucleotide polymor-
phisms (SNPs). However, most of these methods for identifica-
tion are not specific, expensive, or difficult to perform (4, 7, 8, 17).
The results obtained in this work show that ourmultiplex PCR
has demonstrated the specificity to identify the GC1237 genotype
isolates. In contrast to spoligotyping and RFLP, this multiplex
PCR can be used to identify one or more positive isolates. It is a
quick, straightforward, and inexpensive technique. It can be com-
pleted in 1 day, and it does not require hybridization to a panel of
species-specific probes, as RFLP does. Moreover, sample prepara-
tion is simple (simple heating of the bacteria), and trained person-
nel can interpret the gels with minimal difficulty. In contrast to
24-locus MIRU-VNTR, a single reaction is needed. It can be used
by laboratories lacking a real-time PCRmachine and easily imple-
mented for a large-scale GC1237 strain screening. This designed
PCR would allow its use in the clinical setting and facilitate the
detection of new cases aiding a more detailed supervision of pa-
tients and discrimination from cases infected with other Beijing
genotypes.
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